<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.semanticweb.org/hx-jta/ontologies/thyroid_cancer_ontology"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     ontologyIRI="http://www.semanticweb.org/hx-jta/ontologies/thyroid_cancer_ontology">
    <Prefix name="" IRI="http://www.semanticweb.org/hx-jta/ontologies/thyroid_cancer_ontology"/>
    <Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/>
    <Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/>
    <Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/>
    <Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/>
    <Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/>
    <Declaration>
        <Class IRI="#A88F"/>
    </Declaration>
    <Declaration>
        <Class IRI="#AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA-A_Mutation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA-B_Mutation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA-C_Mutation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA-D_Mutation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA_Categorization_for_MTC"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATA_Reporting_system"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ATC_Complete_Resection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ablation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adjacent_Structure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adjuvant_I-131_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adrenal_Gland_Pheochromocytoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adverse_Effect"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adverse_Reaction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Age"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Age_at_First_Live_Birth"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Age_of_Menpause"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Alcohol"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Amlotinib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Amyloidosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anterior_Branches"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anti-TPO_Antibodies"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Arc-like"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Artery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Asphyxia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Atrial_fibrillation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Atypical_Mitoses"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Axitinib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#BRAF_Kinase_Inhibitors"/>
    </Declaration>
    <Declaration>
        <Class IRI="#BRAF_V600E"/>
    </Declaration>
    <Declaration>
        <Class IRI="#BTA_reporting_system"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Basic_Information_of_Patient"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Benign"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Berry-picking"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Beta-Catenin_Accumulation_Pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bilateral_Malignant_Neoplasm"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Biochemical_Incomplete_Response"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Biochemical_Pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Biochemical_remission"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Biphasic_Spindle_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bisphosphonate_or_Denosumab_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bizarre_Malignant_Giant_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Body_Mass_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bone-Directed_Agents"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bone_Marrow_Depression"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Brachial_Plexus_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Bystander_Effect"/>
    </Declaration>
    <Declaration>
        <Class IRI="#C-cell_Hyperplasia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#CD45"/>
    </Declaration>
    <Declaration>
        <Class IRI="#CDKN1B_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#CEA"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cabozantinib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Calcification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Calcitomin-secreting_Parafollicular_C_cells"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Calcitonin_Tests"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carboplatin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carcinoembryonic_antigen"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Care"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carotid_Sheaths"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cement_Injections"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Central_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chemotherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chromogranin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chylous_Fistula"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cisplatin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Classical_Papillary_Thyroid_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Clinical_Aspects"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Clinically_Evident_Metastasis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Coarse_Needle_Biopsy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Coast"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Colonic_Disturbances"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Columnar_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Complication"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Composition"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Computed_Tomography"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Convoluted_Nuclei"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cricoid_Cartilage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cryoballoon_Ablation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cushing_Syndrome"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cystic-solid_Mixing"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cystic_Neoplasm"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cytologic_Test"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#DICER1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dacarbazin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dehydration"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diabetes_Mellitus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diagnosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diagnostic_Imaging"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diarrhea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_Fluorine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_Intake"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_Selenium"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_iodine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Digestive_System_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Digestive_System_Fistula"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Digestive_Tract_Reaction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Distant_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Docetaxel"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dosage_of_131I"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Doxorubicin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Drug_abuse"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dual_Cancer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dysphagia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dyspnea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#E-Cadherin_Signaling_Pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Echogenicity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Education_Level"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Elastography"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Empiric_RAI_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Endocrine_Syndrome"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Endocrine_System_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Endoscopic_Procedure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Environment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Esophagus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ethanol_Ablation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Etiology"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Excellent_Response"/>
    </Declaration>
    <Declaration>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#External_Branches"/>
    </Declaration>
    <Declaration>
        <Class IRI="#External_beam_radiation_therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Extracapsular_Nodal_Extension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Extrathyroidal_Extension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#FNA-Tg"/>
    </Declaration>
    <Declaration>
        <Class IRI="#FNA-calcitonin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#FOXE1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Failure_to_Thrive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Family_Medical_History"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Fatigue"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Fine-Needle_Aspiration"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Fluorouracil"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Flushed_Face"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Follow-up"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Free_Thyroxine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Free_Triiodothyronine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Frozen_Section_Procedure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Functioning_Forearm_Autograft"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ganglioneuromatosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ganglioneuromatosis_of_the_Intestine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gastroenteritis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gender"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Giant_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gland_Size"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gravel-like"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gross_Tumor_Resection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#HABP2_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#HRAS_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Habits_and_Behavious"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hashimoto_Thyroiditis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Have_Noticed_New_Changes_in_Skin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Heart_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Heart_Failure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hemoptysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hemorrhage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hepatotoxicity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hereditary_Thyroid_Gland_Medullary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Heterogeneous_Echotexture"/>
    </Declaration>
    <Declaration>
        <Class IRI="#High_Molecular_Weight_Keratins"/>
    </Declaration>
    <Declaration>
        <Class IRI="#High_Risk"/>
    </Declaration>
    <Declaration>
        <Class IRI="#High_suspicion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Histology"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Homogeneity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Horner_Syndrome"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyoid_Bone"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperechoic"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypertension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperthyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypocalcemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypoechoic"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypoglossal_Nerve_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypoparathyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypopnea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypothyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#III_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#II_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#IV_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ileus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Increased_LT4_Dosage_Requirement"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Indeterminate"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Indeterminate_Response"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Infection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Inferior_Thyroid_Artery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Inferior_Thyroid_Vein"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Inflammatory_Infiltrate"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Initial_Risk_Stratification_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Insular_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Insular_carcinoma_of_the_thyroid"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intensity-Modulated_Radiation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intermediate_Risk"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intermediate_suspicion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Internal_Branches"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intestinal_Perforation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intratumoral_Fibrosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Investigation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Iobenguane_I-131"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Iodine_Deficiency"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Iodine_I_123_Iodobenzamide"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Iodine_excess"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ipsilateral_Neck_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Irradiation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ischemic_heart_disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Island-like"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Isoechoic"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Isoechoic_Spongiform_Isoechoic_Spongiform"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Jugular_Vein"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Larger_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Laryngeal_Exam"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Laryngoscopy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Laser_Ablation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Left_Thyroid_Gland_Lobe"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lenvatinib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Leukopenia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Levothyroxine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lifestyle"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lithium_in_131I_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Location"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Loss_of_Appetite"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Low_Risk"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Low_suspicion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lowest_Thyroid_Artery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Lymphadenectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#M0_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#M1_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MAPK_Signaling_Pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MEK_Inhibitor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MINPP1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MRI-Based_Angiogram"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MTC_Manifestation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MTOR_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MUTYH_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#MX_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#M_Category"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Macrocalcifications"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Magnetic_Resonance_Imaging"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Main_Manifestation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Malignant"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Marfanoid"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Margin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Marital_Status"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Mass_Fixation_to_the_Airway_or_Neck_Structure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Mediastinal_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Medullated_Corneal-Nerve_Fibers"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Menstrual_Cycle"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Menstrual_Volume"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Menstrual_disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastasis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Bone"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Brain"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Liver"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Lung"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Mediastinum"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Microcalcification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Microwave_Ablation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Middle_Thyroid_Vein"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multi-detector_Computed_Tomography_Angiography"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multifocal_Lesion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2A"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2B"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multiple_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multiple_Mucosal_Neuromas"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Musculoskeletal_Deformity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N0_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N0a_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N0b_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N1_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N1a_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N1b_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NDUFA13_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NKX2-1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NRAS_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NTRK1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NX_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#N_Category"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nasolacrimal_Duct_Obstruction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#National_Origin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nausea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neck_Mass"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neck_Pain"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Needle_Core_Biopsy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neoplastic_Bone_and_Cartilage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neovascularization"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nerve_Damage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nodular_Goiter"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nodule_Size"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nondiagnosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Notice_Change_in_the_Way_Food_Tastes"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Number_of_Births"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Number_of_Pregnancies"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Occupation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ongoing_Risk_Stratification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Osteoclast-like_Giant_Cells"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Osteoporosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Other_Diagnosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Others"/>
    </Declaration>
    <Declaration>
        <Class IRI="#PAX8_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#PTEN_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Paclitaxel"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Palliative_Surgery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Palliative_therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Palpitation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Panoramic_lymphadenectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parathyroid_Autotransplantation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parathyroid_Gland"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parathyroid_Gland_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parathyroid_Hormone"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parenchyma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Parenteral_Therapeutic_Nutritional_Supplementation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Partial_Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathological_Characteristics"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathological_Classification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathology"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathology_TNM_stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Paucicellular_Variant"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pazopanib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pectus_Excavatum"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Permanent_Hypoparathyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Permanent_Recurrent_Laryngeal_Nerve_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Personal_Medical_History"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pes_Cavus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Phosphorus_Urine_Excretion_Rate"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Phrenic_Nerve_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Physiological_Characteristics"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pituitary_Gland_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pituitary_Gland_Neoplasm"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Plateau"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Platinum"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pleomorphic_Giant_Cell_Pattern"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Poorly_Differentiated_Thyroid_Gland_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Positron_Emission_Tomography_and_Computed_Tomography_Scan"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Posterior_Branches"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Potassium_Iodate"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Primary_Hyperparathyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Prophylactic_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Prophylactic_Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Protein_Kinase_B"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Proximal_Muscle_Weakness"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pruritis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pulmonary_Fibrosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pyramidal_Lobe"/>
    </Declaration>
    <Declaration>
        <Class IRI="#RAI-refractory_disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#RAS_Family_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#RET_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Race"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Radiation-induced_thyroiditis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Radiofrequency_Ablation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Radioimmunotherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Radioisotope"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Radionuclide_Imaging"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Recurrent_Laryngeal_Nerve"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Region"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Regional_Lymph_Node_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Reporting_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Reproductive_history"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Resection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Respiratory_Compromise"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Respiratory_Tract_Aspiration"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Response_to_Therapy_Categories"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Right_Thyroid_Gland_Lobe"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Risk_Stratification_of_Recurrence"/>
    </Declaration>
    <Declaration>
        <Class IRI="#SRGAP1_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Scar"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Seafood"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Seroma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Serum_Calcitonin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Serum_Calcium"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Serum_Magnesium_Measurement"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Serum_Phosphorus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Single-like"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Skip_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Smoking"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Solid"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Solitary_nodule"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sorafenib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Spinal_Accessory_Nerve"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Spindle_Cell_Pattern"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Spindle_and_Squamoid_Cells"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Spongiform"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sporadic_Thyroid_Gland_Medullary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Squamous_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Staging_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stereotactic_Body_Radiation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sternocleidomastoid_Autograft"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sternocleidomastoid_Muscle"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stimulated_Serum_Calcitonin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Structural_Incomplete_Response"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Subacute_Thyroiditis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Subclinical_Thyrotoxicosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Subtotal_Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sunitinib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Superior_Laryngeal_Nerve"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Superior_Thyroid_Artery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Superior_Thyroid_Vein"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Surgery"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Surgical_Complications"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Survivorship_Care_Plan"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Suspicious_for_Malignancy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Symptoms"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Synaptophysin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#System_chemotherapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T0_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T1_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T1a_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T1b_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T2_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T3_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T3a_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T3b_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T4_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T4a_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T4b_Stage_Finding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#TERT_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#TNM_Staging_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#TP53_Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#TSH_Inhibited_Serum_Thyroglobulin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#TSH_suppressive_therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#T_Category"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tall-cell_Papillary_Thyroid_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Taxane_Compound"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Technetium_TC-99m"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Temporary_Recurrent_Laryngeal_Nerve_Injury"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Therapeutic_Glucocorticoid"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Therapeutic_Lymphadenectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Therapeutic_Procedure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Therapeutic_Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thermal_Ablation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thick_Capsule"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thickness_of_Neck"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thrombosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thymus_Gland"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroglobulin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid-Stimulating_Hormone"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Adjuvant_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Antithyroglobulin_Antibody"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Blood_Supply"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Cancer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Dominant_Nerve"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Function_Tests"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Anaplastic_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Follicular_Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Hurthle_Cell_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Isthmus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Squamous_Cell_Carcinoma"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Isthmectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Lateral_Lobectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Remnant_Ablation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Stimulating_Hormone_Receptor_Antibody"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Structure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Transcription_Factor_1"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroxine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ti-Rads_level"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Total_Parenteral_Nutrition"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Total_Thyroidectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Trabecular_Architecture"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Trachea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tracheotomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Trans-triiodothyronine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Transient_Neonatal_Hypoparathyroidism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment_of_Brain_Metastases"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Triiodothyronine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Capsule_Invasion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Cell_Necrosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Debulking"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Enlargement"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Marker"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tumor_Vascular_Invasion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Typical_Revision_Lateral_Neck_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#U1_normal"/>
    </Declaration>
    <Declaration>
        <Class IRI="#U2_benign"/>
    </Declaration>
    <Declaration>
        <Class IRI="#U3_indeterminate_equivocal"/>
    </Declaration>
    <Declaration>
        <Class IRI="#U4_suspicious"/>
    </Declaration>
    <Declaration>
        <Class IRI="#U5_Malignant"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ultrasonography"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ultrasound_Characteristics"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Unclear_Information"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Urine_Calcium"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Urine_Magnesium"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VII_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VIa_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VIb_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VIc_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VId_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#VIe_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#V_Level_Lymph_Node_Dissection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Vandetanib"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Venous"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Very_low_suspicion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Vocal_Cord_Paralysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Voice_Alteration"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Voice_Assessment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Vomiting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Weight_Loss"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Whole-Body_Scintigraphy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#codon_634"/>
    </Declaration>
    <Declaration>
        <Class IRI="#codon_883"/>
    </Declaration>
    <Declaration>
        <Class IRI="#exon_10"/>
    </Declaration>
    <Declaration>
        <Class IRI="#exon_15"/>
    </Declaration>
    <Declaration>
        <Class IRI="#exon_16"/>
    </Declaration>
    <Declaration>
        <Class IRI="#rh_TSH_Stimulated_Serum_Thyroglobulin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#131I-labeled_Bivalent_Hapten"/>
    </Declaration>
    <Declaration>
        <Class IRI="#131I_Treatment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#25-OH-Vitamin_D"/>
    </Declaration>
    <Declaration>
        <Class IRI="#3-Dimensional_Conformal_Radiation_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dental_Caries,_CTCAE"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Grossly_Negative_Margins_(R1_resection)"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Injection_(medicine)"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pankeratin(AE1/AE3)"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Salivary_Gland_Intra-Operative_Injury,_CTCAE"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#codon_918_(M918T)"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ligandâ€“directed_agent_denosumab"/>
    </Declaration>
    <Declaration>
        <Class IRI="#rhTSH_(Thyrogen)-Mediated_131I_Therapy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#describes"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#is_a"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#part_of"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#CDISC_definition"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#ChineseLabel"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#Definition"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#NCI_code"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#URL"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#reference"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#synonyms"/>
    </Declaration>
    <EquivalentClasses>
        <Class IRI="#A88F"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA-A_Mutation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#ATA_Categorization_for_MTC"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA-B_Mutation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#ATA_Categorization_for_MTC"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA-C_Mutation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#ATA_Categorization_for_MTC"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA-D_Mutation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#ATA_Categorization_for_MTC"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA_Categorization_for_MTC"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Cellular_or_Molecular_Interactions"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATA_Reporting_system"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Reporting_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ATC_Complete_Resection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ablation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Adjacent_Structure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Anatomy_and_Histoembryology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Adjuvant_I-131_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Adverse_Effect"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Adverse_Reaction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#TSH_suppressive_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Age"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Age_at_First_Live_Birth"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Reproductive_history"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Age_of_Menpause"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Reproductive_history"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Alcohol"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Habits_and_Behavious"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Amlotinib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Amyloidosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anatomy_and_Histoembryology"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anterior_Branches"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anti-TPO_Antibodies"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Arc-like"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Macrocalcifications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Artery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Blood_Supply"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Asphyxia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Atrial_fibrillation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Heart_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Atypical_Mitoses"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Axitinib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#BRAF_Kinase_Inhibitors"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Protein_Kinase_Inhibitor"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#BRAF_V600E"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#BTA_reporting_system"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Reporting_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Basic_Information_of_Patient"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Benign"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#ATA_Reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Benign"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Cytologic_Test"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Berry-picking"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Beta-Catenin_Accumulation_Pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bilateral_Malignant_Neoplasm"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Biochemical_Incomplete_Response"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Ongoing_Risk_Stratification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Biochemical_Pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Cellular_or_Molecular_Interactions"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Biochemical_remission"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Other_Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Biphasic_Spindle_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bisphosphonate_or_Denosumab_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radioimmunotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bizarre_Malignant_Giant_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Body_Mass_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Physiological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bone-Directed_Agents"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bone_Marrow_Depression"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Brachial_Plexus_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Nerve_Damage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Bystander_Effect"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#C-cell_Hyperplasia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#CD45"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#CDKN1B_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#CEA"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cabozantinib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Calcification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Calcitomin-secreting_Parafollicular_C_cells"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Histology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Calcitonin_Tests"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Calcitonin_Tests"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Tumor_Marker"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carboplatin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Platinum"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carcinoembryonic_antigen"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Tumor_Marker"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Care"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Follow-up"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carotid_Sheaths"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cement_Injections"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Injection_(medicine)"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Central_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Chemotherapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Chromogranin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Chylous_Fistula"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cisplatin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Platinum"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Classical_Papillary_Thyroid_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Clinical_Aspects"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Clinically_Evident_Metastasis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Coarse_Needle_Biopsy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Coast"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Region"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Colonic_Disturbances"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Columnar_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Complication"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Composition"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Computed_Tomography"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Convoluted_Nuclei"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cricoid_Cartilage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cryoballoon_Ablation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ablation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cystic-solid_Mixing"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Composition"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cystic_Neoplasm"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Composition"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cytologic_Test"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#DICER1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dacarbazin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dehydration"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diagnosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Clinical_Aspects"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diagnostic_IHC_Markers"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Cellular_or_Molecular_Interactions"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diagnostic_Imaging"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diarrhea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diarrhea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_Fluorine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Dietary_Intake"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_Intake"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_Selenium"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Dietary_Intake"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_iodine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Dietary_Intake"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Classification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Digestive_System_Disorder"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Digestive_System_Fistula"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Digestive_Tract_Reaction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Distant_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastasis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Docetaxel"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Paclitaxel"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dosage_of_131I"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Doxorubicin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Drug_abuse"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Habits_and_Behavious"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dual_Cancer"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dysphagia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dyspnea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#E-Cadherin_Signaling_Pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Echogenicity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Education_Level"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Elastography"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Empiric_RAI_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Endoscopic_Procedure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Environment"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Esophagus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ethanol_Ablation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Injection_(medicine)"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Etiology"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Excellent_Response"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Ongoing_Risk_Stratification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#External_Branches"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#External_beam_radiation_therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#External_Beam_Radiation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Extracapsular_Nodal_Extension"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Extrathyroidal_Extension"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#FNA-Tg"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Fine-Needle_Aspiration"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#FNA-calcitonin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Fine-Needle_Aspiration"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#FOXE1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Failure_to_Thrive"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Family_Medical_History"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Fatigue"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Fine-Needle_Aspiration"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Fluorouracil"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Flushed_Face"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Follow-up"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Clinical_Aspects"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Free_Thyroxine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Free_Triiodothyronine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Frozen_Section_Procedure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Functioning_Forearm_Autograft"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Autotransplantation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ganglioneuromatosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ganglioneuromatosis_of_the_Intestine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gastroenteritis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gender"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Cellular_or_Molecular_Interactions"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Giant_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gland_Size"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gravel-like"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Microcalcification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gross_Tumor_Resection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#HABP2_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#HRAS_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Habits_and_Behavious"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lifestyle"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Have_Noticed_New_Changes_in_Skin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Heart_Disorder"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Reaction"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Heart_Failure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hemoptysis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hemorrhage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hemorrhage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hepatotoxicity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hereditary_Thyroid_Gland_Medullary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Heterogeneous_Echotexture"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Parenchyma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#High_Molecular_Weight_Keratins"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#High_Risk"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Initial_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#High_suspicion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#ATA_Reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Histology"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Anatomy_and_Histoembryology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Homogeneity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Parenchyma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Horner_Syndrome"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Horner_Syndrome"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyoid_Bone"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperechoic"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Echogenicity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypertension"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypertension"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypocalcemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypoechoic"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Echogenicity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypoglossal_Nerve_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Nerve_Damage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypoparathyroidism"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypopnea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#III_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#II_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#IV_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ileus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Increased_LT4_Dosage_Requirement"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Indeterminate"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Cytologic_Test"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Indeterminate_Response"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Ongoing_Risk_Stratification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Infection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Inferior_Thyroid_Artery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Artery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Inferior_Thyroid_Vein"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Venous"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Inflammatory_Infiltrate"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Initial_Risk_Stratification_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Recurrent_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Insular_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Insular_carcinoma_of_the_thyroid"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intensity-Modulated_Radiation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#External_Beam_Radiation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intermediate_Risk"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Initial_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intermediate_suspicion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#ATA_Reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Internal_Branches"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intestinal_Perforation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intratumoral_Fibrosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Investigation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Clinical_Aspects"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Iobenguane_I-131"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Iodine_Deficiency"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Dietary_iodine"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Iodine_I_123_Iodobenzamide"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radionuclide_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Iodine_excess"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Dietary_iodine"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ipsilateral_Neck_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Irradiation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Environment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ischemic_heart_disease"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Heart_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Island-like"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Macrocalcifications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Isoechoic"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Echogenicity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Isoechoic_Spongiform_Isoechoic_Spongiform"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Jugular_Vein"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Larger_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Laryngeal_Exam"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Voice_Assessment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Laryngoscopy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Voice_Assessment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Laser_Ablation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thermal_Ablation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Left_Thyroid_Gland_Lobe"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Thyroid_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lenvatinib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Leukopenia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Levothyroxine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#TSH_suppressive_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lifestyle"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lithium_in_131I_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Location"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Loss_of_Appetite"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Low_Risk"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Initial_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Low_suspicion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#ATA_Reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lowest_Thyroid_Artery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Artery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Lymphadenectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#M0_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#M_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#M1_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#M_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MAPK_Signaling_Pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biochemical_Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MEK_Inhibitor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Protein_Kinase_Inhibitor"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MINPP1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MRI-Based_Angiogram"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MTC_Manifestation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Symptoms"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MTOR_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biochemical_Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MUTYH_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#MX_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#M_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#M_Category"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#TNM_Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Macrocalcifications"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Calcification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Magnetic_Resonance_Imaging"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Main_Manifestation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Symptoms"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Malignant"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Cytologic_Test"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Marfanoid"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Margin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Marital_Status"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Mass_Fixation_to_the_Airway_or_Neck_Structure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Mediastinal_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Medullated_Corneal-Nerve_Fibers"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Menstrual_Cycle"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Menstrual_disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Menstrual_Volume"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Menstrual_disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Menstrual_disorder"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastasis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastasis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Bone"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Distant_Metastases"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Brain"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Distant_Metastases"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Liver"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Distant_Metastases"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Lung"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Distant_Metastases"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Mediastinum"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Distant_Metastases"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Microcalcification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Calcification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Microwave_Ablation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thermal_Ablation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Middle_Thyroid_Vein"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Venous"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Multi-detector_Computed_Tomography_Angiography"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Multifocal_Lesion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Multiple_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Multiple_Mucosal_Neuromas"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Musculoskeletal_Deformity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N0_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N0a_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N0_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N0b_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N0_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N1_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N1a_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N1_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N1b_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N1_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#NDUFA13_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#NKX2-1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#NRAS_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#NTRK1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#NX_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#N_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#N_Category"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#TNM_Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nasolacrimal_Duct_Obstruction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#National_Origin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nausea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neck_Mass"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neck_Pain"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neck_Pain"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Needle_Core_Biopsy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neoplastic_Bone_and_Cartilage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neovascularization"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nerve_Damage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nodule_Size"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nondiagnosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Cytologic_Test"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Notice_Change_in_the_Way_Food_Tastes"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Number_of_Births"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Reproductive_history"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Number_of_Pregnancies"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Reproductive_history"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Occupation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ongoing_Risk_Stratification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Recurrent_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Osteoclast-like_Giant_Cells"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Osteoporosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Reaction"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Other_Diagnosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Others"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Cellular_or_Molecular_Interactions"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#PAX8_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#PTEN_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Paclitaxel"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Palliative_Surgery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Palliative_therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Palpitation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Panoramic_lymphadenectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parathyroid_Autotransplantation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parathyroid_Function_Tests"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parathyroid_Gland"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parathyroid_Hormone"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parenchyma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Parenteral_Therapeutic_Nutritional_Supplementation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Follow-up"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Partial_Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathological_Characteristics"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Pathology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathological_Classification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Pathology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathology"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathology_TNM_stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Paucicellular_Variant"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pazopanib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pectus_Excavatum"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Permanent_Hypoparathyroidism"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Hypoparathyroidism"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Permanent_Recurrent_Laryngeal_Nerve_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Personal_Medical_History"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pes_Cavus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Phosphorus_Urine_Excretion_Rate"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Phrenic_Nerve_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Nerve_Damage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Physiological_Characteristics"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lifestyle"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Plateau"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Region"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Platinum"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pleomorphic_Giant_Cell_Pattern"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Poorly_Differentiated_Thyroid_Gland_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Classification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Positron_Emission_Tomography_and_Computed_Tomography_Scan"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Posterior_Branches"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Potassium_Iodate"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Dietary_iodine"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Prophylactic_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Prophylactic_Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Protein_Kinase_B"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biochemical_Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Proximal_Muscle_Weakness"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#MTC_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pruritis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pulmonary_Fibrosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pyramidal_Lobe"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Thyroid_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#RAI-refractory_disease"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Other_Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#RAS_Family_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#RET_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Race"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Basic_Information_of_Patient"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Radiation-induced_thyroiditis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#External_Beam_Radiation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Radiofrequency_Ablation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thermal_Ablation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Radioimmunotherapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Radioisotope"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Radionuclide_Imaging"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Dominant_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Nerve_Damage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Region"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Environment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Regional_Lymph_Node_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Reporting_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Ultrasonography"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Reproductive_history"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Etiology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Resection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Respiratory_Compromise"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Respiratory_Tract_Aspiration"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Response_to_Therapy_Categories"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Right_Thyroid_Gland_Lobe"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Thyroid_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Risk_Stratification_of_Recurrence"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Recurrent_Risk_Stratification_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#SRGAP1_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Scar"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Seafood"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Dietary_Intake"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Seroma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgical_Complications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Serum_Calcitonin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Calcitonin_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Serum_Calcitonin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Tumor_Marker"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Serum_Calcium"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Serum_Magnesium_Measurement"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Serum_Phosphorus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Single-like"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Macrocalcifications"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Skip_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Smoking"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Habits_and_Behavious"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Solid"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Composition"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Solid"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Solitary_nodule"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ultrasound_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sorafenib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Spinal_Accessory_Nerve"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Spindle_Cell_Pattern"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Spindle_and_Squamoid_Cells"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Spongiform"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Composition"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sporadic_Thyroid_Gland_Medullary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Squamous_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Staging_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stereotactic_Body_Radiation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#External_Beam_Radiation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sternocleidomastoid_Autograft"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Autotransplantation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sternocleidomastoid_Muscle"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stimulated_Serum_Calcitonin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Calcitonin_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stimulated_Serum_Calcitonin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Tumor_Marker"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Structural_Incomplete_Response"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Ongoing_Risk_Stratification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Subclinical_Thyrotoxicosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Osteoporosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Subtotal_Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sunitinib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Superior_Laryngeal_Nerve"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Dominant_Nerve"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Superior_Thyroid_Artery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Artery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Superior_Thyroid_Vein"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Venous"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Surgery"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Surgical_Complications"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Survivorship_Care_Plan"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Follow-up"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Suspicious_for_Malignancy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Cytologic_Test"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Symptoms"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Clinical_Aspects"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Synaptophysin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#System_chemotherapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T0_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T1_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T1a_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T1_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T1b_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T1_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T2_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T3_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T3a_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T3_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T3b_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T3_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T4_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T_Category"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T4a_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T4_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T4b_Stage_Finding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#T4_Stage_Finding"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TERT_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TNM_Staging_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TP53_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TP53_Gene"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TSH_Inhibited_Serum_Thyroglobulin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#TSH_suppressive_therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#T_Category"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#TNM_Staging_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tall-cell_Papillary_Thyroid_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Taxane_Compound"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Cytotoxic_Chemotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Technetium_TC-99m"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radionuclide_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Temporary_Recurrent_Laryngeal_Nerve_Injury"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Therapeutic_Glucocorticoid"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Therapeutic_Lymphadenectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Therapeutic_Procedure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Clinical_Aspects"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Therapeutic_Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thermal_Ablation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Ablation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thick_Capsule"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thickness_of_Neck"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thrombosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thymus_Gland"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroglobulin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroglobulin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid-Stimulating_Hormone"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Adjuvant_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Antithyroglobulin_Antibody"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Blood_Supply"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Anatomy_and_Histoembryology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Dominant_Nerve"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Anatomy_and_Histoembryology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Function_Tests"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Anaplastic_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Classification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Follicular_Cell"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Histology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Hurthle_Cell_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Isthmus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Thyroid_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Classification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#AJCC_v8_Stage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Squamous_Cell_Carcinoma"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Classification"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Isthmectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Lateral_Lobectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Remnant_Ablation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Stimulating_Hormone_Receptor_Antibody"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Structure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Anatomy_and_Histoembryology"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Transcription_Factor_1"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroxine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ti-Rads_level"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Reporting_System"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Total_Parenteral_Nutrition"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Follow-up"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Total_Thyroidectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroidectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Trabecular_Architecture"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Trachea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adjacent_Structure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tracheotomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Trans-triiodothyronine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Transient_Neonatal_Hypoparathyroidism"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Hypoparathyroidism"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treatment_of_Brain_Metastases"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Triiodothyronine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Capsule_Invasion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Cell_Necrosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Debulking"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Palliative_Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Enlargement"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Marker"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tumor_Vascular_Invasion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Pathological_Characteristics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Typical_Revision_Lateral_Neck_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lymphadenectomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#U1_normal"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#BTA_reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#U2_benign"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#BTA_reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#U3_indeterminate_equivocal"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#BTA_reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#U4_suspicious"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#BTA_reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#U5_Malignant"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#BTA_reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ultrasonography"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ultrasound_Characteristics"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Ultrasonography"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Unclear_Information"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Lifestyle"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Urine_Calcium"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Urine_Magnesium"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Protein_Kinase_Inhibitor"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VII_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Central_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Central_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VIa_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VIb_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VIc_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VId_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#VIe_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#V_Level_Lymph_Node_Dissection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Vandetanib"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Venous"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Blood_Supply"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Very_low_suspicion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#ATA_Reporting_system"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Vocal_Cord_Paralysis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Voice_Alteration"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Main_Manifestation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Voice_Assessment"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Investigation"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Vomiting"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Digestive_System_Disorder"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Weight_Loss"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Adverse_Effect"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Whole-Body_Scintigraphy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_Imaging"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#codon_634"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#codon_883"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#exon_10"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#exon_15"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#exon_16"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#rh_TSH_Stimulated_Serum_Thyroglobulin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Thyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#131I-labeled_Bivalent_Hapten"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radioimmunotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#131I_Treatment"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#25-OH-Vitamin_D"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Parathyroid_Function_Tests"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#3-Dimensional_Conformal_Radiation_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#External_Beam_Radiation_Therapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radioimmunotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Nerve_Damage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dental_Caries,_CTCAE"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Grossly_Negative_Margins_(R1_resection)"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Palliative_Surgery"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Injection_(medicine)"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Therapeutic_Procedure"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pankeratin(AE1/AE3)"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Diagnostic_IHC_Markers"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Biochemical_Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Salivary_Gland_Intra-Operative_Injury,_CTCAE"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Positron_Emission_Tomography_and_Computed_Tomography_Scan"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#describes"/>
            <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#codon_918_(M918T)"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#part_of"/>
            <Class IRI="#RET_Gene"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#ligandâ€“directed_agent_denosumab"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#Radioimmunotherapy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#rhTSH_(Thyrogen)-Mediated_131I_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#is_a"/>
            <Class IRI="#131I_Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <SubClassOf>
        <Class IRI="#A88F"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#AJCC_v8_Stage"/>
        <Class IRI="#Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA-A_Mutation"/>
        <Class IRI="#ATA_Categorization_for_MTC"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA-B_Mutation"/>
        <Class IRI="#ATA_Categorization_for_MTC"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA-C_Mutation"/>
        <Class IRI="#ATA_Categorization_for_MTC"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA-D_Mutation"/>
        <Class IRI="#ATA_Categorization_for_MTC"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA_Categorization_for_MTC"/>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATA_Reporting_system"/>
        <Class IRI="#Reporting_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ATC_Complete_Resection"/>
        <Class IRI="#Palliative_Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ablation_Therapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adjacent_Structure"/>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adjuvant_I-131_Therapy"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adrenal_Gland_Pheochromocytoma"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adverse_Effect"/>
        <Class IRI="#Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adverse_Reaction"/>
        <Class IRI="#TSH_suppressive_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Age"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Age_at_First_Live_Birth"/>
        <Class IRI="#Reproductive_history"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Age_of_Menpause"/>
        <Class IRI="#Reproductive_history"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Alcohol"/>
        <Class IRI="#Habits_and_Behavious"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Amlotinib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Amyloidosis"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anatomy_and_Histoembryology"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anterior_Branches"/>
        <Class IRI="#Recurrent_Laryngeal_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anti-TPO_Antibodies"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Arc-like"/>
        <Class IRI="#Macrocalcifications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Artery"/>
        <Class IRI="#Thyroid_Blood_Supply"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Asphyxia"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Atrial_fibrillation"/>
        <Class IRI="#Heart_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Atypical_Mitoses"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Axitinib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#BRAF_Kinase_Inhibitors"/>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#BRAF_V600E"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#BTA_reporting_system"/>
        <Class IRI="#Reporting_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Basic_Information_of_Patient"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Benign"/>
        <Class IRI="#ATA_Reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Benign"/>
        <Class IRI="#Cytologic_Test"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Berry-picking"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Beta-Catenin_Accumulation_Pathway"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bilateral_Malignant_Neoplasm"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biochemical_Incomplete_Response"/>
        <Class IRI="#Ongoing_Risk_Stratification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biochemical_Incomplete_Response"/>
        <Class IRI="#Response_to_Therapy_Categories"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biochemical_Pathway"/>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biochemical_remission"/>
        <Class IRI="#Other_Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Biphasic_Spindle_Cell"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bisphosphonate_or_Denosumab_Therapy"/>
        <Class IRI="#Radioimmunotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bizarre_Malignant_Giant_Cell"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Body_Mass_Index"/>
        <Class IRI="#Physiological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bone-Directed_Agents"/>
        <Class IRI="#Palliative_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bone_Marrow_Depression"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Brachial_Plexus_Injury"/>
        <Class IRI="#Nerve_Damage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Bystander_Effect"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#C-cell_Hyperplasia"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#CD45"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#CDKN1B_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#CEA"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cabozantinib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Calcification"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Calcitomin-secreting_Parafollicular_C_cells"/>
        <Class IRI="#Histology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Calcitonin_Tests"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Calcitonin_Tests"/>
        <Class IRI="#Tumor_Marker"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carboplatin"/>
        <Class IRI="#Platinum"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carcinoembryonic_antigen"/>
        <Class IRI="#Tumor_Marker"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Care"/>
        <Class IRI="#Follow-up"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carotid_Sheaths"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cement_Injections"/>
        <Class IRI="#Injection_(medicine)"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Central_Lymph_Node_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chemotherapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chromogranin"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chylous_Fistula"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cisplatin"/>
        <Class IRI="#Platinum"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Classical_Papillary_Thyroid_Carcinoma"/>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Clinical_Aspects"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Clinically_Evident_Metastasis"/>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Coarse_Needle_Biopsy"/>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Coast"/>
        <Class IRI="#Region"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Colonic_Disturbances"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Columnar_Cell"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Complication"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Composition"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Computed_Tomography"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Convoluted_Nuclei"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cricoid_Cartilage"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cryoballoon_Ablation_Therapy"/>
        <Class IRI="#Ablation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cushing_Syndrome"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cystic-solid_Mixing"/>
        <Class IRI="#Composition"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cystic_Neoplasm"/>
        <Class IRI="#Composition"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cytologic_Test"/>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
        <Class IRI="#Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#DICER1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dacarbazin"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dehydration"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diabetes_Mellitus"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diagnosis"/>
        <Class IRI="#Clinical_Aspects"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diagnostic_IHC_Markers"/>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diagnostic_Imaging"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diarrhea"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diarrhea"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_Fluorine"/>
        <Class IRI="#Dietary_Intake"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_Intake"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_Selenium"/>
        <Class IRI="#Dietary_Intake"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_iodine"/>
        <Class IRI="#Dietary_Intake"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
        <Class IRI="#Pathological_Classification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Digestive_System_Disorder"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Digestive_System_Fistula"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Digestive_Tract_Reaction"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Distant_Metastases"/>
        <Class IRI="#Metastasis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Docetaxel"/>
        <Class IRI="#Paclitaxel"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dosage_of_131I"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Doxorubicin"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Drug_abuse"/>
        <Class IRI="#Habits_and_Behavious"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dual_Cancer"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dysphagia"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dyspnea"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#E-Cadherin_Signaling_Pathway"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Echogenicity"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Education_Level"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Elastography"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Empiric_RAI_Therapy"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Endocrine_Syndrome"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Endocrine_System_Disorder"/>
        <Class IRI="#Personal_Medical_History"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Endoscopic_Procedure"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Environment"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Esophagus"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ethanol_Ablation_Therapy"/>
        <Class IRI="#Injection_(medicine)"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Etiology"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Excellent_Response"/>
        <Class IRI="#Ongoing_Risk_Stratification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Excellent_Response"/>
        <Class IRI="#Response_to_Therapy_Categories"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#External_Branches"/>
        <Class IRI="#Superior_Laryngeal_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#External_beam_radiation_therapy"/>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Extracapsular_Nodal_Extension"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Extrathyroidal_Extension"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#FNA-Tg"/>
        <Class IRI="#Fine-Needle_Aspiration"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#FNA-calcitonin"/>
        <Class IRI="#Fine-Needle_Aspiration"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#FOXE1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Failure_to_Thrive"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Family_Medical_History"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Fatigue"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Fine-Needle_Aspiration"/>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Fluorouracil"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Flushed_Face"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Follow-up"/>
        <Class IRI="#Clinical_Aspects"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Free_Thyroxine"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Free_Triiodothyronine"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Frozen_Section_Procedure"/>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Functioning_Forearm_Autograft"/>
        <Class IRI="#Parathyroid_Autotransplantation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ganglioneuromatosis"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ganglioneuromatosis_of_the_Intestine"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gastroenteritis"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gender"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gene"/>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Giant_Cell"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gland_Size"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gravel-like"/>
        <Class IRI="#Microcalcification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gross_Tumor_Resection"/>
        <Class IRI="#Palliative_Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#HABP2_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#HRAS_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Habits_and_Behavious"/>
        <Class IRI="#Lifestyle"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hashimoto_Thyroiditis"/>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Have_Noticed_New_Changes_in_Skin"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Heart_Disorder"/>
        <Class IRI="#Adverse_Reaction"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Heart_Failure"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hemoptysis"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hemorrhage"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hemorrhage"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hepatotoxicity"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hereditary_Thyroid_Gland_Medullary_Carcinoma"/>
        <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Heterogeneous_Echotexture"/>
        <Class IRI="#Parenchyma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#High_Molecular_Weight_Keratins"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#High_Risk"/>
        <Class IRI="#Initial_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#High_suspicion"/>
        <Class IRI="#ATA_Reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Histology"/>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Homogeneity"/>
        <Class IRI="#Parenchyma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Horner_Syndrome"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Horner_Syndrome"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyoid_Bone"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperechoic"/>
        <Class IRI="#Echogenicity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertension"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertension"/>
        <Class IRI="#Endocrine_Syndrome"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertension"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperthyroidism"/>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypocalcemia"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypoechoic"/>
        <Class IRI="#Echogenicity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypoglossal_Nerve_Injury"/>
        <Class IRI="#Nerve_Damage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypoparathyroidism"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypopnea"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypothyroidism"/>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#III_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#II_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#IV_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ileus"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Increased_LT4_Dosage_Requirement"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Indeterminate"/>
        <Class IRI="#Cytologic_Test"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Indeterminate_Response"/>
        <Class IRI="#Ongoing_Risk_Stratification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Indeterminate_Response"/>
        <Class IRI="#Response_to_Therapy_Categories"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Infection"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Inferior_Thyroid_Artery"/>
        <Class IRI="#Artery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Inferior_Thyroid_Vein"/>
        <Class IRI="#Venous"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Inflammatory_Infiltrate"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Initial_Risk_Stratification_System"/>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Insular_Carcinoma"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Insular_carcinoma_of_the_thyroid"/>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intensity-Modulated_Radiation_Therapy"/>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intermediate_Risk"/>
        <Class IRI="#Initial_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intermediate_suspicion"/>
        <Class IRI="#ATA_Reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Internal_Branches"/>
        <Class IRI="#Superior_Laryngeal_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intestinal_Perforation"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intratumoral_Fibrosis"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Investigation"/>
        <Class IRI="#Clinical_Aspects"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Iobenguane_I-131"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Iodine_Deficiency"/>
        <Class IRI="#Dietary_iodine"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Iodine_I_123_Iodobenzamide"/>
        <Class IRI="#Radionuclide_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Iodine_excess"/>
        <Class IRI="#Dietary_iodine"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ipsilateral_Neck_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Irradiation"/>
        <Class IRI="#Environment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ischemic_heart_disease"/>
        <Class IRI="#Heart_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Island-like"/>
        <Class IRI="#Macrocalcifications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Isoechoic"/>
        <Class IRI="#Echogenicity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Isoechoic_Spongiform_Isoechoic_Spongiform"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Jugular_Vein"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Larger_Metastases"/>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Laryngeal_Exam"/>
        <Class IRI="#Voice_Assessment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Laryngoscopy"/>
        <Class IRI="#Voice_Assessment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Laser_Ablation"/>
        <Class IRI="#Thermal_Ablation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Left_Thyroid_Gland_Lobe"/>
        <Class IRI="#Thyroid_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lenvatinib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Leukopenia"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Levothyroxine"/>
        <Class IRI="#TSH_suppressive_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lifestyle"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lithium_in_131I_Therapy"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Location"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Loss_of_Appetite"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Low_Risk"/>
        <Class IRI="#Initial_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Low_suspicion"/>
        <Class IRI="#ATA_Reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lowest_Thyroid_Artery"/>
        <Class IRI="#Artery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Lymphadenectomy"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#M0_Stage_Finding"/>
        <Class IRI="#M_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#M1_Stage_Finding"/>
        <Class IRI="#M_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MAPK_Signaling_Pathway"/>
        <Class IRI="#Biochemical_Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MEK_Inhibitor"/>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MINPP1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MRI-Based_Angiogram"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MTC_Manifestation"/>
        <Class IRI="#Symptoms"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MTOR_Gene"/>
        <Class IRI="#Biochemical_Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MUTYH_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#MX_Stage_Finding"/>
        <Class IRI="#M_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#M_Category"/>
        <Class IRI="#TNM_Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Macrocalcifications"/>
        <Class IRI="#Calcification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Magnetic_Resonance_Imaging"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Main_Manifestation"/>
        <Class IRI="#Symptoms"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Malignant"/>
        <Class IRI="#Cytologic_Test"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Marfanoid"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Margin"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Marital_Status"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Mass_Fixation_to_the_Airway_or_Neck_Structure"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Mediastinal_Lymph_Node_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Medullated_Corneal-Nerve_Fibers"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Menstrual_Cycle"/>
        <Class IRI="#Menstrual_disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Menstrual_Volume"/>
        <Class IRI="#Menstrual_disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Menstrual_disorder"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastasis"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
        <Class IRI="#Metastasis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Bone"/>
        <Class IRI="#Distant_Metastases"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Brain"/>
        <Class IRI="#Distant_Metastases"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Liver"/>
        <Class IRI="#Distant_Metastases"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Lung"/>
        <Class IRI="#Distant_Metastases"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metastatic_Malignant_Neoplasm_in_the_Mediastinum"/>
        <Class IRI="#Distant_Metastases"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Microcalcification"/>
        <Class IRI="#Calcification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Microwave_Ablation"/>
        <Class IRI="#Thermal_Ablation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Middle_Thyroid_Vein"/>
        <Class IRI="#Venous"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multi-detector_Computed_Tomography_Angiography"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multifocal_Lesion"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2"/>
        <Class IRI="#Endocrine_Syndrome"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2A"/>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2B"/>
        <Class IRI="#Multiple_Endocrine_Neoplasia_Type_2"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multiple_Metastases"/>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multiple_Mucosal_Neuromas"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Musculoskeletal_Deformity"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N0_Stage_Finding"/>
        <Class IRI="#N_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N0a_Stage_Finding"/>
        <Class IRI="#N0_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N0b_Stage_Finding"/>
        <Class IRI="#N0_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N1_Stage_Finding"/>
        <Class IRI="#N_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N1a_Stage_Finding"/>
        <Class IRI="#N1_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N1b_Stage_Finding"/>
        <Class IRI="#N1_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NDUFA13_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NKX2-1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NRAS_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NTRK1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NX_Stage_Finding"/>
        <Class IRI="#N_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#N_Category"/>
        <Class IRI="#TNM_Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nasolacrimal_Duct_Obstruction"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#National_Origin"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nausea"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neck_Mass"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neck_Pain"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neck_Pain"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Needle_Core_Biopsy"/>
        <Class IRI="#Biopsy_of_Thyroid_Gland"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neoplastic_Bone_and_Cartilage"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neovascularization"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nerve_Damage"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nodular_Goiter"/>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nodule_Size"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nondiagnosis"/>
        <Class IRI="#Cytologic_Test"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Notice_Change_in_the_Way_Food_Tastes"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Number_of_Births"/>
        <Class IRI="#Reproductive_history"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Number_of_Pregnancies"/>
        <Class IRI="#Reproductive_history"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Occupation"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ongoing_Risk_Stratification"/>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Osteoclast-like_Giant_Cells"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Osteoporosis"/>
        <Class IRI="#Adverse_Reaction"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Other_Diagnosis"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Others"/>
        <Class IRI="#Cellular_or_Molecular_Interactions"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#PAX8_Gene"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#PTEN_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Paclitaxel"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Palliative_Surgery"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Palliative_therapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Palpitation"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Panoramic_lymphadenectomy"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parathyroid_Autotransplantation"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parathyroid_Function_Tests"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parathyroid_Gland"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parathyroid_Gland_Disorder"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parathyroid_Hormone"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parenchyma"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Parenteral_Therapeutic_Nutritional_Supplementation"/>
        <Class IRI="#Follow-up"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Partial_Thyroidectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathological_Characteristics"/>
        <Class IRI="#Pathology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathological_Classification"/>
        <Class IRI="#Pathology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathology"/>
        <Class IRI="#Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathology_TNM_stage"/>
        <Class IRI="#Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Paucicellular_Variant"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pazopanib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pectus_Excavatum"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Permanent_Hypoparathyroidism"/>
        <Class IRI="#Hypoparathyroidism"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Permanent_Recurrent_Laryngeal_Nerve_Injury"/>
        <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Personal_Medical_History"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pes_Cavus"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Phosphorus_Urine_Excretion_Rate"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Phrenic_Nerve_Injury"/>
        <Class IRI="#Nerve_Damage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Physiological_Characteristics"/>
        <Class IRI="#Lifestyle"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pituitary_Gland_Disorder"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pituitary_Gland_Neoplasm"/>
        <Class IRI="#Pituitary_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Plateau"/>
        <Class IRI="#Region"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Platinum"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pleomorphic_Giant_Cell_Pattern"/>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Poorly_Differentiated_Thyroid_Gland_Carcinoma"/>
        <Class IRI="#Pathological_Classification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Positron_Emission_Tomography_and_Computed_Tomography_Scan"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Posterior_Branches"/>
        <Class IRI="#Recurrent_Laryngeal_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Potassium_Iodate"/>
        <Class IRI="#Dietary_iodine"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Primary_Hyperparathyroidism"/>
        <Class IRI="#Parathyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Prophylactic_Lymph_Node_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Prophylactic_Thyroidectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Protein_Kinase_B"/>
        <Class IRI="#Biochemical_Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Proximal_Muscle_Weakness"/>
        <Class IRI="#MTC_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pruritis"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pulmonary_Fibrosis"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pyramidal_Lobe"/>
        <Class IRI="#Thyroid_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#RAI-refractory_disease"/>
        <Class IRI="#Other_Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#RAS_Family_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#RET_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Race"/>
        <Class IRI="#Basic_Information_of_Patient"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Radiation-induced_thyroiditis"/>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Radiofrequency_Ablation"/>
        <Class IRI="#Thermal_Ablation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Radioimmunotherapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Radioisotope"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Radionuclide_Imaging"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Recurrent_Laryngeal_Nerve"/>
        <Class IRI="#Thyroid_Dominant_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
        <Class IRI="#Nerve_Damage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Region"/>
        <Class IRI="#Environment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Regional_Lymph_Node_Metastases"/>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Reporting_System"/>
        <Class IRI="#Ultrasonography"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Reproductive_history"/>
        <Class IRI="#Etiology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Resection"/>
        <Class IRI="#Palliative_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Respiratory_Compromise"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Respiratory_Tract_Aspiration"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Response_to_Therapy_Categories"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Right_Thyroid_Gland_Lobe"/>
        <Class IRI="#Thyroid_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Risk_Stratification_of_Recurrence"/>
        <Class IRI="#Recurrent_Risk_Stratification_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#SRGAP1_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Scar"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Seafood"/>
        <Class IRI="#Dietary_Intake"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Seroma"/>
        <Class IRI="#Surgical_Complications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Serum_Calcitonin"/>
        <Class IRI="#Calcitonin_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Serum_Calcium"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Serum_Magnesium_Measurement"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Serum_Phosphorus"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Single-like"/>
        <Class IRI="#Macrocalcifications"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Skip_Metastases"/>
        <Class IRI="#Metastastatic_Malignant_Neoplasm_in_Lymph_Node"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Smoking"/>
        <Class IRI="#Habits_and_Behavious"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Solid"/>
        <Class IRI="#Composition"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Solid"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Solitary_nodule"/>
        <Class IRI="#Ultrasound_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sorafenib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Spinal_Accessory_Nerve"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Spindle_Cell_Pattern"/>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Spindle_and_Squamoid_Cells"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Spongiform"/>
        <Class IRI="#Composition"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sporadic_Thyroid_Gland_Medullary_Carcinoma"/>
        <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Squamous_Cell"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8"/>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Staging_System"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stereotactic_Body_Radiation_Therapy"/>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sternocleidomastoid_Autograft"/>
        <Class IRI="#Parathyroid_Autotransplantation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sternocleidomastoid_Muscle"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stimulated_Serum_Calcitonin"/>
        <Class IRI="#Calcitonin_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Structural_Incomplete_Response"/>
        <Class IRI="#Ongoing_Risk_Stratification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Structural_Incomplete_Response"/>
        <Class IRI="#Response_to_Therapy_Categories"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Subacute_Thyroiditis"/>
        <Class IRI="#Thyroid_Gland_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Subclinical_Thyrotoxicosis"/>
        <Class IRI="#Osteoporosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Subtotal_Thyroidectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sunitinib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Superior_Laryngeal_Nerve"/>
        <Class IRI="#Thyroid_Dominant_Nerve"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Superior_Thyroid_Artery"/>
        <Class IRI="#Artery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Superior_Thyroid_Vein"/>
        <Class IRI="#Venous"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Surgery"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Surgical_Complications"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Survivorship_Care_Plan"/>
        <Class IRI="#Follow-up"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Suspicious_for_Malignancy"/>
        <Class IRI="#Cytologic_Test"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Symptoms"/>
        <Class IRI="#Clinical_Aspects"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Synaptophysin"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#System_chemotherapy"/>
        <Class IRI="#Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T0_Stage_Finding"/>
        <Class IRI="#T_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T1_Stage_Finding"/>
        <Class IRI="#T_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T1a_Stage_Finding"/>
        <Class IRI="#T1_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T1b_Stage_Finding"/>
        <Class IRI="#T1_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T2_Stage_Finding"/>
        <Class IRI="#T_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T3_Stage_Finding"/>
        <Class IRI="#T_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T3a_Stage_Finding"/>
        <Class IRI="#T3_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T3b_Stage_Finding"/>
        <Class IRI="#T3_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T4_Stage_Finding"/>
        <Class IRI="#T_Category"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T4a_Stage_Finding"/>
        <Class IRI="#T4_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T4b_Stage_Finding"/>
        <Class IRI="#T4_Stage_Finding"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TERT_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TNM_Staging_System"/>
        <Class IRI="#Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TP53_Gene"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TP53_Gene"/>
        <Class IRI="#Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TSH_Inhibited_Serum_Thyroglobulin"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#TSH_suppressive_therapy"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#T_Category"/>
        <Class IRI="#TNM_Staging_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tall-cell_Papillary_Thyroid_Carcinoma"/>
        <Class IRI="#Highly_Invasive_Papillary_Thyroid_Cancer"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Taxane_Compound"/>
        <Class IRI="#Cytotoxic_Chemotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Technetium_TC-99m"/>
        <Class IRI="#Radionuclide_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Temporary_Recurrent_Laryngeal_Nerve_Injury"/>
        <Class IRI="#Recurrent_Laryngeal_Nerve_Injury"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Therapeutic_Glucocorticoid"/>
        <Class IRI="#Palliative_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Therapeutic_Lymphadenectomy"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Therapeutic_Procedure"/>
        <Class IRI="#Clinical_Aspects"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Therapeutic_Thyroidectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thermal_Ablation_Therapy"/>
        <Class IRI="#Ablation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thick_Capsule"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thickness_of_Neck"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thrombosis"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thymus_Gland"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroglobulin"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroglobulin"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid-Stimulating_Hormone"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Adjuvant_Therapy"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Antithyroglobulin_Antibody"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Blood_Supply"/>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage"/>
        <Class IRI="#AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Dominant_Nerve"/>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Function_Tests"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Anaplastic_Carcinoma"/>
        <Class IRI="#Pathological_Classification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage"/>
        <Class IRI="#AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Disorder"/>
        <Class IRI="#Endocrine_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Follicular_Cell"/>
        <Class IRI="#Histology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage"/>
        <Class IRI="#AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Hurthle_Cell_Carcinoma"/>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Isthmus"/>
        <Class IRI="#Thyroid_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Medullary_Carcinoma"/>
        <Class IRI="#Pathological_Classification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage"/>
        <Class IRI="#AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Papillary_Carcinoma"/>
        <Class IRI="#Differentiated_Thyroid_Gland_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage"/>
        <Class IRI="#AJCC_v8_Stage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Squamous_Cell_Carcinoma"/>
        <Class IRI="#Pathological_Classification"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Isthmectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Lateral_Lobectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Remnant_Ablation"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Stimulating_Hormone_Receptor_Antibody"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Structure"/>
        <Class IRI="#Anatomy_and_Histoembryology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Transcription_Factor_1"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroidectomy"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroxine"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ti-Rads_level"/>
        <Class IRI="#Reporting_System"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Total_Parenteral_Nutrition"/>
        <Class IRI="#Follow-up"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Total_Thyroidectomy"/>
        <Class IRI="#Thyroidectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Trabecular_Architecture"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Trachea"/>
        <Class IRI="#Adjacent_Structure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tracheotomy"/>
        <Class IRI="#Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Trans-triiodothyronine"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Transient_Neonatal_Hypoparathyroidism"/>
        <Class IRI="#Hypoparathyroidism"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment_of_Brain_Metastases"/>
        <Class IRI="#Palliative_therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Triiodothyronine"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Capsule_Invasion"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Cell_Necrosis"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Debulking"/>
        <Class IRI="#Palliative_Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Enlargement"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Marker"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tumor_Vascular_Invasion"/>
        <Class IRI="#Pathological_Characteristics"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Typical_Revision_Lateral_Neck_Dissection"/>
        <Class IRI="#Lymphadenectomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#U1_normal"/>
        <Class IRI="#BTA_reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#U2_benign"/>
        <Class IRI="#BTA_reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#U3_indeterminate_equivocal"/>
        <Class IRI="#BTA_reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#U4_suspicious"/>
        <Class IRI="#BTA_reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#U5_Malignant"/>
        <Class IRI="#BTA_reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ultrasonography"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ultrasound_Characteristics"/>
        <Class IRI="#Ultrasonography"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Unclear_Information"/>
        <Class IRI="#Lifestyle"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Urine_Calcium"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Urine_Magnesium"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
        <Class IRI="#Protein_Kinase_Inhibitor"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VII_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Central_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Central_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VIa_Level_Lymph_Node_Dissection"/>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VIb_Level_Lymph_Node_Dissection"/>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VIc_Level_Lymph_Node_Dissection"/>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VId_Level_Lymph_Node_Dissection"/>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#VIe_Level_Lymph_Node_Dissection"/>
        <Class IRI="#VI_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#V_Level_Lymph_Node_Dissection"/>
        <Class IRI="#Lateral_Level_Lymph_Node_Dissection"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Vandetanib"/>
        <Class IRI="#VEGF-Directed_Kinase_Inhibitor_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Venous"/>
        <Class IRI="#Thyroid_Blood_Supply"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Very_low_suspicion"/>
        <Class IRI="#ATA_Reporting_system"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Vocal_Cord_Paralysis"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Voice_Alteration"/>
        <Class IRI="#Main_Manifestation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Voice_Assessment"/>
        <Class IRI="#Investigation"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Vomiting"/>
        <Class IRI="#Digestive_System_Disorder"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Weight_Loss"/>
        <Class IRI="#Adverse_Effect"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Whole-Body_Scintigraphy"/>
        <Class IRI="#Diagnostic_Imaging"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#codon_634"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#codon_883"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#exon_10"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#exon_15"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#exon_16"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#rh_TSH_Stimulated_Serum_Thyroglobulin"/>
        <Class IRI="#Thyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#131I-labeled_Bivalent_Hapten"/>
        <Class IRI="#Radioimmunotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#131I_Treatment"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#25-OH-Vitamin_D"/>
        <Class IRI="#Parathyroid_Function_Tests"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#3-Dimensional_Conformal_Radiation_Therapy"/>
        <Class IRI="#External_Beam_Radiation_Therapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody"/>
        <Class IRI="#Radioimmunotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE"/>
        <Class IRI="#Nerve_Damage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dental_Caries,_CTCAE"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Grossly_Negative_Margins_(R1_resection)"/>
        <Class IRI="#Palliative_Surgery"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Injection_(medicine)"/>
        <Class IRI="#Therapeutic_Procedure"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pankeratin(AE1/AE3)"/>
        <Class IRI="#Diagnostic_IHC_Markers"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase"/>
        <Class IRI="#Biochemical_Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Salivary_Gland_Intra-Operative_Injury,_CTCAE"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body"/>
        <Class IRI="#Positron_Emission_Tomography_and_Computed_Tomography_Scan"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive"/>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive"/>
        <Class IRI="#Thyroid_Gland_Follicular_Carcinoma"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#codon_918_(M918T)"/>
        <Class IRI="#RET_Gene"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ligandâ€“directed_agent_denosumab"/>
        <Class IRI="#Radioimmunotherapy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#rhTSH_(Thyrogen)-Mediated_131I_Therapy"/>
        <Class IRI="#131I_Treatment"/>
    </SubClassOf>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#A88F</IRI>
        <Literal xml:lang="en">Common mutation sites in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#A88F</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#AJCC_v8_Stage</IRI>
        <Literal>ç¬¬8ç‰ˆAJCCåˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A cancer stage defined according to the AJCC 8th edition criteria.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C132248</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C132248</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA-A_Mutation</IRI>
        <Literal>ATA-Açªå˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA-A_Mutation</IRI>
        <Literal xml:lang="en">ATA level A (ATA-A) mutations carry the â€˜â€˜least highâ€™â€™ risk. Compared to ATA-B mutation carriers of the same age, these patients have lower serum Ct levels, lower tumor stage, and a higher rate of biochemical cure when they undergo prophylactic thyroidectomy at age 4 years old (80). ATA-A mutations include RET gene mutations at codons 768, 790, 791, 804, and 891.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA-A_Mutation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA-B_Mutation</IRI>
        <Literal>ATA-Bçªå˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA-B_Mutation</IRI>
        <Literal xml:lang="en">ATA level B (ATA-B) mutations carry a lower risk for aggressive MTC mutations and include mutations at RET codons 609, 611, 618, 620, and 630</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA-B_Mutation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA-C_Mutation</IRI>
        <Literal>ATA-Cçªå˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA-C_Mutation</IRI>
        <Literal xml:lang="en">ATA level C (ATA-C) mutations carry a lower, yet still high risk of aggressive MTC and include mutations at codon 634.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA-C_Mutation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA-D_Mutation</IRI>
        <Literal>ATA-Dçªå˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA-D_Mutation</IRI>
        <Literal xml:lang="en">ATA level D (ATA-D) mutations carry the highest risk for MTC. These mutations include codons 883 and 918, and are associated with the youngest age of onset and highest risk of metastases and disease specific mortality.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA-D_Mutation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA_Categorization_for_MTC</IRI>
        <Literal>ATAç”²çŠ¶è…ºé«“æ ·ç™Œåˆ†ç±»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA_Categorization_for_MTC</IRI>
        <Literal xml:lang="en">At the Seventh International Workshop on MEN, a classification
system was created for RET mutations based on risk
for aggressive MTC. The purpose of the classification system
was to offer recommendations for age of prophylactic
thyroidectomy, predict phenotype, and establish who should
be screened for PHEO. This systemhas been important, but
may be improved by recognizing the more aggressive course
of the 634 mutation, with young age of onset and a higher rate
of PHPT and PHEO. Additionally, some RET mutations
were not categorized by that system (including codon
630), or were judged appropriate to be reclassified based on
more recent data (e.g. codon 609). For these reasons, ATA
have created a categorization system that makes these changes,
and allows for periodic updating.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA_Categorization_for_MTC</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATA_Reporting_system</IRI>
        <Literal>ç¾Žå›½ç”²çŠ¶è…ºåä¼šæŠ¥å‘Šç³»ç»Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATA_Reporting_system</IRI>
        <Literal xml:lang="en">according to the revised 2015 ATA management guidelines, thyroid nodules can be classified into the following five categories according to US pattern and risk of malignancy: (a) high suspicion, (b) intermediate suspicion, (c) low suspicion, (d) very low suspicion, and (e) benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATA_Reporting_system</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0002961017313673</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ATC_Complete_Resection</IRI>
        <Literal xml:lang="en">æœªåˆ†åŒ–åž‹ç”²çŠ¶è…ºç™Œå…¨åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ATC_Complete_Resection</IRI>
        <Literal xml:lang="en">The majority of patients with ATC present with locally invasive and distant disease that is not amenable to complete resection. In patients with ATC that is amenable to complete extirpation, tumor resection with combination chemoradiotherapy may be beneficial.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ATC_Complete_Resection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781416058977000354?scrollTo=%23hl0000444</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal>æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">C20985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C20985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">ABLATION</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Ablation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Catheter Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Local Ablation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">Local Ablative Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ablation_Therapy</IRI>
        <Literal xml:lang="en">ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Adjacent_Structure</IRI>
        <Literal>æ¯—é‚»ç»“æž„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Adjacent_Structure</IRI>
        <Literal xml:lang="en">Adjacent structure of thyroid gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Adjacent_Structure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780702031311000444?scrollTo=%23hl0000639</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Adjuvant_I-131_Therapy</IRI>
        <Literal>ç³»ç»Ÿæ€§è¾…åŠ©æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Adjuvant_I-131_Therapy</IRI>
        <Literal xml:lang="en">Radioiodine therapy administered in cancer treatment, with the intent of suppressing secondary tumor formation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Adjuvant_I-131_Therapy</IRI>
        <Literal xml:lang="en">C157162</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Adjuvant_I-131_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C157162</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adjuvant_I-131_Therapy</IRI>
        <Literal xml:lang="en">Adjuvant I-131 Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Tumor that forms in the center of the adrenal gland (gland located above the kidney) that causes it to make too much adrenaline. Pheochromocytomas are usually benign (not cancer) but can cause high blood pressure, pounding headaches, heart palpitations, flushing of the face, nausea, and vomiting.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal>å—œé“¬ç»†èƒžç˜¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">A benign or malignant neuroendocrine neoplasm of the sympathetic nervous system that secretes catecholamines.  It arises from the chromaffin cells of the adrenal medulla.  Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">C3326</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3326</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Adrenal Gland Chromafinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Adrenal Gland Paraganglioma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Adrenal Gland Pheochromocytoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Adrenal Medullary Paraganglioma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adrenal_Gland_Pheochromocytoma</IRI>
        <Literal xml:lang="en">Adrenal Medullary Pheochromocytoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Adverse_Effect</IRI>
        <Literal>å‰¯ä½œç”¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Adverse_Effect</IRI>
        <Literal xml:lang="en">An adverse effect is an undesired harmful effect resulting from a medication or other intervention such as surgery. An adverse effect may be termed a &quot;side effect&quot;, when judged to be secondary to a main or therapeutic effect.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Adverse_Effect</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Adverse_effect</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">A response to a medicinal product, devices, or procedures, which is noxious and unintended. Response in this context means that a causal relationship between a medicinal product and an adverse event is at least a reasonable possibility. In the context of drug development, the term is used as a synonym of adverse drug reaction. (After ICH E2A)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal>å‰¯ä½œç”¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">Any noxious and unintended response(s) to a medical product or procedure, for which a causal relationship with this product or procedure is at least a reasonable possibility i.e., the relationship cannot be ruled out.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">C41332</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41332</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">ADR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">ADVERSE REACTION</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">AR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">Adverse Effect</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">Adverse Reaction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">adverse effect</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adverse_Reaction</IRI>
        <Literal xml:lang="en">adverse reaction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">How long something has existed; elapsed time since birth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Age</IRI>
        <Literal>å¹´é¾„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">How long something has existed; elapsed time since birth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">C25150</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Age</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25150</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">Age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">Chronological age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">Postnatal Age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age</IRI>
        <Literal xml:lang="en">aged</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal>åˆäº§å¹´é¾„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal xml:lang="en">The age at which a woman gave birth to her first live child.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal xml:lang="en">C19667</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C19667</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal xml:lang="en">Age at First Full-Term Pregnancy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_at_First_Live_Birth</IRI>
        <Literal xml:lang="en">Age at First Live Birth</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">The age at which permanent cessation of menses occurred.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal>ç»ç»å¹´é¾„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">The age at which permanent cessation of menses occurs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">C106497</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">Age at Menopause</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">MENOAGE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal xml:lang="en">Menopause Age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_of_Menpause</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C106497</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Alcohol</IRI>
        <Literal>é¥®é…’</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">C2190</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Alcohol</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2190</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">ALCOHOL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Absolute Ethanol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Absolute ethanol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Alcohol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">ETHANOL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Ethanol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Ethyl Alcohol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">Methylcarbinol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Alcohol</IRI>
        <Literal xml:lang="en">alcohol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Amlotinib</IRI>
        <Literal>å®‰ä¹æ›¿å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Amlotinib</IRI>
        <Literal xml:lang="en">Anlotinib is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Amlotinib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://pubchem.ncbi.nlm.nih.gov/compound/Anlotinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">An accumulation of amyloid protein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Amyloidosis</IRI>
        <Literal>æ‰å¹³è‹”ç™£æ·€ç²‰æ ·å˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">C2868</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Amyloidosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2868</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">AMYLOID</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">Amyloidosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">Lichen planus amyloidosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Amyloidosis</IRI>
        <Literal xml:lang="en">amyloidosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Anatomy_and_Histoembryology</IRI>
        <Literal>è§£å‰–ä¸Žç»„ç»‡èƒšèƒŽå­¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Anatomy_and_Histoembryology</IRI>
        <Literal xml:lang="en">The embryology, anatomy and histology of the thyroid gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Anatomy_and_Histoembryology</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781455733828000220?scrollTo=%233-s2.0-B9781455733828000220-f026-002a-9781455733828</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Anterior_Branches</IRI>
        <Literal>å‰æ”¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Anterior_Branches</IRI>
        <Literal xml:lang="en">The anterior branch of the recurrent laryngeal nerve ascends posterior to the cricothyroid joint and its ligament, and is usually covered by fibres of posterior cricoarytenoid at this point. It bends over the joint, continuing forwards over the lateral cricoarytenoid muscle before terminating within thyroarytenoid.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Anterior_Branches</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780702052309000352?scrollTo=%23hl0000639</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Anti-TPO_Antibodies</IRI>
        <Literal>ç”²çŠ¶è…ºè¿‡æ°§åŒ–ç‰©é…¶æŠ—ä½“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Anti-TPO_Antibodies</IRI>
        <Literal xml:lang="en">Anti-thyroid peroxidase (anti-TPO) antibodies are specific for the autoantigen TPO, a 105kDa glycoprotein that catalyses iodine oxidation and thyroglobulin tyrosyl iodination reactions in the thyroid gland.[5] Most antibodies produced are directed to conformational epitopes of the immunogenic carboxyl-terminal region of the TPO protein, although antibodies to linear epitopes have been seen.[4] Anti-TPO antibodies are the most common anti-thyroid autoantibody, present in approximately 90% of Hashimoto&apos;s thyroiditis, 75% of Graves&apos; disease and 10-20% of nodular goiter or thyroid carcinoma. Also, 10-15% of normal individuals can have high level anti-TPO antibody titres.[4][6][7] High serum antibodies are found in active phase chronic autoimmune thyroiditis. Thus, an antibody titer can be used to assess disease activity in patients that have developed such antibodies.[4][7][8] The majority of anti-TPO antibodies are produced by thyroid infiltrating lymphocytes, with minor contributions from lymph nodes and the bone marrow.[9] They cause thyroid cell damage by complement activation and antibody dependent cell cytotoxicity.[7] However, anti-TPO antibodies are not believed to contribute to the destruction of the thyroid.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Anti-TPO_Antibodies</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Antithyroid_autoantibodies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Arc-like</IRI>
        <Literal>åœ†å¼§æ ·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Arc-like</IRI>
        <Literal xml:lang="en">one of Ultrasonographic features of calcification in thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Arc-like</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">A blood vessel that carries blood away from the heart.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Artery</IRI>
        <Literal>åŠ¨è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">A blood vessel that carries blood away from the heart.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">C12372</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Artery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12372</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">ARTERY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">Arterial</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">Artery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Artery</IRI>
        <Literal xml:lang="en">artery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Asphyxia</IRI>
        <Literal>çª’æ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Asphyxia</IRI>
        <Literal xml:lang="en">A state of general hypoxia and hypercapnea, resulting in acidosis, which affects all tissues in the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Asphyxia</IRI>
        <Literal xml:lang="en">C50465</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Asphyxia</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50465</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Asphyxia</IRI>
        <Literal xml:lang="en">Asphyxia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal>å¿ƒæˆ¿é¢¤åŠ¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">C50466</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50466</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">AF</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">Afib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">Atrial Fibrillation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Atrial_fibrillation</IRI>
        <Literal xml:lang="en">Atrial fibrillation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Atypical_Mitoses</IRI>
        <Literal>éžå…¸åž‹çš„æœ‰ä¸åˆ†è£‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Atypical_Mitoses</IRI>
        <Literal xml:lang="en">1) lagâ€type mitoses with nonattached condensed chromatin near the main plate of chromosomes, subdivided into 2â€group metaphase with lag chromosomes on just one polar side of a metaphase plate (Figure 2j), 3â€group metaphase with lag chromosomes on both sides of the metaphase plate (Figure 2k), and other lagâ€type mitoses; 2) multipolar mitoses, subdivided into tripolar and quadripolar mitoses; and 3) other atypical mitoses, including ring mitoses, asymmetrical mitoses, and dispersed mitoses.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Atypical_Mitoses</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://onlinelibrary.wiley.com/doi/full/10.1111/j.1939-165X.2009.00201.x</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Axitinib</IRI>
        <Literal>é˜¿è¥¿æ›¿å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">C38718</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Axitinib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C38718</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">AG-013736</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">AG013736</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">AXITINIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">Axitinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">Inlyta</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Axitinib</IRI>
        <Literal xml:lang="en">axitinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#BRAF_Kinase_Inhibitors</IRI>
        <Literal>BRAFæ¿€é…¶æŠ‘åˆ¶å‰‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#BRAF_Kinase_Inhibitors</IRI>
        <Literal xml:lang="en">A substance that blocks a protein called BRAF. BRAF is a kinase enzyme that helps control cell growth and signaling. It may be found in a mutated (changed) form in some types of cancer, including melanoma and colorectal cancer. Blocking mutated BRAF kinase proteins may help keep cancer cells from growing. Some BRAF kinase inhibitors are used to treat cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#BRAF_Kinase_Inhibitors</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.cancer.gov/publications/dictionaries/cancer-terms/def/braf-kinase-inhibitor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal>é¼ ç±»è‚‰ç˜¤æ»¤è¿‡æ€§æ¯’èŒè‡´ç™ŒåŒæºä½“B1 V600EåŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">C98342</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C98342</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">Activating BRAF V600E Mutation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF NP_004324.2:p.V600E</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF NP_004324.2:p.Val600Glu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF V600E</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF V600E Activating Mutation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF V600E Mutation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF Val600Glu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF p.V600E</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">BRAF p.Val600Glu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">NP_004324.2:p.V600E</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">NP_004324.2:p.Val600Glu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">Serine/Threonine-Protein Kinase B-raf V600E</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#BRAF_V600E</IRI>
        <Literal xml:lang="en">Serine/Threonine-Protein Kinase B-raf Val600Glu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#BTA_reporting_system</IRI>
        <Literal>è‹±å›½ç”²çŠ¶è…ºåä¼šæŠ¥å‘Šç³»ç»Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#BTA_reporting_system</IRI>
        <Literal xml:lang="en">the British Thyroid Association (BTA) published clinical guidelines on the management of thyroid cancer, in which they recommended the use of a U1 to U5 grading system for assessing risk of malignancy and guiding FNA cytology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#BTA_reporting_system</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0009926019302685</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal>ç—…äººåŸºæœ¬ä¿¡æ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal xml:lang="en">A file containing demographic, medical, and treatment information pertaining to an individual patient.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://purl.bioontology.org/ontology/LNC/52460-3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#reference"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal xml:lang="en">BioPortal cui:C2598117</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal xml:lang="en">Patient File</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal xml:lang="en">Patient information</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Basic_Information_of_Patient</IRI>
        <Literal xml:lang="en">patient file</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Benign</IRI>
        <Literal>è‰¯æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">C14172</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Benign</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C14172</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">BENIGN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">Benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">Negative for malignancy/normal/benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Benign</IRI>
        <Literal xml:lang="en">benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Berry-picking</IRI>
        <Literal>æ·‹å·´ç»“æ‘˜é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Berry-picking</IRI>
        <Literal xml:lang="en">If pathologic appearing nodes are found, FNA biopsy should be performed. In the presence of pathologically confirmed lateral neck nodal disease, an ipsilateral therapeutic lateral neck dissection is indicated. This dissection should be undertaken as a formal clearance of defined lymph node levels, rather than isolated resection of the involved node or â€œberry picking.â€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Berry-picking</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal>è¿žçŽ¯è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal xml:lang="en">Lipopolysaccharide (LPS) from XX bacteria induces a wide range of inflammatory responses, including the response of alveolar macrophages to bacteria in the lungs. CD14 and the Toll-like receptor TLR4 are activated by LPS, initiating a signaling cascade that activates PI3 kinase and increases synthesis of the inositol phosphate PIP3. PIP3 activates the inositol phosphate dependent protein kinase PDK1, which activates AKT (protein kinase B). One of the key actions of AKT is to block apoptosis. AKT phosphorylation of NF-kB promotes the survival and activation of macrophages responding to LPS. Another substrate of AKT is the protein kinase Gsk3-beta. AKT phosphorylates and deactivates Gsk3-beta. Non-phosphorylated Gsk3-beta is active and phosphorylates beta-catenin, leading to its degradation in the ubiquitin dependent proteasome pathway. Stimulation by LPS causes the accumulation of beta-catenin in the nucleus and the activation of genes in concert with the transcription factor LEF1. This pathway is probably not restricted to alveolar pathway, but leads to the activation of beta-catenin dependent genes by LPS in other cells as well. Other pathways regulate this pathway also, such as the modulation of PI3 kinase activity by ceramide and the inhibition of Gsk3-beta activity by the Wnt/frizzled/disheveled (DSH) pathway. (This definition may be outdated - see the DesignNote.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal xml:lang="en">C39098</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C39098</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal xml:lang="en">Beta-Catenin Accumulation Pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Beta-Catenin_Accumulation_Pathway</IRI>
        <Literal xml:lang="en">Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal>åŒä¾§æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal xml:lang="en">A malignant neoplasm that affects both sides of an organ in a simultaneous or non-simultaneous manner.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal xml:lang="en">C7627</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C7627</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal xml:lang="en">Bilateral Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal xml:lang="en">Bilateral Malignant Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Bilateral_Malignant_Neoplasm</IRI>
        <Literal xml:lang="en">Bilateral Malignant Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Biochemical_Incomplete_Response</IRI>
        <Literal>ç”ŸåŒ–ä¸å®Œå…¨ååº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Biochemical_Incomplete_Response</IRI>
        <Literal xml:lang="en">If associated with stable or declining serum Tg values, a biochemical incomplete response should lead to continued observation with ongoing TSH suppression in most patients. Rising Tg or Tg antibody values should prompt additional imaging and potentially additional therapies.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Biochemical_Incomplete_Response</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://eguideline.guidelinecentral.com/i/631815-differentiated-thyroid-cancer/21?</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">A series of actions among molecules in a cell that leads to a certain end point or cell function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">C20633</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal>ç»†èƒžé€šè·¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">A series of biochemical reactions which occurs in a known sequence and can result in all or part of the initiation, progression or completion of a biological process or function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C20633</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">Biochemical Pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">Metabolic Network</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">Pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">Pathways</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biochemical_Pathway</IRI>
        <Literal xml:lang="en">molecular pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Biochemical_remission</IRI>
        <Literal>ç”ŸåŒ–ç¼“è§£</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Biochemical_remission</IRI>
        <Literal xml:lang="en">basal and pentagastrinstimulated serum Ct &lt;10 pg=mL In MTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Biochemical_remission</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Biopsy_of_Thyroid_Gland</IRI>
        <Literal>ç”²çŠ¶è…ºæ´»æ£€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Biopsy_of_Thyroid_Gland</IRI>
        <Literal xml:lang="en">Removal of tissue from the thyroid gland for microscopic examination.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Biopsy_of_Thyroid_Gland</IRI>
        <Literal xml:lang="en">C51613</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Biopsy_of_Thyroid_Gland</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51613</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Biopsy_of_Thyroid_Gland</IRI>
        <Literal xml:lang="en">Biopsy of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Biphasic_Spindle_Cell</IRI>
        <Literal>åŒç›¸æ¢­å½¢ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Biphasic_Spindle_Cell</IRI>
        <Literal xml:lang="en">A common morphologic presentation, and one that is most easily recognized as an anaplastic carcinoma of thyroid, is that of the biphasic spindle and giant cell tumor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Biphasic_Spindle_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2012.0302?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bisphosphonate_or_Denosumab_Therapy</IRI>
        <Literal>åŒè†¦é…¸ç›æˆ–é™ç³–å•æŠ—æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bisphosphonate_or_Denosumab_Therapy</IRI>
        <Literal xml:lang="en">Bisphosphonate or denosumab therapy should be considered in patients with diffuse and/or symptomatic bone metastases from RAI-refractory DTC, either alone or concomitantly with other systemic therapies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Bisphosphonate_or_Denosumab_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bizarre_Malignant_Giant_Cell</IRI>
        <Literal>å¼‚å¸¸æ¶æ€§å·¨ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bizarre_Malignant_Giant_Cell</IRI>
        <Literal xml:lang="en">some of anaplastic thyroid carcinoma are dominated by bizarre malignant giant cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Bizarre_Malignant_Giant_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2012.0302?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">A measure that relates body weight to height. BMI is sometimes used to measure total body fat and whether a person is a healthy weight. Excess body fat is linked to an increased risk of some diseases including heart disease and some cancers.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal>èº«ä½“è´¨é‡æŒ‡æ•°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">A general indicator of the body fat an individual is carrying based upon the ratio of weight to height.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">C16358</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16358</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">BMI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">Body Mass Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">Quetelet Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Mass_Index</IRI>
        <Literal xml:lang="en">body mass index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bone-Directed_Agents</IRI>
        <Literal>éª¨å¯¼å‘å‰‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bone-Directed_Agents</IRI>
        <Literal xml:lang="en">A technique for the treatment of bone metastases from thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bone_Marrow_Depression</IRI>
        <Literal>éª¨é«“æŠ‘åˆ¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bone_Marrow_Depression</IRI>
        <Literal xml:lang="en">Bone marrow suppression also known as myelotoxicity or myelosuppression, is the decrease in production of cells responsible for providing immunity (leukocytes), carrying oxygen (erythrocytes), and/or those responsible for normal blood clotting (thrombocytes). Bone marrow suppression is a serious side effect of chemotherapy and certain drugs affecting the immune system such as azathioprine. The risk is especially high in cytotoxic chemotherapy for leukemia.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Bone_Marrow_Depression</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Bone_marrow_suppression</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Brachial_Plexus_Injury</IRI>
        <Literal>è‡‚ä¸›ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Brachial_Plexus_Injury</IRI>
        <Literal xml:lang="en">Damage to the nerves in the brachial plexus network. These nerves originate in the spinal column and innervate the shoulder, arm and hand. Often, damage is sustained from overstretching or motor vehicle accidents.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Brachial_Plexus_Injury</IRI>
        <Literal xml:lang="en">C103231</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Brachial_Plexus_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C103231</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Brachial_Plexus_Injury</IRI>
        <Literal xml:lang="en">Brachial Plexus Injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Bystander_Effect</IRI>
        <Literal>æ—è§‚è€…æ•ˆåº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Bystander_Effect</IRI>
        <Literal xml:lang="en">The bystander effect, or bystander apathy, is a social psychological phenomenon in which individuals are less likely to offer help to a victim when other people are present. The greater the number of bystanders, the less likely it is that one of them will help. Several factors contribute to the bystander effect, including ambiguity, group cohesiveness, and diffusion of responsibility that reinforces mutual denial of a situation&apos;s severity.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Bystander_Effect</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Bystander_effect</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal>Cç»†èƒžå¢žç”Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal xml:lang="en">Neoplastic or reactive proliferation of the C-cells in the thyroid gland. The neoplastic C-cell hyperplasia is associated with familial medullary thyroid gland carcinoma and multiple endocrine neoplasia type II and IIB. Morphologically, it is characterized by the presence of clusters of intrafollicular C-cells with atypical cytologic features. The reactive C-cell hyperplasia is also known as physiological or secondary C-cell hyperplasia and it is associated with conditions that cause hypercalcemia (e.g., hyperparathyroidism).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal xml:lang="en">C46100</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C46100</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal xml:lang="en">C-Cell Hyperplasia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#C-cell_Hyperplasia</IRI>
        <Literal xml:lang="en">CCH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#CD45</IRI>
        <Literal>ç™½ç»†èƒžå…±åŒæŠ—åŽŸæŠ—ä½“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#CD45</IRI>
        <Literal xml:lang="en">CD45 is a type I transmembrane protein that is present in various isoforms on all differentiated hematopoietic cells (except erythrocytes and plasma cells). CD45 has been shown to be an essential regulator of T- and B-cell antigen receptor signaling.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#CD45</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/PTPRC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">CDKN1B (Cyclin Dependent Kinase Inhibitor 1B) is a Protein Coding gene. Diseases associated with CDKN1B include Multiple Endocrine Neoplasia, Type Iv and Primary Hyperparathyroidism. Among its related pathways are RET signaling and Association Between Physico-Chemical Features and Toxicity Associated Pathways. Gene Ontology (GO) annotations related to this gene include protein phosphatase binding. An important paralog of this gene is CDKN1C.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">This gene is involved in cell cycle regulation and cyclin regulation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">C20060</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN1B&amp;keywords=CDKN1B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">CDKN4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">Cyclin Dependent Kinase Inhibitor 1B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">Cyclin-Dependent Kinase Inhibitor 1B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">Cyclin-Dependent Kinase Inhibitor 1B (P27, Kip1)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">Cyclin-Dependent Kinase Inhibitor P27</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">KIP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">MEN1B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">MEN4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">P27KIP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#CDKN1B_Gene</IRI>
        <Literal xml:lang="en">P27Kip1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#CEA</IRI>
        <Literal>ç™ŒèƒšæŠ—åŽŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#CEA</IRI>
        <Literal xml:lang="en">describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Consequently, CEA is usually present at very low levels in the blood of healthy adults (about 20 ng/mL).[2] However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. Serum levels can also be elevated in heavy smokers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#CEA</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Carcinoembryonic_antigen</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cabozantinib</IRI>
        <Literal>å¡åšæ›¿å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">C52200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cabozantinib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C52200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">1,1-Cyclopropanedicarboxamide, N&apos;-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">CABOZANTINIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">Cabozantinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cabozantinib</IRI>
        <Literal xml:lang="en">N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N&apos;-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Calcification</IRI>
        <Literal>é’™åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">Deposition of calcium in the tissues. It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">C3672</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Calcification</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3672</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">Calcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">Calcium Deposit(s)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">Deposit(s), Calcium</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">calcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">calcinosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcification</IRI>
        <Literal xml:lang="en">macrocalcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal>æ»¤æ³¡æ—é™é’™ç´ åˆ†æ³Œç»†èƒžï¼ˆCç»†èƒžï¼‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal xml:lang="en">A neuroendocrine cell found in the thyroid gland interspersed among the follicular cells or in clusters between the follicles. It produces and secretes calcitonin in response to its calcium receptor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal xml:lang="en">C33261</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C33261</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal xml:lang="en">C cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal xml:lang="en">C-Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitomin-secreting_Parafollicular_C_cells</IRI>
        <Literal xml:lang="en">Parafollicular Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal>é™é’™ç´ æµ‹å®š</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">Calcitonin (32 aa, ~3 kDa) is encoded by the human CALCA gene. This protein is involved in the modulation of blood calcium and phosphate concentrations through promoting incorporation of these ions into bone.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">C2281</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2281</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">CALCA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">CALCITONIN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">Calcitonin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Calcitonin_Tests</IRI>
        <Literal xml:lang="en">calcitonin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Carboplatin</IRI>
        <Literal>å¡é“‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">C1282</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Carboplatin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C1282</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O&apos;]platinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">1,1-cyclobutanedicarboxylic acid platinum complexBlastocarb</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">CARBOPLATIN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">CBDCA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplat</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplatin Hexal</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplatino</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carbosin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carbosol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carbotec</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Cis-Diammine(cyclobutane-1,1-dicarboxylato)platinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Displata</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Ercar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">JM-8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Nealorin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Novoplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Paraplat</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Paraplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Paraplatin AQ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Paraplatine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Platinwa</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Ribocarbo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">carboplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">cis-diammine(cyclobutanedicarboxylato)platinum II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal>ç™ŒèƒšæŠ—åŽŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">A cancer-specific antigen associated with both tumors and the developing fetus. The main use of this antigen is as a tumor marker, especially with respect to intestinal cancers. Production of the antigen ceases shortly before birth, but may reappear in people who develop certain types of cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">C25159</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25159</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">CEA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">CEA Family Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">Carcinoembryonic Antigen</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">Carcinoembryonic Antigen Family Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carcinoembryonic_antigen</IRI>
        <Literal xml:lang="en">carcinoembryonic antigen</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Care</IRI>
        <Literal xml:lang="en">C61488</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Care</IRI>
        <Literal>å…³æ€€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Care</IRI>
        <Literal xml:lang="en">The work of attending to someone or something.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Care</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61488</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Care</IRI>
        <Literal xml:lang="en">Care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Carotid_Sheaths</IRI>
        <Literal>é¢ˆåŠ¨è„‰éž˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Carotid_Sheaths</IRI>
        <Literal xml:lang="en">The carotid sheath is an anatomical term for the fibrous connective tissue that surrounds the vascular compartment of the neck. It is part of the deep cervical fascia of the neck, below the superficial cervical fascia meaning the subcutaneous adipose tissue immediately beneath the skin.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Carotid_Sheaths</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Carotid_sheath</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cellular_or_Molecular_Interactions</IRI>
        <Literal>åˆ†å­ç»†èƒžæœºåˆ¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cellular_or_Molecular_Interactions</IRI>
        <Literal xml:lang="en">Â C1373094</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cellular_or_Molecular_Interactions</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncim.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&amp;code=C1373094</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cellular_or_Molecular_Interactions</IRI>
        <Literal xml:lang="en">Cellular or Molecular Interactions</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cellular_or_Molecular_Interactions</IRI>
        <Literal xml:lang="en">Cellular or Molecular Interactions [MoA]</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cement_Injections</IRI>
        <Literal>æŽ¥åˆå‰‚æ³¨å°„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cement_Injections</IRI>
        <Literal xml:lang="en">Focal treatment of bone metastases of distant metastasis of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cement_Injections</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323297387000149?scrollTo=%23hl0002335</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Central_Lymph_Node_Dissection</IRI>
        <Literal>ä¸­å¤®åŒºæ·‹å·´ç»“æ¸…æ‰«æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Central_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Dissection of the lymph nodes that surround the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Central_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">C118544</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Central_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C118544</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Central_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Central Lymph Node Dissection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Chemotherapy</IRI>
        <Literal>åŒ–ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">C15632</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Chemotherapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15632</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">CHEMOTHERAPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">Chemo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">Chemotherapy (NOS)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">Chemotherapy, Cancer, General</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Chromogranin</IRI>
        <Literal>å—œé“¬ç²’è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Chromogranin</IRI>
        <Literal xml:lang="en">Chromogranins are acidic secretory glycoproteins with a widespread but specific distribution in neuroendocrine tissues. The chromogranin family is heterogenous, consisting of propeptides such as chromogranin-A, chromogranin-B and secretogranin II, which can either elicit an effect themselves, or serve as precursors to a large number of peptides, which are biologically more active.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Chromogranin</IRI>
        <Literal xml:lang="en">C16436</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Chromogranin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16436</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chromogranin</IRI>
        <Literal xml:lang="en">CHG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chromogranin</IRI>
        <Literal xml:lang="en">Chromogranin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Chylous_Fistula</IRI>
        <Literal>ä¹³ç³œç˜˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Chylous_Fistula</IRI>
        <Literal xml:lang="en">Chyle fistula is defined as a leakage of lymphatic fluid from the lymphatic vessels, typically accumulating in the thoracic or abdominal cavities but occasionally manifesting as an external fistula.Â It is a rare but potentially devastating and morbid condition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Chylous_Fistula</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://emedicine.medscape.com/article/190025-overview</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cisplatin</IRI>
        <Literal>é¡ºé“‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">C376</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cisplatin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C376</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">(SP-4-2)-Diamminedichloroplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Abiplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Blastolem</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Briplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">CDDP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">CISPLATIN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-diammine-dichloroplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-diamminedichloridoplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-diamminedichloro Platinum (II)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-diamminedichloroplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-dichloroammine Platinum (II)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-platinous Diamine Dichloride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-platinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-platinum II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cis-platinum II Diamine Dichloride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cismaplat</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cisplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cisplatina</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cisplatinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cisplatyl</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Citoplatino</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Citosin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Cysplatyna</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">DDP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Lederplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Metaplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Neoplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Peyrone&apos;s Chloride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Peyrone&apos;s Salt</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Placis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Plastistil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platamine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platiblastin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platiblastin-S</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinex</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinol- AQ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinol-AQ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinol-AQ VHA Plus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinoxan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinum Diamminodichloride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platinum, Diaminedichloro-, cis- (8CI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platiran</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platistin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">Platosin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cisplatin</IRI>
        <Literal xml:lang="en">cisplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Classical_Papillary_Thyroid_Carcinoma</IRI>
        <Literal>å…¸åž‹ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Classical_Papillary_Thyroid_Carcinoma</IRI>
        <Literal xml:lang="en">Classical PTC has been defined as â€œa malignant epithelial tumor showing evidence of follicular cell differentiation, and characterized by the formation of papillae and/or a set of distinctive nuclear changes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Classical_Papillary_Thyroid_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B9780323297387000149?scrollTo=%23hl0001399</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Classical_Papillary_Thyroid_Carcinoma</IRI>
        <Literal xml:lang="en">CPTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Clinical_Aspects</IRI>
        <Literal>ä¸´åºŠ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Clinical_Aspects</IRI>
        <Literal xml:lang="en">the clinical presentation of thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Clinical_Aspects</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781416058977000354?scrollTo=%23hl0000348</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Clinically_Evident_Metastasis</IRI>
        <Literal>ä¸´åºŠæ€§è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Clinically_Evident_Metastasis</IRI>
        <Literal xml:lang="en">patients with clinically evident disease based on preoperative physical exam, preoperative radiographic evaluation, or intraoperative demonstration of detectable disease (cN1)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Clinically_Evident_Metastasis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Coarse_Needle_Biopsy</IRI>
        <Literal>ç²—é’ˆç©¿åˆº</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Coarse_Needle_Biopsy</IRI>
        <Literal xml:lang="en">Coarse-needle biopsy (CNB) (Tru Cut, Vim Silverman) has not gained wide acceptance, but appreciation of the value of this biopsy technique appears to be increasing in the surgical community</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Coarse_Needle_Biopsy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://link.springer.com/chapter/10.1007/978-1-4612-3612-2_11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Coast</IRI>
        <Literal>æ²¿æµ·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Coast</IRI>
        <Literal xml:lang="en">The coast, also known as the coastline or seashore, is the area where land meets the sea or ocean,or a line that forms the boundary between the land and the ocean or a lake. A precise line that can be called a coastline cannot be determined due to the coastline paradox.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Coast</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Coast</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Colonic_Disturbances</IRI>
        <Literal>ç»“è‚ ç´Šä¹±</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Colonic_Disturbances</IRI>
        <Literal xml:lang="en">MEN 2B patients, 90% had colonic disturbances, typically chronic constipation from birth</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Colonic_Disturbances</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal>æŸ±çŠ¶ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal xml:lang="en">An epithelial cell that is taller than it is wide. The nucleus is oval, usually situated at the base of the cell. These cells line large glands and ducts.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal xml:lang="en">C13158</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C13158</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal xml:lang="en">Columnar Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell</IRI>
        <Literal xml:lang="en">Columnar Cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>æŸ±çŠ¶ç»†èƒžç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of pseudostratified malignant follicular cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C35830</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35830</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Columnar Cell Variant Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Columnar Cell Variant Papillary Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Columnar Cell Variant Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Columnar_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Complication</IRI>
        <Literal>å¹¶å‘ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Complication</IRI>
        <Literal xml:lang="en">Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Complication</IRI>
        <Literal xml:lang="en">C2959</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Complication</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2959</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Complication</IRI>
        <Literal xml:lang="en">Complication</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Complication</IRI>
        <Literal xml:lang="en">Medical Complication</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Complication</IRI>
        <Literal xml:lang="en">complication</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Composition</IRI>
        <Literal>æˆåˆ†</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Composition</IRI>
        <Literal xml:lang="en">The way in which something is made, especially in terms of its different parts; its constituents.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Composition</IRI>
        <Literal xml:lang="en">C53414</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Composition</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C53414</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Composition</IRI>
        <Literal xml:lang="en">COMPOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Composition</IRI>
        <Literal xml:lang="en">Composition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal>è®¡ç®—æœºæ–­å±‚æ‰«æ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">C17204</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17204</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CAT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CAT Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CAT scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CT SCAN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">CT scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">Computed Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">Computerized Axial Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">Computerized Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">computed tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">computerized axial tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">computerized tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computed_Tomography</IRI>
        <Literal xml:lang="en">tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Convoluted_Nuclei</IRI>
        <Literal>æ—‹ç»•åž‹æ ¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Convoluted_Nuclei</IRI>
        <Literal xml:lang="en">Convoluted nuclei are well-defined by the Turin consensus, but convoluted nuclei alone, without the aid of increased mitoses or necrosis, might be viewed as a subjective challenge to non-thyroid pathology experts.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Convoluted_Nuclei</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380407/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cricoid_Cartilage</IRI>
        <Literal>çŽ¯çŠ¶è½¯éª¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cricoid_Cartilage</IRI>
        <Literal xml:lang="en">A cartilage ring around the trachea below the thyroid cartilage.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cricoid_Cartilage</IRI>
        <Literal xml:lang="en">C32400</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cricoid_Cartilage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C32400</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cricoid_Cartilage</IRI>
        <Literal xml:lang="en">Cricoid Cartilage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cryoballoon_Ablation_Therapy</IRI>
        <Literal>å†·å†»æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cryoballoon_Ablation_Therapy</IRI>
        <Literal xml:lang="en">An image-guided, minimally invasive surgical technique that uses a balloon-tipped catheter to deliver cryogenic energy to targeted tissue, resulting in cell death secondary to cryogenic injury.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cryoballoon_Ablation_Therapy</IRI>
        <Literal xml:lang="en">C127818</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cryoballoon_Ablation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C127818</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cryoballoon_Ablation_Therapy</IRI>
        <Literal xml:lang="en">Cryoballoon Ablation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">A condition in which there is too much cortisol (a hormone made by the outer layer of the adrenal gland) in the body. Cushing syndrome may be caused by taking too many steroid drugs or by certain types of tumors. Tumors that make adrenocorticotropic hormone (ACTH) cause the adrenal gland to make too much cortisol. Symptoms of Cushing syndrome include a round face, thin arms and legs, severe fatigue and muscle weakness, high blood pressure, high blood sugar, purple or pink stretch marks on the skin, and weight gain, especially in the abdomen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal>åº“æ¬£ç»¼åˆå¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">A syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">C2969</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2969</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">Cushing Syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">Cushing syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">Cushingâ€˜s Syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cushing_Syndrome</IRI>
        <Literal xml:lang="en">Hypercortisolism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cystic-solid_Mixing</IRI>
        <Literal>å›Šå®žæ··åˆæ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cystic-solid_Mixing</IRI>
        <Literal xml:lang="en">a description of the noduleâ€™s sonographic features</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cystic-solid_Mixing</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal>å›Šæ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal xml:lang="en">A benign or malignant neoplasm that contains a single or multiple cystic spaces. Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal xml:lang="en">C6784</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C6784</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal xml:lang="en">Cystic Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cystic_Neoplasm</IRI>
        <Literal xml:lang="en">Cystic Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cytologic_Test</IRI>
        <Literal>ç»†èƒžå­¦è¯Šæ–­</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cytologic_Test</IRI>
        <Literal xml:lang="en">A diagnostic test utilized to examine and define cellular anatomy or function. The test results are often used by a clinician to diagnose disease or disordered function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cytologic_Test</IRI>
        <Literal xml:lang="en">C49132</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cytologic_Test</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C49132</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cytologic_Test</IRI>
        <Literal xml:lang="en">Cytologic Test</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal>ç»†èƒžæ¯’æ€§åŒ–ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">A drug therapy that is used to destroy cancer cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">C15681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#base64Binary">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">Cytotoxic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">Cytotoxic Chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">Cytotoxic Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cytotoxic_Chemotherapy</IRI>
        <Literal xml:lang="en">cytotoxic chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">DICER1 (Dicer 1, Ribonuclease III) is a Protein Coding gene. Diseases associated with DICER1 include Pleuropulmonary Blastoma and Goiter, Multinodular 1, With Or Without Sertoli-Leydig Cell Tumors. Among its related pathways are Formation of HIV-1 elongation complex containing HIV-1 Tat and RNAi Pathway. Gene Ontology (GO) annotations related to this gene include nucleic acid binding and hydrolase activity.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">C25956</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=DICER1&amp;keywords=DICER1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">DCR1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">DICER</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer 1, Double-Stranded RNA-Specific Endoribonuclease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer 1, Ribonuclease III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer 1, Ribonuclease Type III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer1, Dcr-1 Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer1, Dcr-1 Homolog (Drosophila)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Dicer1e</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.26</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.26.3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Endoribonuclease Dicer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">GLOW</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">HERNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Helicase MOI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Helicase With RNAse Motif</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Helicase With RNase Motif</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">K12H4.8-LIKE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">KIAA0928</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">MNG1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">Multinodular Goitre 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#DICER1_Gene</IRI>
        <Literal xml:lang="en">RMSE2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dacarbazin</IRI>
        <Literal>è¾¾å¡å·´å—ª</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">C411</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dacarbazin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C411</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-4-(Dimethyltriazeno)imidazole-5-carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">5-(Dimethyltriazeno)imidazole-4-carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">5-(dimethyltriazeno)imidazole-4-carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Asercit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Biocarbazine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">DACARBAZINE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">DIC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">DTIC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">DTIC-Dome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dacarbazina Almirall</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dacarbazine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dacarbazine - DTIC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dacatic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dakarbazin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Deticene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Detimedac</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dimethyl (triazeno) imidazolecarboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dimethyl Triazeno Imidazol Carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dimethyl Triazeno Imidazole Carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Dimethyl-triazeno-imidazole-carboximide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Fauldetic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Imidazole Carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Imidazole Carboxamide Dimethyltriazeno</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">Imidazole carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">WR-139007</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">dacarbazine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dacarbazin</IRI>
        <Literal xml:lang="en">dimethyl-triazeno-imidazole carboxamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dehydration</IRI>
        <Literal>è„±æ°´</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dehydration</IRI>
        <Literal xml:lang="en">A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dehydration</IRI>
        <Literal xml:lang="en">C26740</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dehydration</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26740</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dehydration</IRI>
        <Literal xml:lang="en">Dehydrated</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dehydration</IRI>
        <Literal xml:lang="en">Dehydration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dehydration</IRI>
        <Literal xml:lang="en">dehydration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>ç³–å°¿ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">C2985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">Diabetes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">Diabetes Mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">diabetes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal xml:lang="en">diabetes mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results or summary of such an investigation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diagnosis</IRI>
        <Literal>è¯Šæ–­</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">C15220</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Diagnosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15220</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">DIAGNOSIS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">Diagnosed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">Diagnosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">Diagnostic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">Dx</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal xml:lang="en">diagnosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diagnostic_IHC_Markers</IRI>
        <Literal>å…ç–«ç»„åŒ–æ ‡è®°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diagnostic_IHC_Markers</IRI>
        <Literal xml:lang="en">IHC is an excellent detection technique and has the tremendous advantage of being able to show exactly where a given protein is located within the tissue examined. It is also an effective way to examine the tissues. This has made it a widely used technique in the neurosciences, enabling researchers to examine protein expression within specific brain structures. Its major disadvantage is that, unlike immunoblotting techniques where staining is checked against a molecular weight ladder, it is impossible to show in IHC that the staining corresponds with the protein of interest. For this reason, primary antibodies must be well-validated in a Western Blot or similar procedure. The technique is even more widely used in diagnostic surgical pathology for immunophenotyping tumors (e.g. immunostaining for e-cadherin to differentiate between DCIS (ductal carcinoma in situ: stains positive) and LCIS (lobular carcinoma in situ: does not stain positive)[9]). More recently, Immunohistochemical techniques have been useful in differential diagnoses of multiple forms of salivary gland, head, and neck carcinomas.

The diversity of IHC markers used in diagnostic surgical pathology is substantial. Many clinical laboratories in tertiary hospitals will have menus of over 200 antibodies used as diagnostic, prognostic and predictive biomarkers. Examples of some commonly used markers include:

    BrdU: used to identify replicating cells. Used to identify tumors as well as in neuroscience research.
    Cytokeratins: used for identification of carcinomas but may also be expressed in some sarcomas.
    CD15 and CD30 : used for Hodgkin&apos;s disease
    Alpha fetoprotein: for yolk sac tumors and hepatocellular carcinoma
    CD117 (KIT): for gastrointestinal stromal tumors (GIST) and mast cell tumors
    CD10 (CALLA): for renal cell carcinoma and acute lymphoblastic leukemia
    Prostate specific antigen (PSA): for prostate cancer
    estrogens and progesterone receptor (ER &amp; PR) staining are used both diagnostically (breast and gyn tumors) as well as prognostic in breast cancer and predictive of response to therapy (estrogen receptor)
    Identification of B-cell lymphomas using CD20
    Identification of T-cell lymphomas using CD3(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal>å½±åƒå­¦æ£€æŸ¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal xml:lang="en">Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal xml:lang="en">C16502</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16502</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal xml:lang="en">Diagnostic Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal xml:lang="en">Imaging test</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnostic_Imaging</IRI>
        <Literal xml:lang="en">Medical Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diarrhea</IRI>
        <Literal>è…¹æ³»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">Watery bowel movements.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">C2987</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Diarrhea</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2987</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">Diarrhea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">Diarrheal Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">Frequent Stools</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">Loose Stools</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diarrhea</IRI>
        <Literal xml:lang="en">diarrhea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal>æ°Ÿæ‘„å…¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">Form of the element fluorine found in foods.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">C68252</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">Dietary Fluorine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">F</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">Fluorine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal xml:lang="en">Molecular Fluorine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Fluorine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C68252</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal>é¥®é£Ÿæ‘„å…¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal xml:lang="en">Form of the element iodine found in foods.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal xml:lang="en">C68254</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C68254</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal xml:lang="en">Dietary Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal xml:lang="en">Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Intake</IRI>
        <Literal xml:lang="en">Molecular Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal>ç¡’æ‘„å…¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal xml:lang="en">Forms of the element selenium found in foods.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal xml:lang="en">C68281</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C68281</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal xml:lang="en">Dietary Selenium</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Selenium</IRI>
        <Literal xml:lang="en">Selenium</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal>ç¢˜æ‘„å…¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">Form of the element iodine found in foods.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">C2348268</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C68254</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">Dietary Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">I</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_iodine</IRI>
        <Literal xml:lang="en">Molecular Iodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal>åˆ†åŒ–åž‹ç”²çŠ¶è…ºç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">C7153</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C7153</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Differentiated Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Differentiated Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Differentiated Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Differentiated thyroid gland cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Differentiated Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>å¼¥æ¼«ç¡¬åŒ–åž‹ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">A morphologic variant of papillary carcinoma of the thyroid gland that more often affects young patients and commonly metastasizing to the lungs. It is characterized by a diffuse infiltration of the thyroid gland by malignant follicular cells, squamous metaplasia, stromal fibrosis, and lymphocytic infiltration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C7427</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C7427</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Diffuse Sclerosing Variant Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Nonencapsulated Sclerosing Adenocarcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Nonencapsulated Sclerosing Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Nonencapsulated Sclerosing Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Nonencapsulated Sclerosing Papillary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Nonencapsulated Sclerosing Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diffuse_Sclerosing_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Diffuse Sclerosing Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal>èƒƒè‚ è¡¨çŽ°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">C2990</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2990</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Digestive Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Digestive System Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Digestive System Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Disorder of Digestive System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Gastrointestinal Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Gastrointestinal System Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">Gastrointestinal System Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Disorder</IRI>
        <Literal xml:lang="en">stomach or intestinal disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal>èƒƒè‚ é“ç˜˜å½¢æˆ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal xml:lang="en">An abnormal communication between any part of the digestive system and another organ or cavity.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal xml:lang="en">C78319</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C78319</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal xml:lang="en">Digestive System Fistula</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal xml:lang="en">Gastrointestinal Fistula</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Digestive_System_Fistula</IRI>
        <Literal xml:lang="en">Gastrointestinal fistula</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Digestive_Tract_Reaction</IRI>
        <Literal>æ¶ˆåŒ–é“ååº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Digestive_Tract_Reaction</IRI>
        <Literal xml:lang="en">gastrointestinal adverse effects</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Distant_Metastases</IRI>
        <Literal>è¿œå¤„è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Distant_Metastases</IRI>
        <Literal xml:lang="en">Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes. Also known as distant cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Distant_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distant-metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Docetaxel</IRI>
        <Literal>å¤šçƒ¯ç´«æ‰é†‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata. Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death. This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response. Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">C1526</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Docetaxel</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C1526</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">DOCETAXEL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">Docecad</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">Docetaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">RP56976</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">Taxotere</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">Taxotere Injection Concentrate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">[2aR-[2a alphaa,4beta,4a beta,6beta,9alpha,(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-[[(1,1-dimethylethoxy)carbonyl]-amino]-alpha-hydroxybenzemepropanoic Acid 12b-(Acetyloxy)-12(benzyloxy)-2a,3,4,4a,5,6,8,10,11,12,12a,12b-dodecahydeo-4,-6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Docetaxel</IRI>
        <Literal xml:lang="en">docetaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dosage_of_131I</IRI>
        <Literal>ç¢˜131çš„å‰‚é‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dosage_of_131I</IRI>
        <Literal xml:lang="en">131I dose for thyroid cancer patients</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Doxorubicin</IRI>
        <Literal>é˜¿éœ‰ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">C456</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Doxorubicin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C456</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">14-Hydroxydaunomycin;Adriablastin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">DOXORUBICIN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">Doxorubicin;doxorubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">Hydroxydaunomycin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">Hydroxyl Daunorubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">Hydroxyldaunorubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">The use of illegal drugs or the use of prescription or over-the-counter drugs for purposes other than those for which they are meant to be used, or in large amounts. Drug abuse may lead to social, physical, emotional, and job-related problems.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Drug_abuse</IRI>
        <Literal>å¸æ¯’</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">he use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">C16522</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Drug_abuse</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16522</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">Drug Abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">Drug Use Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">Recreational Drug Use</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_abuse</IRI>
        <Literal xml:lang="en">drug abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dual_Cancer</IRI>
        <Literal>äºŒé‡ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dual_Cancer</IRI>
        <Literal xml:lang="en">Other non-thyroid cancer with existing thyroid cancers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dysphagia</IRI>
        <Literal>åžå’½éšœç¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dysphagia</IRI>
        <Literal xml:lang="en">A symptom referring to difficulty in swallowing. It may be observed in patients with stroke, motor neuron disorders, cancer of the throat or mouth, head and neck injuries, Parkinson disease, and multiple sclerosis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dysphagia</IRI>
        <Literal xml:lang="en">C2980</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dysphagia</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2980</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dysphagia</IRI>
        <Literal xml:lang="en">Difficulty Swallowing</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dysphagia</IRI>
        <Literal xml:lang="en">Dysphagia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dysphagia</IRI>
        <Literal xml:lang="en">dysphagia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">Includes dyspnea on exertion, dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dyspnea</IRI>
        <Literal>è¿›è¡Œæ€§åžå’½å›°éš¾ã€å‘¼å¸å›°éš¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">C2998</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dyspnea</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2998</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">Breathing Difficulties</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">DYSPNEA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">Difficulty Breathing</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">Dyspnea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">Shortness of Breath</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dyspnea</IRI>
        <Literal xml:lang="en">dyspnea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#E-Cadherin_Signaling_Pathway</IRI>
        <Literal>ä¸Šçš®ç»†èƒžé’™ç²˜è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#E-Cadherin_Signaling_Pathway</IRI>
        <Literal xml:lang="en">C91575</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#E-Cadherin_Signaling_Pathway</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C91575</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#E-Cadherin_Signaling_Pathway</IRI>
        <Literal xml:lang="en">E-Cadherin Signaling Pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#E-Cadherin_Signaling_Pathway</IRI>
        <Literal xml:lang="en">E-cadherin signaling events</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Echogenicity</IRI>
        <Literal>å›žå£°å¼ºåº¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Echogenicity</IRI>
        <Literal xml:lang="en">Echogenicity (misspelled sometimes as echogenecity) or echogeneity is the ability to bounce an echo, e.g. return the signal in ultrasound examinations. In other words, echogenicity is higher when the surface bouncing the sound echo reflects increased sound waves. Tissues that have higher echogenicity are called &quot;hyperechogenic&quot; and are usually represented with lighter colors on images in medical ultrasonography. In contrast, tissues with lower echogenicity are called &quot;hypoechogenic&quot; and are usually represented with darker colors. Areas that lack echogenicity are called &quot;anechogenic&quot; and are usually displayed as completely dark. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Echogenicity</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Echogenicity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">Highest level of education that a person has attained.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Education_Level</IRI>
        <Literal>å—æ•™è‚²æ°´å¹³</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">An indication of the years of schooling completed in graded public, private, or parochial schools, and in colleges, universities, or professional schools.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">C17953</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Education_Level</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17953</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">Education</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">Education Level Completed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">Education level</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Level</IRI>
        <Literal xml:lang="en">Educational Attainment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Elastography</IRI>
        <Literal xml:lang="en">An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Elastography</IRI>
        <Literal>è¶…å£°å¼¹æ€§æˆåƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Elastography</IRI>
        <Literal xml:lang="en">An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Elastography</IRI>
        <Literal xml:lang="en">C106517</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Elastography</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C106517</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Elastography</IRI>
        <Literal xml:lang="en">ELASTOGRAPHY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Elastography</IRI>
        <Literal xml:lang="en">Elastography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Empiric_RAI_Therapy</IRI>
        <Literal>ç»éªŒæ€§ç¢˜æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Empiric_RAI_Therapy</IRI>
        <Literal xml:lang="en">then empiric therapy with RAI (100â€“200mCi) or dosimetrically determined RAI activities can be considered for two purposes: (i) to aid in disease localization, and/or (ii) as therapy for nonsurgical disease. This approach may identify the location of persistent disease in approximately 50% of patients</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Empiric_RAI_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Endocrine_Syndrome</IRI>
        <Literal>ç»¼åˆå¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Endocrine_Syndrome</IRI>
        <Literal xml:lang="en">A group of signs, symptoms, and clinicopathological characteristics that result from the pathologic function of one or more endocrine organs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Endocrine_Syndrome</IRI>
        <Literal xml:lang="en">C27564</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Endocrine_Syndrome</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C27564</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endocrine_Syndrome</IRI>
        <Literal xml:lang="en">Endocrine Syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal>å†…åˆ†æ³Œç–¾ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">C3009</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">Disorder of Endocrine System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3009</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">Endocrine Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">Endocrine Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">Endocrine System Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endocrine_System_Disorder</IRI>
        <Literal xml:lang="en">Endocrinopathy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">An examination of the body using an endoscope.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal>å†…çª¥é•œæ£€æŸ¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">A diagnostic or therapeutic procedure in which an endoscope is inserted in a tubular organ to examine the structural architecture and/or remove abnormal tissues.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">C16546</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16546</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">ENDOSCOPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">Endoscopic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">Endoscopic Examination</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">Endoscopic Procedure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">Endoscopy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Endoscopic_Procedure</IRI>
        <Literal xml:lang="en">endoscopy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Environment</IRI>
        <Literal>çŽ¯å¢ƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Environment</IRI>
        <Literal xml:lang="en">The totality of surrounding conditions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Environment</IRI>
        <Literal xml:lang="en">C16551</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Environment</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16551</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Environment</IRI>
        <Literal xml:lang="en">Environment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Environment</IRI>
        <Literal xml:lang="en">Environmental</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Esophagus</IRI>
        <Literal>é£Ÿç®¡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">C12389</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Esophagus</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12389</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">ESOPHAGUS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">Esophagus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">Gastrointestinal Tract, Esophagus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Esophagus</IRI>
        <Literal xml:lang="en">esophagus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal>ï¼ˆç»çš®ï¼‰ä¹™é†‡æ³¨å°„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">An injection of ethanol (alcohol) through the skin directly into a tumor to kill cancer cells. Ultrasound or a CT scan is used to guide the needle into the tumor. (NCI-GLOSS Definition)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">C67444</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#base64Binary">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C67444</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">Ethanol Ablation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">PEI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">alcohol ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">ethanol ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ethanol_Ablation_Therapy</IRI>
        <Literal xml:lang="en">percutaneous ethanol injection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Etiology</IRI>
        <Literal>ç—…å› å­¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">The cause of a disease or abnormal condition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">C16390</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Etiology</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16390</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">Causation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">Cause</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">Etiology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology</IRI>
        <Literal xml:lang="en">etiology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Excellent_Response</IRI>
        <Literal>è‰¯å¥½ååº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Excellent_Response</IRI>
        <Literal xml:lang="en">An excellent response to therapy should lead to a decrease in the intensity and frequency of follow up and the degree of TSH suppression
Note: This change in management will be most apparent in ATA intermediate and high risk patients.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Excellent_Response</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://eguideline.guidelinecentral.com/i/631815-differentiated-thyroid-cancer/21?</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">A type of radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal>å¤–éƒ¨æ”¾å°„æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">C15751</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15751</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Definitive Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">EBRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">EXTERNAL BEAM RADIATION THERAPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">External Beam RT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">External Beam Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">External Beam Radiotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">External Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">external radiation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_Beam_Radiation_Therapy</IRI>
        <Literal xml:lang="en">external-beam radiation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#External_Branches</IRI>
        <Literal>å¤–æ”¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#External_Branches</IRI>
        <Literal xml:lang="en">The superior laryngeal nerve has two branches: an internal branch that supplies sensory fibers to the larynx and an external branch that supplies motor fibers to the cricothyroid muscles and tenses the vocal cords. The external branch can run closely adherent to the superior thyroid artery, and care must be exercised during dissection in this area. Injury to the external branch causes voice changes, huskiness, poor volume and projection, voice fatigue, and inability to sing at higher ranges.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#External_Branches</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001962</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">A type of radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal>å¤–æ”¾å°„çº¿ç–—æ³•</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">C15751</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">Definitive Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">EBRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">EXTERNAL BEAM RADIATION THERAPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">External Beam RT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">External Beam Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">External Beam Radiotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">External Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">external radiation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal xml:lang="en">external-beam radiation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#External_beam_radiation_therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15751</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Extracapsular_Nodal_Extension</IRI>
        <Literal>ç»“èŠ‚å›Šå¤–ä¾µçŠ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Extracapsular_Nodal_Extension</IRI>
        <Literal xml:lang="en">Extra-nodal extension (ENE) is a commonly observed microscopic feature in positive nodes  and may be important to better identify patients at increased risk of loco-regional or distant relapse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Extracapsular_Nodal_Extension</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171853</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Extrathyroidal_Extension</IRI>
        <Literal>ç”²çŠ¶è…ºå¤–ä¾µçŠ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Extrathyroidal_Extension</IRI>
        <Literal xml:lang="en">Extrathyroidal extension (ETE) is defined as extension of the primary tumor outside of the thyroid capsule and invasion into the surrounding structures (eg, strap muscles, trachea, larynx, vasculature, esophagus, and recurrent laryngeal nerve)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Extrathyroidal_Extension</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/484778</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#FNA-Tg</IRI>
        <Literal>ç»†é’ˆç©¿åˆºæŠ½å¸ç‰©æ´—è„±æ¶²ç”²çŠ¶è…ºçƒè›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#FNA-Tg</IRI>
        <Literal xml:lang="en">Use with FNA biopsy of thyroid nodules to diagnose benign or malignant non-medullary thyroid nodules.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#FNA-Tg</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://ltd.aruplab.com/Tests/Pub/0020753</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#FNA-calcitonin</IRI>
        <Literal>ç»†é’ˆç©¿åˆºæŠ½å¸ç‰©æ´—è„±æ¶²é™é’™ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#FNA-calcitonin</IRI>
        <Literal xml:lang="en">As an adjunct to cytologic examination of fine-needle aspiration specimens in athyrotic individuals treated for medullary thyroid carcinoma to confirm or exclude metastases in enlarged or ultrasonographically suspicious lymph nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#FNA-calcitonin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.mayocliniclabs.com/test-catalog/Overview/61527</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">FOXE1 (Forkhead Box E1) is a Protein Coding gene. Diseases associated with FOXE1 include Hypothyroidism, Thyroidal Or Athyroidal, With Spiky Hair And Cleft Palate and Thyroid Cancer, Nonmedullary, 4. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and DNA-binding transcription factor activity, RNA polymerase II-specific. An important paralog of this gene is FOXE3.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=FOXE1&amp;keywords=FOXE1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">FKHL15</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">FOXE2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead Box E1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead Box E1 (Thyroid Transcription Factor 2)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead Box E2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead Box Protein E1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead Box Protein E2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead, Drosophila, Homolog-Like 15</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Forkhead-Related Protein FKHL15</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">HFKH4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">HFKL5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">HNF-3/Fork Head-Like Protein 5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">NMTC4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">TITF2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">TTF-2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">TTF2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#FOXE1_Gene</IRI>
        <Literal xml:lang="en">Thyroid Transcription Factor 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Failure_to_Thrive</IRI>
        <Literal>å‘è‚²ä¸è‰¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Failure_to_Thrive</IRI>
        <Literal xml:lang="en">A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Failure_to_Thrive</IRI>
        <Literal xml:lang="en">C107587</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Failure_to_Thrive</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C107587</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Failure_to_Thrive</IRI>
        <Literal xml:lang="en">Failure to Thrive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">A record of the relationships among family members along with their medical histories. This includes current and past illnesses. A family history may show a pattern of certain diseases in a family.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal>å®¶æ—å²</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">A record of a patient&apos;s background regarding health and disease events of blood relatives. A patient&apos;s family medical history may be important in diagnosing existing conditions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">C17726</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17726</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">Epidemiology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">Family History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">Family History of</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">family Medical History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">family history</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_Medical_History</IRI>
        <Literal xml:lang="en">family medical history</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">Unusual tiredness and inability to perform usual activities.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Fatigue</IRI>
        <Literal>ç–²åŠ³</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">Overall tiredness and lack of energy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">C3036</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Fatigue</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3036</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">FATIGUE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">Fatigue</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">Lack of Energy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fatigue</IRI>
        <Literal xml:lang="en">fatigue</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">The removal of tissue specimens or fluid from the living body with a thin needle.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal>ç»†é’ˆç©¿åˆºæŠ½å¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">C15361</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15361</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">Aspirate, Fine Needle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">FINE NEEDLE ASPIRATION</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">FNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">FNA biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">Fine Needle Aspiration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">Fine-Needle Aspiration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fine-Needle_Aspiration</IRI>
        <Literal xml:lang="en">fine-needle aspiration biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Fluorouracil</IRI>
        <Literal>æ°Ÿå°¿å˜§å•¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2&apos;-deoxyuridine-5&apos;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">C505</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Fluorouracil</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C505</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">2,4-Dioxo-5-fluoropyrimidine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5 FU</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5 Fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5 Fluorouracilum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-FU</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-Fluoro-2,4(1H, 3H)-pyrimidinedione</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-Fluoro-2,4(1H,3H)-pyrimidinedione;5-Fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-Fluracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-Fu</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5-fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">5FU</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">AccuSite</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Adrucil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Carac</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">FLUOROURACIL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluoro Uracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Flurablasti</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Flurace</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluril</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluroblastin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Ribofluor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Ro 2-9757</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Ro-2-9757</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Flushed_Face</IRI>
        <Literal>é¢è‰²æ½®çº¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Flushed_Face</IRI>
        <Literal xml:lang="en">These typical phenotypic features of MEN 2B  include proximal muscle weakness</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Flushed_Face</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>æ»¤æ³¡å˜å¼‚åž‹ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C126594</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C126594</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">FVPTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Variant Thyroid Gland Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follicular_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Thyroid Carcinoma,Follicular Variant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Monitoring a person&apos;s health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Follow-up</IRI>
        <Literal>éšè®¿</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">C16033</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Follow-up</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16033</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Active Follow-up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">CLSFUP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Clinical Signs Follow-up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Follow Up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Follow-Up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Follow-up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">Followup</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Follow-up</IRI>
        <Literal xml:lang="en">follow-up</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">A measurement of the free thyroxine in a biological specimen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal>è¡€æ¸…æ¸¸ç¦»ç”²çŠ¶è…ºç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">The determination of the amount of free thyroxine present in a sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">C74786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C74786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">Free T4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">Free Thyroxine Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">T4-Free</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">T4FR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">Thyroxine, Free</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Thyroxine</IRI>
        <Literal xml:lang="en">fT4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">A measurement of the free triiodothyronine in a biological specimen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal>æ¸¸ç¦»ä¸‰ç¢˜ç”²çŠ¶è…ºåŽŸæ°¨é…¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">The determination of the amount of free triiodothyronine present in a sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">C74787</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C74787</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">Free T3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">Free Triiodothyronine Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">T3FR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">Triiodothyronine, Free</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Free_Triiodothyronine</IRI>
        <Literal xml:lang="en">fT3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Frozen_Section_Procedure</IRI>
        <Literal>æœ¯ä¸­å†°å†»åˆ‡ç‰‡æ£€æŸ¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Frozen_Section_Procedure</IRI>
        <Literal xml:lang="en">The frozen section procedure is a pathological laboratory procedure to perform rapid microscopic analysis of a specimen. It is used most often in oncological surgery.[1] The technical name for this procedure is cryosection.

The quality of the slides produced by frozen section is of lower quality than formalin fixed paraffin embedded tissue processing. While diagnosis can be rendered in many cases, fixed tissue processing is preferred in many conditions for more accurate diagnosis.

The intraoperative consultation is the name given to the whole intervention by the pathologist, which includes not only frozen section but also gross evaluation of the specimen, examination of cytology preparations taken on the specimen (e.g. touch imprints), and aliquoting of the specimen for special studies (e.g. molecular pathology techniques, flow cytometry). The report given by the pathologist is usually limited to a &quot;benign&quot; or &quot;malignant&quot; diagnosis, and communicated to the surgeon operating via intercom. When operating on a previously confirmed malignancy, the main purpose of the pathologist is to inform the surgeon if the resection margin is clear of residual cancer, or if residual cancer is present at the resection margin. The method of processing is usually done with the bread loafing technique. But margin controlled surgery (CCPDMA) can be performed using a variety of tissue cutting and mounting methods, including Mohs surgery. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Frozen_Section_Procedure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Frozen_section_procedure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Functioning_Forearm_Autograft</IRI>
        <Literal>åŠŸèƒ½æ€§å‰è‡‚è‡ªä½“ç§»æ¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Functioning_Forearm_Autograft</IRI>
        <Literal xml:lang="en">The site of autotransplantation is within the brachioradialis muscle of the nondominant forearm to prevent a potential cervical reoperation. In follow-up, serum PTH levels obtained from right and left basilic veins can be used to monitor function of the autotransplantation. Prior to autotransplantation, a piece of tissue should be submitted for frozen section to confirm parathyroid tissue.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Functioning_Forearm_Autograft</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781437722277000678?scrollTo=%23hl0000249</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ganglioneuromatosis</IRI>
        <Literal>æ³Œå°¿ç³»ç»Ÿçš„ç¥žç»èŠ‚ç˜¤ç—…å’Œç•¸å½¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ganglioneuromatosis</IRI>
        <Literal xml:lang="en">Extensive and diffuse infiltration of tissues by ganglioneuroma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ganglioneuromatosis</IRI>
        <Literal xml:lang="en">C66804</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ganglioneuromatosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C66804</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ganglioneuromatosis</IRI>
        <Literal xml:lang="en">Ganglioneuromatosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ganglioneuromatosis_of_the_Intestine</IRI>
        <Literal>è‚ ç¥žç»èŠ‚ç˜¤ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ganglioneuromatosis_of_the_Intestine</IRI>
        <Literal xml:lang="en">Intestinal ganglioneuromatosis is a rare neoplastic condition characterized by marked proliferation of ganglion cells, Schwann cells, and nerve fibers in the wall of the bowel. ... We therefore present the imaging findings in a patient with the diffuse form of intestinal ganglioneuromatosis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ganglioneuromatosis_of_the_Intestine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ajronline.org/doi/full/10.2214/ajr.182.5.1821166</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal>èƒƒè‚ ç‚Ž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal xml:lang="en">An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal xml:lang="en">C34632</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C34632</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal xml:lang="en">Gastroenteritis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gastroenteritis</IRI>
        <Literal xml:lang="en">gastroenteritis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Gender</IRI>
        <Literal xml:lang="en">Subject self-identification re: masculine/feminine. [IOM] See also sex.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gender</IRI>
        <Literal>æ€§åˆ«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gender</IRI>
        <Literal xml:lang="en">The assemblage of properties that distinguish people on the basis of the societal roles expected for the two sexes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Gender</IRI>
        <Literal xml:lang="en">C17357</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gender</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17357</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gender</IRI>
        <Literal xml:lang="en">Gender</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gender</IRI>
        <Literal xml:lang="en">gender</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gene</IRI>
        <Literal>åŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">C16612</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16612</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">GENE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">Genes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">An abnormally large cell with more than one nucleus. (INHAND)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Giant_Cell</IRI>
        <Literal>å·¨ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">An abnormally large cell that contains multiple nuclei and an abundant amount of cytoplasm.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Giant_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12607</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">Giant Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">MULTINUCLEATED GIANT CELL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">Multinucleated Giant Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Giant_Cell</IRI>
        <Literal xml:lang="en">syncytium</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gland_Size</IRI>
        <Literal>è…ºä½“å¤§å°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gland_Size</IRI>
        <Literal xml:lang="en">Ultrasound should evaluate the following: thyroid parenchyma(homogeneous or heterogeneous) and gland size; size, location, zand sonographic characteristics of any nodule(s); the presence or absence of any suspicious cervical lymph nodes in the central or lateral compartments.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gland_Size</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gravel-like</IRI>
        <Literal>ç ‚ç ¾æ ·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gravel-like</IRI>
        <Literal xml:lang="en">A Pathological Cell Morphology of Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gravel-like</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Gross_Tumor_Resection</IRI>
        <Literal xml:lang="en">è‚¿ç˜¤å¤§éƒ¨åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Gross_Tumor_Resection</IRI>
        <Literal xml:lang="en">potentially curative surgery, resection of all visible disease, which included leaving minimal residual disease adherent to important neck structures such as the recurrent laryngeal nerve, carotid artery, trachea, or esophagus (R0/R1);</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Gross_Tumor_Resection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0196070917301540</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal>æ˜¾å¾®é•œä¸‹åˆ‡ç¼˜é˜´æ€§ï¼ˆR0åˆ‡é™¤ï¼‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal xml:lang="en">The absence of tumor cells at the edge of a surgically excised specimen, both macroscopically and microscopically.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal xml:lang="en">C120288</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C120288</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal xml:lang="en">Grossly Negative and Microscopically Negative Surgical Margin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Grossly_Negative_and_Microscopically_Negative_Surgical_Margin</IRI>
        <Literal xml:lang="en">Grossly negative and microscopically negative</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">HABP2 (Hyaluronan Binding Protein 2) is a Protein Coding gene. Diseases associated with HABP2 include Thyroid Cancer, Nonmedullary, 5 and Familial Papillary Or Follicular Thyroid Carcinoma. Gene Ontology (GO) annotations related to this gene include calcium ion binding and glycosaminoglycan binding. An important paralog of this gene is HGF.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=HABP2&amp;keywords=HABP2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">EC 3.4.21</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">EC 3.4.21.-</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">EC 3.4.21.4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">EC 3.4.21.92</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">FSAP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Factor Seven-Activating Protease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Factor VII Activating Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Factor VII-Activating Protease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">HABP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">HGFAL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Hepatocyte Growth Factor Activator-Like Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Hyaluronan Binding Protein 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Hyaluronan-Binding Protein 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Hyaluronic Acid Binding Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">NMTC5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">PHBP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Plasma Hyaluronan Binding Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HABP2_Gene</IRI>
        <Literal xml:lang="en">Plasma Hyaluronan-Binding Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">HRAS (HRas Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with HRAS include Costello Syndrome and Schimmelpenning-Feuerstein-Mims Syndrome. Among its related pathways are Gastric cancer and Cytoskeleton remodeling_RalA regulation pathway. Gene Ontology (GO) annotations related to this gene include GTP binding and protein C-terminus binding. An important paralog of this gene is NRAS.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C17060</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=HRAS&amp;keywords=HRAS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-BAS/HAS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-H-RAS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-H-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-HA-RAS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-Has/Bas P21 Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-K-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-Ki-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">C-Ras-Ki-2 Activated Oncogene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">CTLO</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">GTP- And GDP-Binding Peptide B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">GTPase HRas</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">GTPase KRas</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">H-RASIDX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">H-Ras-1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">HAMSV</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">HRAS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">HRas Proto-Oncogene, GTPase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Ha-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Ha-Ras1 Proto-Oncoprotein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Harvey Rat Sarcoma Viral Oncogene Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Harvey Rat Sarcoma Viral Oncoprotein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">K-Ras 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">KRAS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">KRAS2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Ki-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">P19 H-RasIDX Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">P21ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">RASH1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">RASK2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Ras Family Small GTP Binding Protein H-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Transformation Gene: Oncogene HAMSV</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">Transforming Protein P21</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#HRAS_Gene</IRI>
        <Literal xml:lang="en">V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Habits_and_Behavious</IRI>
        <Literal>å—œå¥½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Habits_and_Behavious</IRI>
        <Literal xml:lang="en">Basic behavioral studies designed to strengthen the understanding of the determinants and processes that influence cancer-related risk behaviours</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Habits_and_Behavious</IRI>
        <Literal xml:lang="en">C15942</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Habits_and_Behavious</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15942</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Habits_and_Behavious</IRI>
        <Literal xml:lang="en">Basic behavioral studies in cancer-related behaviors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">An autoimmune condition of the thyroid gland (a gland located beneath the larynx). It is caused by the formation of antibodies that attack the thyroid gland and it usually causes hypothyroidism (too little thyroid hormone). Symptoms include fatigue, weight gain, constipation, dry skin, depression, and the inability to exercise. It is more common in females and can run in families.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal>æ¡¥æœ¬ç”²çŠ¶è…ºç‚Ž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">C27191</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C27191</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Autoimmune Thyroiditis;autoimmune thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Chronic Lymphocytic Thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto Thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto&apos;s Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Hashimoto&apos;s Thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">Lymphocytic Thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hashimoto_Thyroiditis</IRI>
        <Literal xml:lang="en">autoimmune thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal>çš®è‚¤æ”¹å˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">A question about whether an individual has or had noticed changes in their skin.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">C125146</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C125146</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">Changes in skin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">Have Changes in Skin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">Have Noticed New Changes in Skin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Have_Noticed_New_Changes_in_Skin</IRI>
        <Literal xml:lang="en">I have noticed new changes in my skin (lumps, bumps, color)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal>å¿ƒåŠŸèƒ½éšœç¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal xml:lang="en">C3079</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3079</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal xml:lang="en">Heart Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal xml:lang="en">Heart Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Disorder</IRI>
        <Literal xml:lang="en">Heart trouble</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>å¿ƒè¡°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">C50577</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Heart_Failure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50577</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Cardiac Failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Cardiac Insufficiency</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Failure, Heart</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Heart Failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Heart failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal xml:lang="en">Insufficiency, Cardiac</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hemoptysis</IRI>
        <Literal>å’¯è¡€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hemoptysis</IRI>
        <Literal xml:lang="en">Coughing up blood from the respiratory tract.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hemoptysis</IRI>
        <Literal xml:lang="en">C3094</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hemoptysis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3094</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemoptysis</IRI>
        <Literal xml:lang="en">Coughing up Blood</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemoptysis</IRI>
        <Literal xml:lang="en">Hemoptysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemoptysis</IRI>
        <Literal xml:lang="en">hemoptysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hemorrhage</IRI>
        <Literal>å‡ºè¡€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">The flow of blood from a ruptured blood vessel.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">C26791</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hemorrhage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26791</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">Bleeding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">HEMORRHAGE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemorrhage</IRI>
        <Literal xml:lang="en">hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hepatotoxicity</IRI>
        <Literal>è‚æ¯’æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hepatotoxicity</IRI>
        <Literal xml:lang="en">Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury is a cause of acute and chronic liver disease.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hepatotoxicity</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Hepatotoxicity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">An inherited form of medullary thyroid cancer (cancer that forms in the cells of the thyroid that make the hormone calcitonin).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal>å®¶æ—æ€§ç”²çŠ¶è…ºé«“æ ·ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">A medullary thyroid gland carcinoma inherited through an autosomal dominant mode.  It is associated with multiple endocrine neoplasia type II (2a) or III (2b).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">C46099</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C46099</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Familial Thyroid Gland Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Hereditary Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Hereditary Thyroid Gland Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hereditary_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">familial medullary thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Heterogeneous_Echotexture</IRI>
        <Literal>å¯†åº¦ä¸å‡åŒ€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Heterogeneous_Echotexture</IRI>
        <Literal xml:lang="en">A description of heterogeneous density elements seen in a tissue composition image obtained by sonography.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Heterogeneous_Echotexture</IRI>
        <Literal xml:lang="en">C69214</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Heterogeneous_Echotexture</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C69214</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heterogeneous_Echotexture</IRI>
        <Literal xml:lang="en">Heterogeneous Echotexture</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#High_Molecular_Weight_Keratins</IRI>
        <Literal>é«˜åˆ†å­é‡è§’è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#High_Molecular_Weight_Keratins</IRI>
        <Literal xml:lang="en">is a Immunohistochemical Markers Useful for the Diagnosis of Anaplastic Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#High_Molecular_Weight_Keratins</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2012.0302?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#High_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is almost certain.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#High_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is almost certain.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#High_Risk</IRI>
        <Literal xml:lang="en">C102401</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#High_Risk</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C102401</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#High_Risk</IRI>
        <Literal xml:lang="en">HIGH RISK</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#High_Risk</IRI>
        <Literal xml:lang="en">High Risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#High_suspicion</IRI>
        <Literal>é«˜åº¦å¯ç–‘æ¶æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#High_suspicion</IRI>
        <Literal xml:lang="en">Solid hypoechoic nodule or solid hypoechoic component of a partially cystic nodule with one or more of the following features: irregular margins (infiltrative, microlobulated), microcalcifications, taller than wide shape, rim calcifications with small extrusive soft tissue component, evidence of extrathyroidal extension</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#High_suspicion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0002961017313673?scrollTo=%23tbl1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Highly_Invasive_Papillary_Thyroid_Cancer</IRI>
        <Literal>é«˜ä¾µè¢­æ€§ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Highly_Invasive_Papillary_Thyroid_Cancer</IRI>
        <Literal xml:lang="en">the type of papillary thyroid carcinoma has highly aggressive feature</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Highly_Invasive_Papillary_Thyroid_Cancer</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B9781437715347000277?scrollTo=%23hl0002800</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">The study of tissues and cells under a microscope.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Histology</IRI>
        <Literal>ç»„ç»‡å­¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">C16681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Histology</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">Histology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">histology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Histology</IRI>
        <Literal xml:lang="en">microanatomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>å¹³å¤´é’‰å˜å¼‚åž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">A rare variant of papillary thyroid gland carcinoma in which more than 30% of cells have hobnail features. (WHO 2017)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C156050</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C156050</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hobnail_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Hobnail Variant Thyroid Gland Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Homogeneity</IRI>
        <Literal>å¯†åº¦å‡åŒ€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Homogeneity</IRI>
        <Literal xml:lang="en">The quality or state of being similar or comparable in kind or nature or of being uniform throughout in composition or structure.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Homogeneity</IRI>
        <Literal xml:lang="en">C61365</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Homogeneity</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61365</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Homogeneity</IRI>
        <Literal xml:lang="en">Homogeneity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Homogeneity</IRI>
        <Literal xml:lang="en">Homogeneous</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Horner_Syndrome</IRI>
        <Literal>Hornerç»¼åˆå¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Horner_Syndrome</IRI>
        <Literal xml:lang="en">Horner syndrome is a combination of signs and symptoms caused by the disruption of a nerve pathway from the brain to the face and eye on one side of the body. Typically, Horner syndrome results in a decreased pupil size, a drooping eyelid and decreased sweating on the affected side of your face.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Horner_Syndrome</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.mayoclinic.org/diseases-conditions/horner-syndrome/.../syc-20373547</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal xml:lang="en">A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal>èˆŒéª¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal xml:lang="en">A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal xml:lang="en">C32752</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C32752</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal xml:lang="en">HYOID BONE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyoid_Bone</IRI>
        <Literal xml:lang="en">Hyoid Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hyperechoic</IRI>
        <Literal>é«˜å›žå£°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hyperechoic</IRI>
        <Literal xml:lang="en">A radiologic finding describing a region in an image with a signal higher than that of the surrounding regions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hyperechoic</IRI>
        <Literal xml:lang="en">C113199</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hyperechoic</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C113199</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperechoic</IRI>
        <Literal xml:lang="en">Hyperechoic Focus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypertension</IRI>
        <Literal>é«˜è¡€åŽ‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Blood pressure that is abnormally high.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">C3117</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3117</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Blood Pressure, High</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Blood Pressure, Increased</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">HTN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">High Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">High blood pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Hypertension;hypertension</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Increased Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Pressure, High Blood</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">Vascular Hypertensive Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal xml:lang="en">high blood pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">Increased secretion of thyroid hormone(s) by the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal>ç”²çŠ¶è…ºåŠŸèƒ½äº¢è¿›ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves&apos; disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">C3123</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3123</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">Hyperthyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">Overactive Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">hyperthyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperthyroidism</IRI>
        <Literal xml:lang="en">overactive thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypocalcemia</IRI>
        <Literal>ä½Žé’™è¡€ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypocalcemia</IRI>
        <Literal xml:lang="en">Lower than normal levels of calcium in the circulating blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hypocalcemia</IRI>
        <Literal xml:lang="en">C37973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypocalcemia</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C37973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypocalcemia</IRI>
        <Literal xml:lang="en">Hypocalcemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypoechoic</IRI>
        <Literal>ä½Žå›žå£°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypoechoic</IRI>
        <Literal xml:lang="en">A radiologic finding describing a region in an image with a signal lower than that of the surrounding regions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hypoechoic</IRI>
        <Literal xml:lang="en">C113127</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypoechoic</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C113127</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypoechoic</IRI>
        <Literal xml:lang="en">Hypoechoic Focus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypoglossal_Nerve_Injury</IRI>
        <Literal>èˆŒä¸‹ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypoglossal_Nerve_Injury</IRI>
        <Literal xml:lang="en">Hypoglossal nerve injuries can range from subtle deficits to sequelae with a significant impact on quality of life that can affect swallowing and airway functions. Although the potential for traumatic and surgical injury has been noted for a long time, the past several decades have witnessed several advances in surgical management for this injury that serve to minimize its effects. Nonetheless, injury is serious, and early recognition is essential for initiating appropriate management. Although varying by etiology, hypoglossal nerve palsy generally has a poor prognosis, particularly if the nerve has been transected and is not immediately repaired. One retrospective analysis of 1000 patients reported that only 15% of patients experienced significant recovery (Keane, 1996).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypoglossal_Nerve_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.sciencedirect.com/topics/medicine-and-dentistry/hypoglossal-nerve-injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypoparathyroidism</IRI>
        <Literal>ç”²çŠ¶æ—è…ºåŠŸèƒ½å‡é€€ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypoparathyroidism</IRI>
        <Literal xml:lang="en">An endocrine disorder characterized by decreased production of parathyroid hormone by the parathyroid glands. It is usually caused by damage of the parathyroid glands during head and neck surgery. Signs and symptoms include muscle cramps, abdominal pain, dry skin, brittle nails, cataracts, tetany, and convulsions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hypoparathyroidism</IRI>
        <Literal xml:lang="en">C78350</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypoparathyroidism</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C78350</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypoparathyroidism</IRI>
        <Literal xml:lang="en">Hypoparathyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypopnea</IRI>
        <Literal>å‘¼å¸ä¸å…¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypopnea</IRI>
        <Literal xml:lang="en">Hypopnea is overly shallow breathing or an abnormally low respiratory rate. Hypopnea is defined by some to be less severe than apnea (the complete cessation of breathing), while other researchers have discovered hypopnea to have a &quot;&quot;similar if not indistinguishable impact&quot;&quot; on the negative outcomes of sleep breathing disorders. In sleep clinics, obstructive sleep apnea syndrome or obstructive sleep apneaâ€“hypopnea syndrome is normally diagnosed based on the frequent presence of apneas and/or hypopneas rather than differentiating between the two phenomena. Hypopnea is typically defined by a decreased amount of air movement into the lungs and can cause oxygen levels in the blood to drop. It commonly is due to partial obstruction of the upper airway.

Hypopnea during sleep is classed as a sleep disorder. With moderate to severe hypopnea, sleep is disturbed such that patients may get a full night&apos;s sleep but still not feel rested because they did not get the right kind of sleep. The disruption in breathing causes a drop in blood oxygen level, which may in turn disrupt the stages of sleep.

Daytime hypopnea events, however, are mostly limited to those with severely compromised respiratory muscles, as occurs in certain neuromuscular diseases or compromised central respiratory drive, as occurs in conditions such as acquired or congenital central hypoventilation syndrome (ACHS or CCHS). Daytime hypopnea can also cause a drop in blood oxygen level. (Wikipediaï¼‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypopnea</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Hypopnea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">Reduced secretion of thyroid hormone(s) by the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal>ç”²çŠ¶è…ºåŠŸèƒ½å‡é€€ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">Abnormally low levels of thyroid hormone.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">C26800</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26800</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">Hypothyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">hypothyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypothyroidism</IRI>
        <Literal xml:lang="en">underactive thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#III_Level_Lymph_Node_Dissection</IRI>
        <Literal>IIIåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#III_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Level III is the midjugular group, which includes lymph nodes around the middle third of the internal jugular vein from the hyoid bone up to the inferior border of cricoid cartilage. The anterior and posterior borders are the same as those for level II.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#III_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323415187000110?scrollTo=%23hl0001552</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#II_Level_Lymph_Node_Dissection</IRI>
        <Literal>IIåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#II_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Level II is the upper jugular group, which includes lymph nodes around the upper third of the internal jugular vein and the upper part of the spinal accessory nerve, extending from the base of the skull up to the bifurcation of the carotid artery or to the level of the hyoid bone.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#II_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323415187000110?scrollTo=%23hl0001552</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#IV_Level_Lymph_Node_Dissection</IRI>
        <Literal>IVåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#IV_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Level IV is the lower jugular group, which includes lymph nodes around the lower third of the internal jugular vein from the inferior border of cricoid cartilage up to the clavicle. The anterior and posterior borders are the same as those for levels II and III.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#IV_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323415187000110?scrollTo=%23hl0001552</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ileus</IRI>
        <Literal>å¯èƒ½æ€§è‚ æ¢—é˜»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ileus</IRI>
        <Literal xml:lang="en">Decrease in peristalsis in the absence of a mechanical bowel obstruction.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ileus</IRI>
        <Literal xml:lang="en">C37979</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ileus</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C37979</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ileus</IRI>
        <Literal xml:lang="en">Ileus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ileus</IRI>
        <Literal xml:lang="en">Possible intestinal obstraction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ileus</IRI>
        <Literal xml:lang="en">ileus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Increased_LT4_Dosage_Requirement</IRI>
        <Literal>å¢žåŠ å·¦æ—‹ç”²çŠ¶è…ºç´ çš„éœ€æ±‚é‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Increased_LT4_Dosage_Requirement</IRI>
        <Literal xml:lang="en">giving more doses of LT4 to maintain the TSH suppressive therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Cannot distinguish between two or more possible values in the current context.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Indeterminate</IRI>
        <Literal>è‰¯æ¶æ€§å¾…å®šçš„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Cannot distinguish between two or more possible values in the current context.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">C48658</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Indeterminate</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48658</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Cannot Be Determined</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">INDETERMINATE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Inconclusive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Indeterminate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate</IRI>
        <Literal xml:lang="en">Unable to Determine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal xml:lang="en">A response that is neither favorable nor unfavorable.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal>ä¸ç¡®å®šæ€§ååº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal xml:lang="en">A response that is neither favorable nor unfavorable.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal xml:lang="en">C123589</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C123589</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal xml:lang="en">INDETERMINATE RESPONSE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Indeterminate_Response</IRI>
        <Literal xml:lang="en">Indeterminate Response</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Infection</IRI>
        <Literal>æ„ŸæŸ“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Infection</IRI>
        <Literal xml:lang="en">The invasion of an organism&apos;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Infection</IRI>
        <Literal xml:lang="en">C128320</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Infection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C128320</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Infection</IRI>
        <Literal xml:lang="en">Infection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Inferior_Thyroid_Artery</IRI>
        <Literal>ç”²çŠ¶è…ºä¸‹åŠ¨è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Inferior_Thyroid_Artery</IRI>
        <Literal xml:lang="en">The inferior thyroid artery is an artery in the neck. It arises from the thyrocervical trunk and passes upward, in front of the vertebral artery and longus colli muscle.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Inferior_Thyroid_Artery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Inferior_thyroid_artery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Inferior_Thyroid_Vein</IRI>
        <Literal>ç”²çŠ¶è…ºä¸‹é™è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Inferior_Thyroid_Vein</IRI>
        <Literal xml:lang="en">The inferior thyroid veins appear two, frequently three or four, in number, and arise in the venous plexus on the thyroid gland, communicating with the middle and superior thyroid veins. While the superior and middle thyroid veins serve as direct tributaries to the internal jugular vein, the inferior thyroid veins drain directly to the brachiocephalic veins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Inferior_Thyroid_Vein</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Inferior_thyroid_veins</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Inflammatory_Infiltrate</IRI>
        <Literal>ç‚Žæ€§æµ¸æ¶¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Inflammatory_Infiltrate</IRI>
        <Literal xml:lang="en">A microscopic finding indicating the presence of acute, subacute or chronic inflammation in a tissue sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Inflammatory_Infiltrate</IRI>
        <Literal xml:lang="en">C35978</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Inflammatory_Infiltrate</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35978</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Inflammatory_Infiltrate</IRI>
        <Literal xml:lang="en">Inflammatory Infiltrate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Initial_Risk_Stratification_System</IRI>
        <Literal>åˆå§‹é£Žé™©åˆ†å±‚ä½“ç³»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Initial_Risk_Stratification_System</IRI>
        <Literal xml:lang="en">the ATA initial risk stratification system was a three-tiered system in which clinico-pathologic features available at the time of initial treatment were used to classify DTC patients as having either low, intermediate, or high risk of either recurrence or persistent disease.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Initial_Risk_Stratification_System</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Insular_Carcinoma</IRI>
        <Literal>å­¤ç«‹ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Insular_Carcinoma</IRI>
        <Literal xml:lang="en">Insular carcinoma is a little-known thyroid cancer, characterized by the presence of well-defined nidi of small uniform cells with frequent areas of tumor necrosis and microfollicles with thyroglobulin.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Insular_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pubmed/9809566</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Insular_carcinoma_of_the_thyroid</IRI>
        <Literal>å²›çŠ¶ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Insular_carcinoma_of_the_thyroid</IRI>
        <Literal xml:lang="en">Insular carcinoma was named for the clusters of cells that contain small follicles resembling pancreatic islet cells. 185 These tumors are very rare and manifest as an independent lesion or concomitantly with papillary or follicular thyroid carcinomas. These cells stain with thyroglobulin antibodies but not for calcitonin. Typically, capsular and vascular invasion is present at the time of diagnosis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Insular_carcinoma_of_the_thyroid</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B9781455746965001238?scrollTo=%23hl0001627</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal>è°ƒå¼ºæ”¾å°„æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">C16135</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16135</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">IMRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">INTENSITY-MODULATED RADIATION THERAPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Intensity Modulated RT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Intensity-Modulated Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Intensity-Modulated Radiotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intensity-Modulated_Radiation_Therapy</IRI>
        <Literal xml:lang="en">intensity-modulated radiation therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is moderate.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is moderate.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal xml:lang="en">C102402</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C102402</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal xml:lang="en">INTERMEDIATE RISK</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intermediate_Risk</IRI>
        <Literal xml:lang="en">Intermediate Risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Intermediate_suspicion</IRI>
        <Literal>æ¶æ€§å¯ç–‘æ€§ä¸ç¡®å®š</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Intermediate_suspicion</IRI>
        <Literal xml:lang="en">Hypoechoic solid nodule with smooth margins without microcalcifications, extrathyroidal extension, or taller than wide shape</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Intermediate_suspicion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0002961017313673?scrollTo=%23tbl1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Internal_Branches</IRI>
        <Literal>å†…æ”¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Internal_Branches</IRI>
        <Literal xml:lang="en">The superior laryngeal nerve has two branches: an internal branch that supplies sensory fibers to the larynx</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Internal_Branches</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001962</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal>è‚ ç©¿å­”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal xml:lang="en">A rupture in the wall of the small or large intestine due to traumatic or pathologic processes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal xml:lang="en">C39611</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C39611</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal xml:lang="en">Bowel Perforation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal xml:lang="en">Intestinal Perforation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intestinal_Perforation</IRI>
        <Literal xml:lang="en">Perforation of Intestine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Intratumoral_Fibrosis</IRI>
        <Literal>ç˜¤å†…çº¤ç»´åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Intratumoral_Fibrosis</IRI>
        <Literal xml:lang="en">Intratumoral fibrosis is a characteristic component of fiberolamellar carcinoma and is found in essentially all primary tumors and in many metastatic tumors.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Investigation</IRI>
        <Literal>æ£€æŸ¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Investigation</IRI>
        <Literal xml:lang="en">The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Investigation</IRI>
        <Literal xml:lang="en">C41198</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Investigation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41198</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Investigation</IRI>
        <Literal xml:lang="en">Investigation Report</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal>ç¢˜131è¯Šæ–­æˆåƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">C970</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C970</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">(131)I-MIBG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">131I-MIBG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">I 131 Meta-iodobenzylguanidine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">I-131 Metaiodobenzylguanidine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">IOBENGUANE I-131</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">Iobenguane I 131</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">Iobenguane I-131</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">Iodine I 131 Metaiodobenzylguanidine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">MIBG I-131</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iobenguane_I-131</IRI>
        <Literal xml:lang="en">iodine I 131 metaiodobenzylguanidine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal>ä½Žç¢˜é¥®é£Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal xml:lang="en">C157895</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C157895</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal xml:lang="en">Iodine Deficiency</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal xml:lang="en">LID</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_Deficiency</IRI>
        <Literal xml:lang="en">Low iodine diet</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal>ç¢˜123è¯Šæ–­æˆåƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal xml:lang="en">A radiopharmaceutical containing the dopamine D2/D3 receptor agonist iodobenzamide (IBZM) labeled with the radionuclide iodine I 123 with dopamine receptor-binding and radioisotopic activities. Upon administration, iodine I 123 iodobenzamide binds to dopamine D2/D3 receptors; subsequently, tissues expressing these receptors can be visualized using single photon emission computed tomography (SPECT). Dopamine receptors are a class of metabotropic G protein-coupled receptors found in the central nervous system (CNS) and neuroendocrine tumors such as pheochromocytoma and paraganglioma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal xml:lang="en">C85461</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C85461</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal xml:lang="en">123I-IBZM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_I_123_Iodobenzamide</IRI>
        <Literal xml:lang="en">Iodine I 123 Iodobenzamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Iodine_excess</IRI>
        <Literal>é«˜ç¢˜é¥®é£Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Iodine_excess</IRI>
        <Literal xml:lang="en">Intakes of up to 600Ã‚Â Î¼g per day in the European Union and 1100Ã‚Â Î¼g per day in the United States are declared as tolerable for adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Iodine_excess</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-sciencedirect-com-mc.vtrus.net/science/article/pii/S1521690X0900102X</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Iodine_excess</IRI>
        <Literal xml:lang="en">HID</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ipsilateral_Neck_Dissection</IRI>
        <Literal>åŒä¾§é¢ˆéƒ¨æ¸…æ‰«æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ipsilateral_Neck_Dissection</IRI>
        <Literal xml:lang="en">Ipsi-PCND included the removal of prelaryngeal, pretracheal, and the paratracheal nodal basin on the ipsilateral side to the tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ipsilateral_Neck_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0039606012005223</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">Treated with radiation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Irradiation</IRI>
        <Literal>æ”¾å°„å²</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">Treatment with radiation, generally meaning exposure to ionizing radiation or radiation of wavelengths shorter than those of visible light.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">C28365</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Irradiation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C28365</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">Irradiated</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">Irradiation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Irradiation</IRI>
        <Literal xml:lang="en">irradiated</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal>å±€éƒ¨ç¼ºè¡€æ€§å¿ƒè„ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">C50625</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50625</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">Disease, Ischemic Heart</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">Heart Disease, Ischemic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">IHD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_heart_disease</IRI>
        <Literal xml:lang="en">Ischemic Heart Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Island-like</IRI>
        <Literal>å²›æ ·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Island-like</IRI>
        <Literal xml:lang="en">one of Ultrasonographic features of calcification in thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Island-like</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Isoechoic</IRI>
        <Literal>ç­‰å›žå£°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Isoechoic</IRI>
        <Literal xml:lang="en">Referring to echo similarity of 2 or more tissues as measured by ultrasonography, see there.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Isoechoic</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://medical-dictionary.thefreedictionary.com/isoechoic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Isoechoic_Spongiform_Isoechoic_Spongiform</IRI>
        <Literal>ç­‰å›žå£°æµ·ç»µçŠ¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Isoechoic_Spongiform_Isoechoic_Spongiform</IRI>
        <Literal xml:lang="en">nodules with a isoechoic spongiform appearance, generally described as multiple microcytic areas that occupy more than 50% of the nodule volume, and have a very low risk of malignancy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Isoechoic_Spongiform_Isoechoic_Spongiform</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/journal/1-s2.0-S0033838919300016</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Jugular_Vein</IRI>
        <Literal xml:lang="en">One of the veins of the neck; in general it arises from the junction of the maxillary and linguofacial veins and drains into the brachiocephalic or the cranial caval vein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Jugular_Vein</IRI>
        <Literal>é¢ˆé™è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Jugular_Vein</IRI>
        <Literal xml:lang="en">Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Jugular_Vein</IRI>
        <Literal xml:lang="en">C12738</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Jugular_Vein</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12738</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Larger_Metastases</IRI>
        <Literal>å¤§è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Larger_Metastases</IRI>
        <Literal xml:lang="en">characteristics of the lymph node metastases can further discriminate the risk of recurrence to the patient, especially in patients with clinically evident metastasis, multiple metastases, larger metastases, and/or extracapsular nodal extension, compared with those withmore limited microscopic nodal disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Larger_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Laryngeal_Exam</IRI>
        <Literal>å–‰æµ‹è¯•</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Laryngeal_Exam</IRI>
        <Literal xml:lang="en">Only routine pre- and postoperative laryngoscopy will allow surgeons to make informed decisions and to assess objectively the impact of the operation on VC function. Laryngoscopy both preoperatively and postoperatively should become part of the full assessment of all patients undergoing thyroid surgery, as this is the only reliable way to accurately determine the quality of the outcome as it relates to RLN injury.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Laryngeal_Exam</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781437722277000150?scrollTo=%233-s2.0-B9781437722277000150-f15-02-9781437722277</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal>å–‰é•œæ£€æŸ¥</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal xml:lang="en">Endoscopic examination of the larynx.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal xml:lang="en">C16781</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16781</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal xml:lang="en">Laryngoscopy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Laryngoscopy</IRI>
        <Literal xml:lang="en">laryngoscopy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal>æ¿€å…‰æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by light amplification by stimulated emission of radiation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">C111241</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C111241</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">ABLATION, LASER</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">Laser Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Laser_Ablation</IRI>
        <Literal xml:lang="en">Photoablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lateral_Level_Lymph_Node_Dissection</IRI>
        <Literal>ä¾§åŒºæ·‹å·´ç»“æ¸…æ‰«æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lateral_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">he terms functional neck dissection , lateral neck dissection , and compartment-oriented neck dissection may be used interchangeably with modified radical neck dissection . Some centers advocate dissection of only those levels of the neck documented to contain biopsy-proven disease or at highest risk of containing disease (i.e., levels IIIâ€“IV or levels IIâ€“IV); however, dissection of levels IIA to VB offers patients the best opportunity for removal of macroscopic disease that could result in recurrence.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lateral_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323376914001452?scrollTo=%23hl0000135</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">The cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal>å·¦å¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">The cone-like lobe of the thyroid gland that is located in the left side of the trachea.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">C32973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C32973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">Lefe Thyroid Gland Lobe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">Left Lobe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Left_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">THYROID GLAND LEFT LOBE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lenvatinib</IRI>
        <Literal>ä¹ä¼æ›¿å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. Lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">C95124</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lenvatinib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C95124</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-E7080</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">ER-203492-00</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">LENVATINIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">Lenvatinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lenvatinib</IRI>
        <Literal xml:lang="en">Multi-Kinase Inhibitor E7080</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Leukopenia</IRI>
        <Literal>ç™½ç»†èƒžå‡å°‘ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">C26816</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Leukopenia</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26816</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">Leukocytopenia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">Leukopenia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">White blood cell decreased</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Leukopenia</IRI>
        <Literal xml:lang="en">leukopenia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Levothyroxine</IRI>
        <Literal>å·¦æ—‹ç”²çŠ¶è…ºç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">A synthetic levoisomer of thyroxine (T4), similar to the endogenous hormone produced by the thyroid gland. Thyroxine is de-iodinated to form triiodothyronine (T3) in the peripheral tissues. T3 enters the cell and binds to nuclear thyroid hormone receptors, and the hormone-receptor complex in turn triggers gene expression and produces proteins required in the regulation of cellular respiration, thermogenesis, cellular growth and differentiation, and metabolism of proteins, carbohydrates and lipids. T4 and T3 also possess cardiac stimulatory effect.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">C62080</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">(-)-Thyroxine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">L-Thyroxine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">LEVOTHYROXINE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Levothyroxine</IRI>
        <Literal xml:lang="en">Levothyroxine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Levothyroxine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C62080</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lifestyle</IRI>
        <Literal>ç”Ÿæ´»æ–¹å¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lifestyle</IRI>
        <Literal xml:lang="en">A manner of living that reflects the person&apos;s values and attitudes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Lifestyle</IRI>
        <Literal xml:lang="en">C16795</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lifestyle</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16795</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lifestyle</IRI>
        <Literal xml:lang="en">Lifestyle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lithium_in_131I_Therapy</IRI>
        <Literal>é”‚è”åˆç¢˜131æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lithium_in_131I_Therapy</IRI>
        <Literal xml:lang="en">Lithium inhibits iodine release from the thyroid without impairing iodine uptake, thus enhancing 131I retention in normal thyroid and tumor cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lithium_in_131I_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Location</IRI>
        <Literal>ä½ç½®</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Location</IRI>
        <Literal xml:lang="en">A position, site, or point in space where something can be found.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Location</IRI>
        <Literal xml:lang="en">C25341</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Location</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25341</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Location</IRI>
        <Literal xml:lang="en">LOC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Location</IRI>
        <Literal xml:lang="en">Location</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal>é£Ÿæ¬²ä¸‹é™</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal xml:lang="en">A question about whether an individual has or had a loss of appetite.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal xml:lang="en">C113630</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C113630</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal xml:lang="en">I have a loss of appetite</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Loss_of_Appetite</IRI>
        <Literal xml:lang="en">Loss of Appetite</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Low_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is small.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Low_Risk</IRI>
        <Literal>ä½Žé£Žé™©</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Low_Risk</IRI>
        <Literal xml:lang="en">The potential future harm that may arise from some present action or attribute or condition is small.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Low_Risk</IRI>
        <Literal xml:lang="en">C102403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Low_Risk</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C102403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Low_Risk</IRI>
        <Literal xml:lang="en">LOW RISK</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Low_Risk</IRI>
        <Literal xml:lang="en">Low Risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Low_suspicion</IRI>
        <Literal>ä½Žåº¦å¯ç–‘æ¶æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Low_suspicion</IRI>
        <Literal xml:lang="en">Isoechoic or hyperechoic solid nodule, or partially cystic nodule with eccentric solid areas, without microcalcification, irregular margin or extrathyroidal extension, or taller than wide shape.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Low_suspicion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0002961017313673?scrollTo=%23tbl1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lowest_Thyroid_Artery</IRI>
        <Literal>ç”²çŠ¶è…ºæœ€ä¸‹åŠ¨è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lowest_Thyroid_Artery</IRI>
        <Literal xml:lang="en">The thyroid ima artery (thyroidea ima artery, arteria thyroidea ima, thyroid artery of Neubauer or the lowest thyroid artery) is an artery of the head and neck. It is an anatomical variant that, when present, supplies blood to the thyroid gland primarily, or the trachea, the parathyroid gland and the thymus gland (as thymica accessoria) in rare cases. It has also been reported to be a compensatory artery when one or both of the inferior thyroid arteries are absent and in a few cases the only source of blood to the thyroid gland. It varies in origin, size, blood supply, and termination, and occurs in only 3â€“10% of the population. Because of the variations and rarity, it may lead to surgical complications.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lowest_Thyroid_Artery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Thyroid_ima_artery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal>æ·‹å·´ç»“æ¸…æ‰«æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">Surgical removal of lymph nodes, usually done to assess the spread of cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">C15275</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15275</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">Lymph Node Dissection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">Lymph Node Neck Dissection performed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">Lymphadenectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">excision of the lymph node</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">lymph node dissection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">lymph node excision</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Lymphadenectomy</IRI>
        <Literal xml:lang="en">lymphadenectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal>M0æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">C48699</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48699</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Distant Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Distant Metastasis Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Metastasis Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">M0 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M0_Stage_Finding</IRI>
        <Literal xml:lang="en">Metastasis Stage M0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal>M1æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">A clinical and/or pathologic distant metastasis TNM finding indicating the spread of cancer to distant anatomic sites.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">C48700</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48700</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Distant Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Distant Metastasis Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Metastasis Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">M1 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M1_Stage_Finding</IRI>
        <Literal xml:lang="en">Metastasis Stage M1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MAPK_Signaling_Pathway</IRI>
        <Literal>ä¸è£‚åŽŸæ¿€æ´»è›‹ç™½æ¿€é…¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MAPK_Signaling_Pathway</IRI>
        <Literal xml:lang="en">The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation, differentiation and migration. Mammals express at least four distinctly regulated groups of MAPKs, extracellular signal-related kinases (ERK)-1/2, Jun amino-terminal kinases (JNK1/2/3), p38 proteins (p38alpha/beta/gamma/delta) and ERK5, that are activated by specific MAPKKs: MEK1/2 for ERK1/2, MKK3/6 for the p38, MKK4/7 (JNKK1/2) for the JNKs, and MEK5 for ERK5. Each MAPKK, however, can be activated by more than one MAPKKK, increasing the complexity and diversity of MAPK signalling. Presumably each MAPKKK confers responsiveness to distinct stimuli. For example, activation of ERK1/2 by growth factors depends on the MAPKKK c-Raf, but other MAPKKKs may activate ERK1/2 in response to pro-inflammatory stimuli.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#MAPK_Signaling_Pathway</IRI>
        <Literal xml:lang="en">C38834</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MAPK_Signaling_Pathway</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C38834</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MAPK_Signaling_Pathway</IRI>
        <Literal xml:lang="en">MAPK Signaling Pathway</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MEK_Inhibitor</IRI>
        <Literal>MEKæ¿€é…¶æŠ‘åˆ¶å‰‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MEK_Inhibitor</IRI>
        <Literal xml:lang="en">A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2. They can be used to affect the MAPK/ERK pathway which is often overactive in some cancers. (See MAPK/ERK pathway#Clinical significance.) (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MEK_Inhibitor</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/MEK_inhibitor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">MINPP1 (Multiple Inositol-Polyphosphate Phosphatase 1) is a Protein Coding gene. Diseases associated with MINPP1 include Thyroid Cancer, Nonmedullary, 2 and Familial Papillary Or Follicular Thyroid Carcinoma. Among its related pathways are Synthesis of IPs in the ER lumen and Inositol phosphate metabolism. Gene Ontology (GO) annotations related to this gene include phosphatase activity.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=MINPP1&amp;keywords=MINPP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">2,3-BPG Phosphatase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">2,3-Bisphosphoglycerate 3-Phosphatase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.3.62</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.3.80</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">HIPER1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Inositol (1,3,4,5)-Tetrakisphosphate 3-Phosphatase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Ins(1,3,4,5)P(4) 3-Phosphatase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">MINPP2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">MIPP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Multiple Inositol Polyphosphate Histidine Phosphatase, 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Multiple Inositol Polyphosphate Phosphatase 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Multiple Inositol Polyphosphate Phosphatase 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MINPP1_Gene</IRI>
        <Literal xml:lang="en">Multiple Inositol-Polyphosphate Phosphatase 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">A type of magnetic resonance imaging that is used to construct images of blood vessels.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal>ç£å…±æŒ¯è¡€ç®¡æˆåƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">An image of blood vessels constructed using magnetic resonance imaging.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">C114867</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C114867</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">MAGNETIC RESONANCE ANGIOGRAPHY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">MRA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">MRI-Based Angiogram</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MRI-Based_Angiogram</IRI>
        <Literal xml:lang="en">Magnetic Resonance Angiogram</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MTC_Manifestation</IRI>
        <Literal>é«“æ ·ç™Œçš„ä¸´åºŠè¡¨çŽ°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MTC_Manifestation</IRI>
        <Literal xml:lang="en">Clinical manifestations of MTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MTC_Manifestation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal>é›·å¸•éœ‰ç´ é¶è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">This gene plays a role in apoptosis, cell growth, differentiation and proliferation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C38928</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">C38928</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">MTOR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">MTOR Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MTOR_Gene</IRI>
        <Literal xml:lang="en">Mechanistic Target of Rapamycin Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MUTYH (MutY DNA Glycosylase) is a Protein Coding gene. Diseases associated with MUTYH include Familial Adenomatous Polyposis 2 and Pilomatrixoma. Among its related pathways are Telomere C-strand (Lagging Strand) Synthesis and Recognition and association of DNA glycosylase with site containing an affected purine. Gene Ontology (GO) annotations related to this gene include hydrolase activity and hydrolase activity, acting on glycosyl bonds. An important paralog of this gene is NTHL1.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">C61056</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUTYH&amp;keywords=MUTYH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">A/G-Specific Adenine DNA Glycosylase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">Adenine DNA Glycosylase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">EC 3.2.2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">EC 3.2.2.31</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">HMYH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MYH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MutY DNA Glycosylase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MutY Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MutY Homolog (E. Coli)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MUTYH_Gene</IRI>
        <Literal xml:lang="en">MutY-Like Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal>MXæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">C48704</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48704</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Distant Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Distant Metastasis Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Metastasis Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Metastasis Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">MX TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#MX_Stage_Finding</IRI>
        <Literal xml:lang="en">Metastasis Stage MX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#M_Category</IRI>
        <Literal>Måˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">One criteria of the TNM staging system. M refers to the presence of metastasis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">C25727</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#M_Category</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25727</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">M</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">M Category</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">M Classification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#M_Category</IRI>
        <Literal xml:lang="en">M Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Macrocalcifications</IRI>
        <Literal>ç²—å¤§é’™åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Macrocalcifications</IRI>
        <Literal xml:lang="en">A small deposit of calcium in the breast that cannot be felt but can be seen on a mammogram. It is usually caused by aging, an old injury, or inflamed tissue and is usually not related to cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Macrocalcifications</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.cancer.gov/publications/dictionaries/cancer-terms/def/macrocalcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal>ç£å…±æŒ¯æˆåƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">C16809</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16809</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">MRI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">MRI Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Magnetic Resonance Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Magnetic Resonance Imaging Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">NMR Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">NMRI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">Nuclear Magnetic Resonance Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">magnetic resonance imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Magnetic_Resonance_Imaging</IRI>
        <Literal xml:lang="en">nuclear magnetic resonance imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Main_Manifestation</IRI>
        <Literal>ä¸»è¦ä¸´åºŠè¡¨çŽ°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Main_Manifestation</IRI>
        <Literal xml:lang="en">Clinical main manifestations of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Main_Manifestation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Malignant</IRI>
        <Literal>æ¶æ€§çš„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">C14143</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Malignant</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C14143</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">MALIGNANT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">Malignant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Malignant</IRI>
        <Literal xml:lang="en">malignant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Marfanoid</IRI>
        <Literal>é©¬å‡¡ç»¼åˆå¾ä½“å½¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Marfanoid</IRI>
        <Literal xml:lang="en">Marfanoid (or Marfanoid habitus) is a constellation of symptoms resembling those of Marfan syndrome, including long limbs, with an arm span that exceeds the height of the individual, and a crowded oral maxilla, sometimes with a high arch in the palate, arachnodactyly, and hyperlaxity.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Marfanoid</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Marfanoid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Margin</IRI>
        <Literal>è¾¹ç¼˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Margin</IRI>
        <Literal xml:lang="en">A boundary line or the area immediately inside the boundary.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Margin</IRI>
        <Literal xml:lang="en">C25563</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Margin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25563</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Margin</IRI>
        <Literal xml:lang="en">Margin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Margin</IRI>
        <Literal xml:lang="en">Marginal</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">A demographic parameter indicating a person&apos;s current conjugal status.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Marital_Status</IRI>
        <Literal>å©šå§»çŠ¶å†µ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">A demographic parameter indicating a person&apos;s current conjugal status.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">C25188</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Marital_Status</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25188</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">MARISTAT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">MaritaStatusUB92</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">Marital Status</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Marital_Status</IRI>
        <Literal xml:lang="en">Marital or partnership status</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Mass_Fixation_to_the_Airway_or_Neck_Structure</IRI>
        <Literal>æ°”ç®¡æˆ–é¢ˆéƒ¨ç»“æž„çš„å›ºå®šè‚¿å—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Mass_Fixation_to_the_Airway_or_Neck_Structure</IRI>
        <Literal xml:lang="en">Locally invasive primary tumors may be associated with characteristic signs and symptoms</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Mass_Fixation_to_the_Airway_or_Neck_Structure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Mediastinal_Lymph_Node_Dissection</IRI>
        <Literal>çºµéš”æ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Mediastinal_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Complete mediastinal lymph node dissection refers to the routine complete removal of all mediastinal tissue as described by the authors.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Mediastinal_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://emedicine.medscape.com/article/1895005-overview</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Medullated_Corneal-Nerve_Fibers</IRI>
        <Literal>è§’è†œç¥žç»çº¤ç»´é«“è´¨åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Medullated_Corneal-Nerve_Fibers</IRI>
        <Literal xml:lang="en">These typical phenotypic features of MEN 2B  include proximal muscle weakness</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Medullated_Corneal-Nerve_Fibers</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal>æœˆç»å‘¨æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal xml:lang="en">The Menstrual Cycle involves regularly recurring hormonal changes and physiologic endometrial changes during the reproductive period in human females, and some primates, and culminates in partial sloughing of the endometrium (menstruation) in the absence of fertilization. For most women, one cycle takes 28 days.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal xml:lang="en">C16838</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16838</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal xml:lang="en">Menstrual Cycle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Menstrual_Cycle</IRI>
        <Literal xml:lang="en">menstrual cycle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Menstrual_Volume</IRI>
        <Literal>æœˆç»é‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Menstrual_Volume</IRI>
        <Literal xml:lang="en">The average volume of menstrual fluid during a monthly menstrual period is 35 milliliters (2.4 tablespoons of menstrual fluid) with 10â€“80 milliliters (1â€“6 tablespoons of menstrual fluid) considered typical.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Menstrual_Volume</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Menstruation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal xml:lang="en">C34815</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal xml:lang="en">Category of disorders related to menstruation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal>æœˆç»å²</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal xml:lang="en">A category of conditions related to menses.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C34815</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal xml:lang="en">Menstrual Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Menstrual_disorder</IRI>
        <Literal xml:lang="en">Menstrual Problem</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastasis</IRI>
        <Literal>è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">C19151</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastasis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C19151</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">Metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">Metastasize</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">Tumor Cell Migration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastasis</IRI>
        <Literal xml:lang="en">metastasize</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal>æ·‹å·´ç»“è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">The spread of a malignant neoplasm to the lymph nodes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">C4904</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C4904</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Metastases to Lymph Nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Metastasis to Lymph Node</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Metastastic Neoplasm to the Lymph Node</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in Lymph Nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Lymph Nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastastatic_Malignant_Neoplasm_in_Lymph_Node</IRI>
        <Literal xml:lang="en">Regional lymph node(metastasis)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal>éª¨è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">C3580</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3580</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Bone Metastases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Bone Metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastases to bone, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastatic Cancer to the Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in the Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastatic Neoplasm to the Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">Metastatic Tumor to the Bone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Bone</IRI>
        <Literal xml:lang="en">bone metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal>è„‘è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">A malignant neoplasm that has spread to the brain from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">C3813</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3813</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Brain Metastases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Brain Metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metast. to brain parenchyma, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metastases to brain parenchyma, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in the Brain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Brain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metastatic Neoplasm to the Brain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">Metastatic Tumor to the Brain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Brain</IRI>
        <Literal xml:lang="en">brain metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal>è‚è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Such malignant neoplasms may be carcinomas, lymphomas, melanomas, or sarcomas.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">C4758</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C4758</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Liver Metastases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Liver Metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Metastases to liver, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in the Liver</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Liver</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Metastatic Neoplasm to the Liver</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">Metastatic Tumor to the Liver</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Liver</IRI>
        <Literal xml:lang="en">liver metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal>è‚ºè½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">The spread of a malignant neoplasm to the lung. This may be from a primary lung malignant neoplasm, or from a malignant neoplasm at a distant site.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">C3577</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3577</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Lung Metastases;lung metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastases to Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastases to lung, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastasis to Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastasis to the Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in the Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastatic Neoplasm to the Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Metastatic Tumor to the Lung</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Lung</IRI>
        <Literal xml:lang="en">Pulmonary Metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal>çºµè†ˆè½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">The spread of a malignant neoplasm to the mediastinum from an adjacent or distant anatomic site.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">C3578</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3578</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastases to Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastases to the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastasis to the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm in the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastatic Malignant Neoplasm to the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastatic Neoplasm to the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metastatic_Malignant_Neoplasm_in_the_Mediastinum</IRI>
        <Literal xml:lang="en">Metastatic Tumor to the Mediastinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Microcalcification</IRI>
        <Literal>å¾®å°é’™åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Microcalcification</IRI>
        <Literal xml:lang="en">Tiny deposits of calcium in tissue. In the breast they can be seen using mammography, and if found in clusters may be indicative of breast cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Microcalcification</IRI>
        <Literal xml:lang="en">C8433</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Microcalcification</IRI>
        <Literal xml:lang="en">Microcalcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Microcalcification</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C8433</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Microcalcification</IRI>
        <Literal xml:lang="en">microcalcification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Microwave_Ablation</IRI>
        <Literal>å¾®æ³¢æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Microwave_Ablation</IRI>
        <Literal xml:lang="en">A treatment modality that uses directed electromagnetic waves within the microwave spectrum to heat the targeted tissue for the purpose of causing tissue necrosis within solid tissue tumors.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Microwave_Ablation</IRI>
        <Literal xml:lang="en">C116643</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Microwave_Ablation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C116643</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Microwave_Ablation</IRI>
        <Literal xml:lang="en">Microwave Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Middle_Thyroid_Vein</IRI>
        <Literal>ç”²çŠ¶è…ºä¸­é™è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Middle_Thyroid_Vein</IRI>
        <Literal xml:lang="en">The middle thyroid vein (Latin: vena thyreoidea media) collects the blood from the lower part of the thyroid gland, and after being joined by some veins from the larynx and trachea, ends in the lower part of the internal jugular vein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Middle_Thyroid_Vein</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Middle_thyroid_vein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multi-detector_Computed_Tomography_Angiography</IRI>
        <Literal>CTè¡€ç®¡é€ å½±</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multi-detector_Computed_Tomography_Angiography</IRI>
        <Literal xml:lang="en">Computed tomography angiography (also called CT angiography or CTA) is a computed tomography technique used to visualize arterial and venous vessels throughout the body. Using contrast injected into the blood vessels, images are created to look for blockages, aneurysms (dilations of walls), dissections (tearing of walls), and stenosis (narrowing of vessel). CTA can be used to visualize the vessels of the heart, the aorta and other large blood vessels, the lungs, the kidneys, the head and neck, and the arms and legs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multi-detector_Computed_Tomography_Angiography</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Computed_tomography_angiography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multi-detector_Computed_Tomography_Angiography</IRI>
        <Literal xml:lang="en">CTA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multifocal_Lesion</IRI>
        <Literal>å¤šç¶æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multifocal_Lesion</IRI>
        <Literal xml:lang="en">A lesion arising from or having many locations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Multifocal_Lesion</IRI>
        <Literal xml:lang="en">C36180</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multifocal_Lesion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C36180</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multifocal_Lesion</IRI>
        <Literal xml:lang="en">Multifocal Lesion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal>å¤šå‘æ€§å†…åˆ†æ³Œè…ºç˜¤ç—…2åž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal xml:lang="en">Multiple endocrine neoplasia caused by mutation of the RET gene. It includes the following neoplastic processes: multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and hereditary thyroid gland medullary carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal xml:lang="en">C123329</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C123329</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal xml:lang="en">MEN-2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal>å¤šå‘æ€§å†…åˆ†æ³Œè…ºç˜¤ç—…2Aåž‹/Sippleç»¼åˆå¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">C3226</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3226</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">MEA Type 2a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">MEA Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">MEN 2A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">MEN Type 2a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">MEN Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Adenomatosis Type 2A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Adenomatosis Type 2a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Adenomatosis Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Adenomatosis, Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type 2A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type 2a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2A</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia, Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal>å¤šå‘æ€§å†…åˆ†æ³Œè…ºç˜¤ç—…2Båž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas and numerous neural defects including neuromas.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">C3227</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3227</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">MEN 2B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">MEN IIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">MEN Type 2B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">MEN Type IIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Adenomatosis Type IIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type 2B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type 2b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type IIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia Type III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Endocrine_Neoplasia_Type_2B</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia, Type III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multiple_Metastases</IRI>
        <Literal>å¤šå‘æ€§è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Multiple_Metastases</IRI>
        <Literal xml:lang="en">characteristics of the lymph node metastases can further discriminate the risk of recurrence to the patient, especially in patients with clinically evident metastasis, multiple metastases, larger metastases, and/or extracapsular nodal extension, compared with those withmore limited microscopic nodal disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multiple_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Multiple_Mucosal_Neuromas</IRI>
        <Literal>å”‡ã€èˆŒå‰å¤–ä¾§è¡¨é¢å’Œç»“è†œç¥žç»ç˜¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Multiple_Mucosal_Neuromas</IRI>
        <Literal xml:lang="en">C6559</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Multiple_Mucosal_Neuromas</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C6559</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Multiple_Mucosal_Neuromas</IRI>
        <Literal xml:lang="en">Multiple Mucosal Neuromas</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal>è‚Œè‚‰éª¨éª¼ç•¸å½¢</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal xml:lang="en">Congenital or acquired deformity of the musculoskeletal system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal xml:lang="en">C78488</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C78488</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal xml:lang="en">Musculoskeletal Deformity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Musculoskeletal_Deformity</IRI>
        <Literal xml:lang="en">Musculoskeletal deformity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal>N0æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">C48705</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48705</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">Lymph Node Stage N0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Lymph Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Lymph Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Regional Lymph Node Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Regional Lymph Nodes Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">N0 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N0_Stage_Finding</IRI>
        <Literal xml:lang="en">Node Stage N0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N0a_Stage_Finding</IRI>
        <Literal>N0aæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N0b_Stage_Finding</IRI>
        <Literal>N0bæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal>N1æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">C48706</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48706</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">Lymph Node Stage N1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Lymph Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Lymph Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Regional Lymph Node Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Regional Lymph Nodes Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">N1 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1_Stage_Finding</IRI>
        <Literal xml:lang="en">Node Stage N1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal>N1aæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">C48707</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48707</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">Lymph Node Stage N1a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Lymph Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Lymph Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Regional Lymph Node Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Regional Lymph Nodes Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">N1a TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1a_Stage_Finding</IRI>
        <Literal xml:lang="en">Node Stage N1a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal>N1bæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for cutaneous melanoma it refers to macrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in 2-3 regional lymph nodes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">C48708</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48708</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">Lymph Node Stage N1b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Lymph Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Lymph Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Regional Lymph Node Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Regional Lymph Nodes Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">N1b TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N1b_Stage_Finding</IRI>
        <Literal xml:lang="en">Node Stage N1b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">NDUFA13 (NADH:Ubiquinone Oxidoreductase Subunit A13) is a Protein Coding gene. Diseases associated with NDUFA13 include Mitochondrial Complex I Deficiency, Nuclear Type 28 and Thyroid Carcinoma, Hurthle Cell. Among its related pathways are Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. and GABAergic synapse. Gene Ontology (GO) annotations related to this gene include NADH dehydrogenase (ubiquinone) activity and NADH dehydrogenase activity.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=NDUFA13&amp;keywords=NDUFA13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">B16.6</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">CDA016</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">CGI-39</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">CI-B16.6</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Cell Death Regulatory Protein GRIM-19</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Cell Death-Regulatory Protein GRIM19</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Complex I B16.6 Subunit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Complex I-B16.6</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">GRIM-19</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">GRIM19</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Gene Associated With Retinoic And IFN-Induced Mortality 19 Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">Gene Associated With Retinoic And Interferon-Induced Mortality 19 Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">MC1DN28</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex, 13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">NADH Dehydrogenase [Ubiquinone] 1 Alpha Subcomplex Subunit 13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">NADH-Ubiquinone Oxidoreductase B16.6 Subunit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NDUFA13_Gene</IRI>
        <Literal xml:lang="en">NADH:Ubiquinone Oxidoreductase Subunit A13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NKX2-1 (NK2 Homeobox 1) is a Protein Coding gene. Diseases associated with NKX2-1 include Choreoathetosis And Congenital Hypothyroidism With Or Without Pulmonary Dysfunction and Chorea, Benign Hereditary. Among its related pathways are Mesodermal Commitment Pathway and Neuroscience. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and enzyme binding. An important paralog of this gene is NKX2-4.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">C73443</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=NKX2-1&amp;keywords=NKX2-1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">BCH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">BHC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Benign Chorea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Homeobox Protein NK-2 Homolog A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Homeobox Protein Nkx-2.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NK-2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NK-2 Homolog A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NK2 Homeobox 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NKX2.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NKX2A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">NMTC1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">T/EBP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">TEBP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">TITF1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">TTF-1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">TTF1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Thyroid Nuclear Factor 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Thyroid Transcription Factor 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NKX2-1_Gene</IRI>
        <Literal xml:lang="en">Thyroid-Specific Enhancer-Binding Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">NRAS (NRAS Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with NRAS include Ras-Associated Autoimmune Leukoproliferative Disorder and Melanocytic Nevus Syndrome, Congenital. Among its related pathways are Gastric cancer and Downstream signaling of activated FGFR2. Gene Ontology (GO) annotations related to this gene include GTP binding. An important paralog of this gene is HRAS.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">C25786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRAS&amp;keywords=NRAS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">ALPS4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">CMNS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">GTPase NRas</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">HRAS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">N-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">N-Ras Protein Part 4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">NCMS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">NRAS Proto-Oncogene, GTPase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">NRAS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">NS6</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">Neuroblastoma RAS Viral Oncogene Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">Transforming Protein N-Ras</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NRAS_Gene</IRI>
        <Literal xml:lang="en">V-Ras Neuroblastoma RAS Viral Oncogene Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">NTRK1 (Neurotrophic Receptor Tyrosine Kinase 1) is a Protein Coding gene. Diseases associated with NTRK1 include Insensitivity To Pain, Congenital, With Anhidrosis and Thyroid Carcinoma, Familial Medullary. Among its related pathways are GPCR Pathway and Nanog in Mammalian ESC Pluripotency. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and protein kinase activity. An important paralog of this gene is NTRK3.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">C18551</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTRK1&amp;keywords=NTRK1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.10</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.10.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Gp140trk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">High Affinity Nerve Growth Factor Receptor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">MTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Neurotrophic Receptor Tyrosine Kinase 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Neurotrophic Tyrosine Kinase Receptor Type 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Neurotrophic Tyrosine Kinase, Receptor, Type 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Oncogene TRK</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">P140-TrkA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">TRK</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">TRK1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">TRK1-Transforming Tyrosine Kinase Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">TRKA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Trk-A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Tropomyosin-Related Kinase A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Tyrosine Kinase Receptor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NTRK1_Gene</IRI>
        <Literal xml:lang="en">Tyrosine Kinase Receptor A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal>NXæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">C48718</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48718</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">Lymph Node Stage NX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Lymph Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Lymph Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Node Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Node Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Regional Lymph Node Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Regional Lymph Nodes Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">NX TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#NX_Stage_Finding</IRI>
        <Literal xml:lang="en">Node Stage NX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#N_Category</IRI>
        <Literal>Nåˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">One criteria of the TNM staging system. N refers to the extent of lymph node involvement.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">C25580</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#N_Category</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25580</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">N</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">N Category</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">N Classification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#N_Category</IRI>
        <Literal xml:lang="en">N Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nasolacrimal_Duct_Obstruction</IRI>
        <Literal>é¼»æ³ªç®¡é˜»å¡ž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Nasolacrimal_Duct_Obstruction</IRI>
        <Literal xml:lang="en">Nasolacrimal duct obstruction is the obstruction of the nasolacrimal duct and may be either congenital or acquired. Obstruction of the nasolacrimal duct leads to the excess overflow of tears called epiphora.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nasolacrimal_Duct_Obstruction</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Nasolacrimal_duct_obstruction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#National_Origin</IRI>
        <Literal xml:lang="en">System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#National_Origin</IRI>
        <Literal>æ°‘æ—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#National_Origin</IRI>
        <Literal xml:lang="en">System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#National_Origin</IRI>
        <Literal xml:lang="en">C28407</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#National_Origin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C28407</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#National_Origin</IRI>
        <Literal xml:lang="en">NATORIG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#National_Origin</IRI>
        <Literal xml:lang="en">nationality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nausea</IRI>
        <Literal>æ¶å¿ƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Nausea</IRI>
        <Literal xml:lang="en">Upper abdominal discomfort associated with an urge to vomit.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Nausea</IRI>
        <Literal xml:lang="en">C3258</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nausea</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3258</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nausea</IRI>
        <Literal xml:lang="en">Nausea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nausea</IRI>
        <Literal xml:lang="en">nausea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Neck_Mass</IRI>
        <Literal>é¢ˆéƒ¨åŒ…å—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Neck_Mass</IRI>
        <Literal xml:lang="en">An abnormal growth in the neck.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Neck_Mass</IRI>
        <Literal xml:lang="en">C35160</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Neck_Mass</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35160</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Mass</IRI>
        <Literal xml:lang="en">Neck Lump</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Mass</IRI>
        <Literal xml:lang="en">Neck Mass</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Neck_Pain</IRI>
        <Literal>é¢ˆç–¼ç—›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">Painful sensation in the neck area.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">C50663</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Neck_Pain</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50663</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">Neck Pain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">Neck pain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">Pain In Neck</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neck_Pain</IRI>
        <Literal xml:lang="en">Pain, Neck</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal>ç»†é’ˆç©¿åˆºæ´»æ£€</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">C15680</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15680</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">Core Biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">Core Needle Biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">core biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Needle_Core_Biopsy</IRI>
        <Literal xml:lang="en">core needle biopsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Neoplastic_Bone_and_Cartilage</IRI>
        <Literal>è‚¿ç˜¤éª¨å’Œè½¯éª¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Neoplastic_Bone_and_Cartilage</IRI>
        <Literal xml:lang="en">Neoplastic bone and cartilage may also be identified in anaplastic thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Neoplastic_Bone_and_Cartilage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2012.0302?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">The formation of new blood vessels.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Neovascularization</IRI>
        <Literal>è¡€ä¾›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">The formation of new or recent blood vessels. The vasculature network is critical to the development of neoplasms. As the tumor burden grows, vascular endothelial cells are recruited to form new blood vessels as an increased demand for blood and nourishment is required.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">C16900</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Neovascularization</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16900</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">NEOVASCULARIZATION</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">Neoangiogenesis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">Neovascularization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">Neovascularization, Pathologic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neovascularization</IRI>
        <Literal xml:lang="en">Vascularization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal>ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal xml:lang="en">Injury to nervous tissue.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal xml:lang="en">C50669</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50669</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal xml:lang="en">Damage To Nerve(s)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal xml:lang="en">Nerve Damage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nerve_Damage</IRI>
        <Literal xml:lang="en">Nerve Injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal xml:lang="en">Goiter characterized by discrete tissue mass(es) that may or may not produce thyroid hormones.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal>ç”²çŠ¶è…ºè‚¿</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal xml:lang="en">Goiter characterized by discrete tissue mass(es) that may or may not produce thyroid hormones.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal xml:lang="en">C131437</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C131437</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal xml:lang="en">Nodular Goiter</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nodular_Goiter</IRI>
        <Literal xml:lang="en">Nodular Hyperplasia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nodule_Size</IRI>
        <Literal>ç»“èŠ‚å¤§å°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Nodule_Size</IRI>
        <Literal xml:lang="en">Ultrasound should evaluate the following: thyroid parenchyma(homogeneous or heterogeneous) and gland size; size, location, zand sonographic characteristics of any nodule(s); the presence or absence of any suspicious cervical lymph nodes in the central or lateral compartments.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nodule_Size</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal>æ— æ³•è¯Šæ–­çš„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal xml:lang="en">C0679837</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncim.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&amp;code=C0679837</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal xml:lang="en">nondiagnosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal xml:lang="en">underdiagnosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal xml:lang="en">undiagnosed disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nondiagnosis</IRI>
        <Literal xml:lang="en">unrecognized disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal>å‘³è§‰æ”¹å˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">A question about whether an individual notices or noticed a change in the way food tastes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">C104934</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C104934</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">Change in the way food tastes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">Changes in taste</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">Have Change in the Way Food Tastes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">I have had a change in the way food tastes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Notice_Change_in_the_Way_Food_Tastes</IRI>
        <Literal xml:lang="en">Notice Change in the Way Food Tastes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Number_of_Births</IRI>
        <Literal xml:lang="en">A measurement of the total number of birth events experienced by a female.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Number_of_Births</IRI>
        <Literal>ç”Ÿäº§æ•°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Number_of_Births</IRI>
        <Literal xml:lang="en">A measurement of the total number of birth events experienced by a female.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Number_of_Births</IRI>
        <Literal xml:lang="en">C158275</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Number_of_Births</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C158275</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Number_of_Births</IRI>
        <Literal xml:lang="en">BRTHN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Number_of_Births</IRI>
        <Literal xml:lang="en">Number of Births</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal xml:lang="en">A measurement of the total number of pregnancy events experienced by a female.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal>å¦Šå¨ æ•°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal xml:lang="en">A measurement of the total number of pregnancy events experienced by the female subject.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C106551</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal xml:lang="en">Number of Pregnancies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal xml:lang="en">PREGNN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Number_of_Pregnancies</IRI>
        <Literal xml:lang="en">Total Number of Pregnancies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Occupation</IRI>
        <Literal>èŒä¸š</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">The principal activity that a person does to earn money.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">C25193</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Occupation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25193</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">EMPJOB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">Employee Job</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">Job</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">OCCUPATION</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Occupation</IRI>
        <Literal xml:lang="en">Occupation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ongoing_Risk_Stratification</IRI>
        <Literal>æŒç»­çš„å±é™©åˆ†å±‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ongoing_Risk_Stratification</IRI>
        <Literal xml:lang="en">A process in which case managers assign clients to risk groups upon or after they access a healthcare practice setting or enrollment in a health insurance plan and perhaps are receiving care. Case managers in this case update the risk stratification level of the client using administrative data such as claims data or assessments such as the health risk assessment (HRA) and various screening tools.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ongoing_Risk_Stratification</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.cmbodyofknowledge.com/content/ongoing-risk-stratification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Osteoclast-like_Giant_Cells</IRI>
        <Literal>ç ´éª¨ç»†èƒžæ ·å·¨ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Osteoclast-like_Giant_Cells</IRI>
        <Literal xml:lang="en">Peculiar microscopic picture of round or spindle shaped mononucleated stromal cells admixed with multinucleated giant cellsï¼›Likely represents a reactive lesion of mesenchymal ovarian stromal cells stimulated by substances in associated tumor or cyst, with monocytic / macrophage originï¼›Mostly associated with mucinous cyst, rarely with serous / hemorrhagic cysts ï¼›Benign clinical course, without recurrence or metastasis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Osteoclast-like_Giant_Cells</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://www.pathologyoutlines.com/topic/ovarytumorosteoclastlike.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Osteoporosis</IRI>
        <Literal xml:lang="en">A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Osteoporosis</IRI>
        <Literal>éª¨è´¨ç–æ¾ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Osteoporosis</IRI>
        <Literal xml:lang="en">C3298</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Osteoporosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3298</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Osteoporosis</IRI>
        <Literal xml:lang="en">Osteoporosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Osteoporosis</IRI>
        <Literal xml:lang="en">osteoporosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Other_Diagnosis</IRI>
        <Literal>å…¶ä»–è¯Šæ–­</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Other_Diagnosis</IRI>
        <Literal xml:lang="en">Diagnostic results of low incidence of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Others</IRI>
        <Literal>å…¶ä»–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal>é…å¯¹ç›’åŸºå› 8æŠ—åŽŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal xml:lang="en">This gene is involved in thyroid development and transcriptional regulation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal xml:lang="en">C97687</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C97687</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal xml:lang="en">PAX8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal xml:lang="en">PAX8 Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PAX8_Gene</IRI>
        <Literal xml:lang="en">Paired Box 8 Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal>ç£·é…¸é…¶å¼ åŠ›è›‹ç™½åŒç³»ç‰©åŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">PTEN (Phosphatase And Tensin Homolog) is a Protein Coding gene. Diseases associated with PTEN include Cowden Syndrome 1 and Macrocephaly/Autism Syndrome. Among its related pathways are Gastric cancer and VEGF Signaling Pathway. Gene Ontology (GO) annotations related to this gene include protein kinase binding and magnesium ion binding. An important paralog of this gene is TNS1.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">C18256</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTEN&amp;keywords=PTEN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">10q23del</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">BZS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">CWS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">DEC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.3.16</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.3.48</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">EC 3.1.3.67</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">GLM2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">MHAM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">MMAC1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">MMAC1 Phosphatase And Tensin Homolog Deleted On Chromosome 10</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Mitochondrial PTENalpha</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Mitochondrial Phosphatase And Tensin Protein Alpha</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Mutated In Multiple Advanced Cancers 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">PTEN1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">PTENbeta</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Phosphatase And Tensin Homolog</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Phosphatase And Tensin-Like Protein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Phosphatidylinositol 3,4,5-Trisphosphate 3-Phosphatase And Dual-Specificity Protein Phosphatase PTEN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Phosphatidylinositol-3,4,5-Trisphosphate 3-Phosphatase And Dual-Specificity Protein Phosphatase PTEN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">Protein Tyrosine Phosphatase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#PTEN_Gene</IRI>
        <Literal xml:lang="en">TEP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Paclitaxel</IRI>
        <Literal>ç´«æ‰é†‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">C1411</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Paclitaxel</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C1411</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester with (2R,3S)-N-Benzoyl-3-phenylisoserine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Anzatax</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Asotax</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Bristaxol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">PACLITAXEL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Paclitaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Praxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Taxol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Taxol Konzentrat</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">[2aR-[2a Alpha,4beta,4a beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic acid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">paclitaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Palliative_Surgery</IRI>
        <Literal>å§‘æ¯æ€§æ‰‹æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Palliative_Surgery</IRI>
        <Literal xml:lang="en">Surgery that does not alter the course of a disease, but improves the quality of life.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Palliative_Surgery</IRI>
        <Literal xml:lang="en">C17883</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Palliative_Surgery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17883</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_Surgery</IRI>
        <Literal xml:lang="en">Palliative Surgery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal>å§‘æ¯æ€§æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">C15292</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15292</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Comfort Care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Palliative Care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Palliative Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Palliative Treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Symptom Management</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">Symptoms Management</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">comfort care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">palliation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">palliative care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">palliative therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palliative_therapy</IRI>
        <Literal xml:lang="en">symptom management</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Palpitation</IRI>
        <Literal>å¿ƒæ‚¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Palpitation</IRI>
        <Literal xml:lang="en">An unpleasant sensation of irregular and/or forceful beating of the heart.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Palpitation</IRI>
        <Literal xml:lang="en">C37999</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Palpitation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C37999</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palpitation</IRI>
        <Literal xml:lang="en">Palpitation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palpitation</IRI>
        <Literal xml:lang="en">Palpitations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Palpitation</IRI>
        <Literal xml:lang="en">palpitation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Panoramic_lymphadenectomy</IRI>
        <Literal>å…¨æ™¯æ€§æ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Panoramic_lymphadenectomy</IRI>
        <Literal xml:lang="en">Panoramic dissection of cervical lymph nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parathyroid_Autotransplantation</IRI>
        <Literal>ç”²çŠ¶æ—è…ºè‡ªä½“ç§»æ¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parathyroid_Autotransplantation</IRI>
        <Literal xml:lang="en">Parathyroid autotransplantation involves taking parathyroid tissue and placing it into the muscle of either the neck or forearm. In cases where the autotransplant is made of hyperactive parathyroid tissue, it is usually placed in the arm for easy access in the future if it were to grow and overfunction. If some of the tissue has to be removed, this can be done very safely under local anesthesia without the risks of reoperating in the neck. Autotransplantation is usually done in re-operative cases or in cases of total parathyroidectomy for four gland hyperplasia. The parathyroid tissue is usually cut into 1 to 2 mm pieces and is placed in small pockets within the muscle. While the gland does not function immediately, it will develop a new blood supply and will typically start working within 4 to 6 weeks. The patient will need to take both calcium and calcitriol (Vitamin D) pills and occassionally intravenous (IV) calcium until the autotransplant starts working.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parathyroid_Autotransplantation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://endocrinediseases.org/parathyroid/surgery_autotransplantation.shtml</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parathyroid_Function_Tests</IRI>
        <Literal>ç”²çŠ¶æ—è…ºåŠŸèƒ½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parathyroid_Function_Tests</IRI>
        <Literal xml:lang="en">Parathyroid function tests is a collective term for blood tests used to check the function of the parathyroid.

Parathyroid function tests may be requested if a patient is thought to suffer from hyperthyroidism (overactive parathyroid) or hypothyroidism (underactive parathyroid), or to monitor the effectiveness of either parathyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to parathyroid disease, such as atrial fibrillation and anxiety disorder.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">Endocrine gland, usually in close proximity to the thyroid gland, that produces parathyroid hormone.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal>ç”²çŠ¶æ—è…º</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">C12765</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal>https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12765</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">GLAND, PARATHYROID</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">Head and Neck, Parathyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">PARATHYROID GLAND</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">Parathyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">Parathyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland</IRI>
        <Literal xml:lang="en">parathyroid gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal>ç”²çŠ¶æ—è…ºç–¾ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the parathyroid glands. Representative examples include hyperparathyroidism, hypoparathyroidism, adenoma, and carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">C26844</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26844</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Parathyroid Gland Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Parathyroid Gland Diseases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Parathyroid Gland Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Parathyroid Gland Disorders</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal>ç”²çŠ¶æ—è…ºæ¿€ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Parathyroid hormone (115 aa, ~13 kDa) is encoded by the human PTH gene. This protein is involved in the modulation of calcium ion and phosphate concentration in the blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">C41027</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41027</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">PTH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Parathormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Parathyrin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Parathyroid Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Parathyroid Hormone 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Prepro-PTH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">Preproparathyroid Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">parathormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">parathyrin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parathyroid_Hormone</IRI>
        <Literal xml:lang="en">parathyroid hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parenchyma</IRI>
        <Literal>ç”²çŠ¶è…ºå®žè´¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parenchyma</IRI>
        <Literal xml:lang="en">The tissue that constitutes the essential part of an organ as contrasted with e.g., connective tissue and blood vessels.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Parenchyma</IRI>
        <Literal xml:lang="en">C74601</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parenchyma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C74601</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parenchyma</IRI>
        <Literal xml:lang="en">Parenchyma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parenchyma</IRI>
        <Literal xml:lang="en">parenchyma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal>è‚ å¤–è¥å…»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal xml:lang="en">Parenteral nutrition (PN) is the feeding of specialist nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The products are made by specialist pharmaceutical compounding companies and are considered to be the highest risk pharmaceutical preparations available as the products cannot undergo any form of terminal sterilization. The person receives highly complex nutritional formulae that contain nutrients such as glucose, salts, amino acids, lipids and added vitamins and dietary minerals. It is called total parenteral nutrition (TPN) or total nutrient admixture (TNA) when no significant nutrition is obtained by other routes, and partial parenteral nutrition (PPN) when nutrition is also partially enteric. It may be called peripheral parenteral nutrition (PPN) when administered through vein access in a limb rather than through a central vein as central venous nutrition (CVN).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal xml:lang="en">C67019</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Parenteral_nutrition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C67019</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Parenteral_Therapeutic_Nutritional_Supplementation</IRI>
        <Literal xml:lang="en">Parenteral Therapeutic Nutritional Supplementation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal>éƒ¨åˆ†ç”²çŠ¶è…ºåˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal xml:lang="en">Surgery involving partial excision of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal xml:lang="en">C51921</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51921</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal xml:lang="en">Partial Thyroidectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Partial_Thyroidectomy</IRI>
        <Literal xml:lang="en">Subtotal Thyroidectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pathological_Characteristics</IRI>
        <Literal>ç—…ç†ç‰¹ç‚¹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pathological_Characteristics</IRI>
        <Literal xml:lang="en">the pathological characteristics of thyroid cancer are well identified by cytology, fine-needle aspiration is the most appropriate method for evaluating patients with nodules. In most cases, operative pathology is required to confirm the diagnosis of thyroid cancer and to determine the extent of disease.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pathological_Characteristics</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B978032352950100585X?scrollTo=%23hl0000132</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pathological_Classification</IRI>
        <Literal>ç—…ç†åˆ†ç±»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pathological_Classification</IRI>
        <Literal xml:lang="en">The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pathological_Classification</IRI>
        <Literal xml:lang="en">C37978</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pathological_Classification</IRI>
        <Literal xml:lang="en">ICD-O</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pathological_Classification</IRI>
        <Literal xml:lang="en">International Classification of Diseases for Oncology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pathology</IRI>
        <Literal>ç—…ç†</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pathology</IRI>
        <Literal xml:lang="en">The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pathology</IRI>
        <Literal xml:lang="en">C18189</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pathology</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C18189</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pathology</IRI>
        <Literal xml:lang="en">Pathological</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pathology</IRI>
        <Literal xml:lang="en">Pathology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pathology_TNM_stage</IRI>
        <Literal>ç—…ç†å­¦TNMåˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pathology_TNM_stage</IRI>
        <Literal xml:lang="en">Thyroid Carcinoma TNM Finding v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Paucicellular_Variant</IRI>
        <Literal>å¯¡ç»†èƒžå˜å¼‚åž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Paucicellular_Variant</IRI>
        <Literal xml:lang="en">Paucicellular carcinoma is a very rare variant of anaplastic carcinoma thyroid, which mimics reactive conditions of thyroid like Riedel disease and a fibrous variant of Hashimoto thyroiditis (FVHT).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Paucicellular_Variant</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://www.ccij-online.org/article.asp?issn=2278-0513;year=2016;volume=5;issue=1;spage=56;epage=58;aulast=Sharma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pazopanib</IRI>
        <Literal>å¸•å”‘å¸•å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pazopanib</IRI>
        <Literal xml:lang="en">A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pazopanib</IRI>
        <Literal xml:lang="en">C74547</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pazopanib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C74547</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pazopanib</IRI>
        <Literal xml:lang="en">Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl- GW786034</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pazopanib</IRI>
        <Literal xml:lang="en">PAZOPANIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pazopanib</IRI>
        <Literal xml:lang="en">Pazopanib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pectus_Excavatum</IRI>
        <Literal>æ¼æ–—èƒ¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pectus_Excavatum</IRI>
        <Literal xml:lang="en">Pectus excavatum is a structural deformity of the anterior thoracic wall in which the sternum and rib cage are shaped abnormally. This produces a caved-in or sunken appearance of the chest. It can either be present at birth or develop after puberty.

Pectus excavatum can impair cardiac and respiratory function and cause pain in the chest and back.

People with the condition may experience severe negative psychosocial effects and avoid activities that expose the chest.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pectus_Excavatum</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Pectus_excavatum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Permanent_Hypoparathyroidism</IRI>
        <Literal>æ°¸ä¹…æ€§ç”²çŠ¶æ—è…ºåŠŸèƒ½å‡é€€ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Permanent_Hypoparathyroidism</IRI>
        <Literal xml:lang="en">Permanent hypoparathyroidism after total thyroidectomy is a rare but potentially serious iatrogenic complication. ... Recovery from permanent hypoparathyroidism was defined as return to normal serum levels of PTH (15-65 pg/mL) and calcium (8.5-10.1 mg/dL) without calcium and/or vitamin D supplementation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Permanent_Hypoparathyroidism</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pubmed/25905773</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Permanent_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal>æ°¸ä¹…æ€§å–‰è¿”ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Permanent_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal xml:lang="en">Recurrent laryngeal nerve injury. Vocal cord paresis was defined as a dysfunction of the vocal cord mobility compared to the contralateral one, based on postoperative fiberoptic laryngoscopy. ... RLN injury lasting more than 1 year was classified as permanent injury.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Permanent_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413231/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">A collection of information about a person&apos;s health. It may include information about allergies, illnesses and surgeries, and dates and results of physical exams, tests, screenings, and immunizations. It may also include information about medicines taken and about diet and exercise.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal>ä¸ªäººç–¾ç—…å²</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">A record of a patient&apos;s background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">C18772</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C18772</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">General Medical History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">Medical History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">Past Medical History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Personal_Medical_History</IRI>
        <Literal xml:lang="en">personal health record</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pes_Cavus</IRI>
        <Literal>å¼“å½¢è¶³</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pes_Cavus</IRI>
        <Literal xml:lang="en">Pes cavus, also known as high arch, is a human foot type in which the sole of the foot is distinctly hollow when bearing weight. That is, there is a fixed plantar flexion of the foot. A high arch is the opposite of a flat foot and is somewhat less common.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Phosphorus_Urine_Excretion_Rate</IRI>
        <Literal>å°¿ç£·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Phosphorus_Urine_Excretion_Rate</IRI>
        <Literal xml:lang="en">A determination of the amount of phosphorus being excreted in urine over a defined period of time.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Phosphorus_Urine_Excretion_Rate</IRI>
        <Literal xml:lang="en">C117845</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Phosphorus_Urine_Excretion_Rate</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C117845</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphorus_Urine_Excretion_Rate</IRI>
        <Literal xml:lang="en">Phosphorus Urine Excretion Rate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Phrenic_Nerve_Injury</IRI>
        <Literal>è†ˆç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Phrenic_Nerve_Injury</IRI>
        <Literal xml:lang="en">Damage to the phrenic nerve.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Phrenic_Nerve_Injury</IRI>
        <Literal xml:lang="en">C99016</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Phrenic_Nerve_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C99016</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phrenic_Nerve_Injury</IRI>
        <Literal xml:lang="en">Phrenic Nerve Injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Physiological_Characteristics</IRI>
        <Literal>ç”Ÿç†ç‰¹å¾</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Physiological_Characteristics</IRI>
        <Literal xml:lang="en">Physiological characteristics derives from the structural information of the human body. Fingerprint, Face, Ear, Iris, Retina, Palmprint, Veins etc. falls under the physiolosical traits.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Physiological_Characteristics</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.igi-global.com/dictionary/human-ear-recognition-system/43370</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal>åž‚ä½“ç–¾ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the pituitary gland. Representative examples of non-neoplastic disorders include pituitary gland hypoplasia and apoplexy. Representative examples of neoplastic disorders include pituitary gland adenoma and carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal xml:lang="en">C26854</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26854</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal xml:lang="en">Pituitary Gland Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal xml:lang="en">Pituitary Gland Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Disorder</IRI>
        <Literal xml:lang="en">Pituitary disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">A tumor that forms in the pituitary gland. The pituitary is a pea-sized organ in the center of the brain above the back of the nose. It makes hormones that affect other glands and many body functions, especially growth. Most pituitary tumors are benign (not cancer).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal>åž‚ä½“ç˜¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">A benign or malignant neoplasm affecting the pituitary gland. The vast majority are adenomas arising from the anterior lobe of the pituitary gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">C3330</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3330</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Neoplasm of Pituitary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Neoplasm of Pituitary Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Neoplasm of the Pituitary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Neoplasm of the Pituitary Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Pituitary Gland Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Pituitary Gland Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Pituitary Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Pituitary Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Tumor of Pituitary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Tumor of Pituitary Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Tumor of the Pituitary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">Tumor of the Pituitary Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pituitary_Gland_Neoplasm</IRI>
        <Literal xml:lang="en">pituitary tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Plateau</IRI>
        <Literal>é«˜åŽŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Plateau</IRI>
        <Literal xml:lang="en">In geology and physical geography, a plateau ( /plÉ™ËˆtoÊŠ/, /plÃ¦ËˆtoÊŠ/ or /ËˆplÃ¦toÊŠ/; plural plateaus or plateaux), also called a high plain or a tableland, is an area of a highland, usually consisting of relatively flat terrain, that is raised significantly above the surrounding area, often with one or more sides with steep slopes. Plateaus can be formed by a number of processes, including upwelling of volcanic magma, extrusion of lava, and erosion by water and glaciers. Plateaus are classified according to their surrounding environment as intermontane, piedmont, or continental.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Plateau</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Plateau</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Platinum</IRI>
        <Literal>é“‚ç±»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">C756</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Platinum</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">URL:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C756</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">C.I. 77795</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">PLATINUM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">Platinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">Platinum Metallicum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">Pt</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Platinum</IRI>
        <Literal xml:lang="en">platinum</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pleomorphic_Giant_Cell_Pattern</IRI>
        <Literal>å¤šå½¢æ€§å·¨ç»†èƒžåž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pleomorphic_Giant_Cell_Pattern</IRI>
        <Literal xml:lang="en">Carcinoma comprised of markedly pleomorphic epithelioid and giant cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pleomorphic_Giant_Cell_Pattern</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://www.pathologyoutlines.com/topic/esophaguspleomorphic.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal>ä½Žåˆ†åŒ–åž‹ç”²çŠ¶è…ºç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">An adenocarcinoma arising from the thyroid gland showing only limited evidence of follicular cell differentiation. Microscopically, the adenocarcinoma cells are arranged in insular, solid, and trabecular patterns. There is associated necrosis, and vascular invasion. The prognosis depends on the tumor stage, complete or partial surgical removal of the tumor, and the degree of response to radioactive iodine therapy. (adapted from WHO Tumors of Endocrine Organs, IARC Press, Lyon 2004)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">C6040</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C6040</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Insular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">PDTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Poorly Differentiated Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Poorly Differentiated Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Poorly_Differentiated_Thyroid_Gland_Carcinoma</IRI>
        <Literal xml:lang="en">Poorly Differentiated Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal>æ­£ç”µå­å‘å°„æ–­å±‚æ‰«æ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">C103512</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C103512</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">PET-CT Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">PET/CT SCAN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">Positron Emission Tomography and Computed Tomography Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Positron_Emission_Tomography_and_Computed_Tomography_Scan</IRI>
        <Literal xml:lang="en">Positron Emission Tomography/Computed Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Posterior_Branches</IRI>
        <Literal>åŽæ”¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Posterior_Branches</IRI>
        <Literal xml:lang="en">The posterior branch of the recurrent laryngeal nerve ascends deep to posterior cricoarytenoid to join the descending branch of the internal laryngeal nerve. The ansa Galeni, lying on the interarytenoid muscles, forms a direct connection between the recurrent and internal laryngeal nerves</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Posterior_Branches</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780702052309000352?scrollTo=%23hl0000639</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal>ç¢˜ç›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">C87200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C87200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">Iodic Acid (HIO3) Potassium Salt (1:1)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">Iodic Acid (HIO3), Potassium Salt</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">Iodic Acid, Potassium Salt</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">POTASSIUM IODATE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Potassium_Iodate</IRI>
        <Literal xml:lang="en">Potassium Iodate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">Hyperparathyroidism due to a condition originating within the parathyroid glands, resulting in hypercalcemia due to increased release of calcium and phosphate from bone matrix, increased renal calcium reabsorption, and increased renal production of 1,25-dihydroxyvitamin D, which increases intestinal absorption of calcium. Primary hyperparathyroidism is also associated with hypophosphatemia as a result of phosphaturia. Clinical features include weakness, fatigue, nausea, vomiting, constipation, depression, and, if chronic, bone pain, osteoporosis, cystic bone lesions, and kidney stones.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal>åŽŸå‘æ€§ç”²çŠ¶æ—è…ºåŠŸèƒ½äº¢è¿›ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">C48280</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48280</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">PHPT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Primary_Hyperparathyroidism</IRI>
        <Literal xml:lang="en">Primary Hyperparathyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Prophylactic_Lymph_Node_Dissection</IRI>
        <Literal>é¢„é˜²æ€§æ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Prophylactic_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">A prophylactic dissection is the clearance of a clinically uninvolved nodal basin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Prophylactic_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Prophylactic_Thyroidectomy</IRI>
        <Literal>é¢„é˜²æ€§ç”²çŠ¶è…ºåˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Prophylactic_Thyroidectomy</IRI>
        <Literal xml:lang="en">Prophylactic thyroidectomy may be performed for patients with a history of familial medullary carcinoma (familial MTC, MEN2, or variants) if a germline mutation in the RET proto-oncogene has been detected.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Prophylactic_Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323065160100347?scrollTo=%23hl0000489</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal>AKTä¿¡å·é€šè·¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">C41625</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41625</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">AKT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">Akt</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">Protein Kinase B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Protein_Kinase_B</IRI>
        <Literal xml:lang="en">protein kinase B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Protein_Kinase_Inhibitor</IRI>
        <Literal>æ¿€é…¶æŠ‘åˆ¶å‰‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Protein_Kinase_Inhibitor</IRI>
        <Literal xml:lang="en">A protein kinase inhibitor is a type of enzyme inhibitor that blocks the action of one or more protein kinases. Protein kinases are enzymes that add a phosphate (PO4) group to a protein, and can modulate its function. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Protein_Kinase_Inhibitor</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Protein_kinase_inhibitor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Proximal_Muscle_Weakness</IRI>
        <Literal>è¿‘ç«¯è‚Œæ— åŠ›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Proximal_Muscle_Weakness</IRI>
        <Literal xml:lang="en">These typical phenotypic features of MEN 2B  include proximal muscle weakness</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Proximal_Muscle_Weakness</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pruritis</IRI>
        <Literal>ç˜™ç—’</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">An intense itching sensation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">C3344</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pruritis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3344</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">Itch</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">Itching</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">Itching (pruritus)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">Pruritus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pruritis</IRI>
        <Literal xml:lang="en">pruritus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal>è‚ºçº¤ç»´åŒ–</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal xml:lang="en">Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal xml:lang="en">C26869</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26869</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal xml:lang="en">Pulmonary Fibrosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal xml:lang="en">Pulmonary Interstitial Fibrosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pulmonary_Fibrosis</IRI>
        <Literal xml:lang="en">Pulmonary fibrosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal>é”¥çŠ¶å¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal xml:lang="en">A conical thyroid gland lobe. When it is present, it usually arises from the isthmus.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal xml:lang="en">C33437</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C33437</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal xml:lang="en">Pyramidal Lobe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pyramidal_Lobe</IRI>
        <Literal xml:lang="en">Pyramidal Lobe of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#RAI-refractory_disease</IRI>
        <Literal>æ”¾å°„æ€§ç¢˜æŠµæŠ—ç–¾ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#RAI-refractory_disease</IRI>
        <Literal xml:lang="en">If empiric RAI therapy is given and the posttherapy scan is negative, the patient should be considered to have RAI-refractory disease and no further RAI therapy should be administered.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#RAI-refractory_disease</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal>ç”²çŠ¶è…ºæ»¤æ³¡ç»†èƒžå‘ç”Ÿå¤§é¼ è‚‰ç˜¤ç™ŒåŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal xml:lang="en">A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal xml:lang="en">C25784</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25784</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal xml:lang="en">RAS Family Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RAS_Family_Gene</IRI>
        <Literal xml:lang="en">ras gene family</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#RET_Gene</IRI>
        <Literal>è½¬æŸ“é‡æŽ’åŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">RET (Ret Proto-Oncogene) is a Protein Coding gene. Diseases associated with RET include Thyroid Carcinoma, Familial Medullary and Multiple Endocrine Neoplasia, Type Iia. Among its related pathways are RET signaling and Innate Immune System. Gene Ontology (GO) annotations related to this gene include calcium ion binding and protein kinase activity. An important paralog of this gene is PDGFRA.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">C18257</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#RET_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=RET&amp;keywords=RET</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">CDHF12</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">CDHR16</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Cadherin Family Member 12</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Cadherin-Related Family Member 16</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.10</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.10.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">HSCR1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Hirschsprung Disease 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">MEN2A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">MEN2B</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">MTC1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">PTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Proto-Oncogene C-Ret</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">RET Receptor Tyrosine Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">RET-ELE1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">RET51</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Rearranged During Transfection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Ret Proto-Oncogene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#RET_Gene</IRI>
        <Literal xml:lang="en">Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Race</IRI>
        <Literal>ç§æ—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">C17049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Race</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">RACE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">Race</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">Racial Group</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal xml:lang="en">race</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Radiation-induced_thyroiditis</IRI>
        <Literal>æ”¾å°„æ€§ç”²çŠ¶è…ºç‚Ž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Radiation-induced_thyroiditis</IRI>
        <Literal xml:lang="en">Radiation-induced thyroiditis is a form of painful, acute thyroiditis resulting from radioactive therapy to treat hyperthyroidism or from radiation to treat head and neck cancer or lymphoma. It affects 1% of those who have received radioactive iodine (I-131) therapy for Graves&apos; Disease, typically presenting between 5 and 10 days after the procedure.[1] Stored T3 and T4 are released as rapid destruction of thyroid tissue occurs, resulting in pain, tenderness, and exacerbation of hyperthyroidism. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal>å°„é¢‘æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">A therapeutic procedure to kill tissue using radiowaves to generate heat. The procedure is performed by the insertion of an electrode into a target tissue. Electrical energy delivered to the electrode heats and destroys the tissue.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">C15666</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15666</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">RFA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">Radiofrequency Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">Radiofrequency Interstitial Ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radiofrequency_Ablation</IRI>
        <Literal xml:lang="en">radiofrequency ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal>æ”¾å°„å…ç–«ç–—æ³•</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">Treatment with a radioactive substance that is linked to an antibody so that it will attach to a tumor when injected into the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">C15355</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15355</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">Immunoradiotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">Immunotherapy, Cancer, Radioisotope</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">Radioimmunotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">radioimmunotherapeutics</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioimmunotherapy</IRI>
        <Literal xml:lang="en">radioimmunotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">An unstable isotope of an element that decays or disintegrates spontaneously, emitting energy (radiation).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Radioisotope</IRI>
        <Literal>ç¢˜æ”¾å°„æ€§åŒä½ç´ è¯Šæ–­è¯•éªŒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">A version of a chemical element that has an unstable nucleus and emits radiation during its decay to a stable form.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">C799</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Radioisotope</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C799</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">RADIOISOTOPE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">Radioisotope</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">Radionuclide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">radioisotope</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radioisotope</IRI>
        <Literal xml:lang="en">radionuclide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal>ç”²çŠ¶è…ºæ˜¾åƒ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">C62667</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C62667</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">Radionuclide Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">Radionuclide Scanning</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">SCINTIGRAPHY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">Scanning</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">Scintigraphy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">nuclear medicine scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">radioimaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">radionuclide scanning</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Radionuclide_Imaging</IRI>
        <Literal xml:lang="en">scintigraphy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Recurrent_Laryngeal_Nerve</IRI>
        <Literal>å–‰è¿”ç¥žç»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Recurrent_Laryngeal_Nerve</IRI>
        <Literal xml:lang="en">The recurrent laryngeal nerve (RLN) is a branch of the vagus nerve (cranial nerve X) that supplies all the intrinsic muscles of the larynx, with the exception of the cricothyroid muscles. There are two recurrent laryngeal nerves, right and left, in the human body. The right and left nerves are not symmetrical, with the left nerve looping under the aortic arch, and the right nerve looping under the right subclavian artery then traveling upwards. They both travel alongside of the trachea. Additionally, the nerves are one of few nerves that follow a recurrent course, moving in the opposite direction to the nerve they branch from, a fact from which they gain their name.

The recurrent laryngeal nerves supply sensation to the larynx below the vocal cords, gives cardiac branches to the deep cardiac plexus, and branches to the trachea, esophagus and the inferior constrictor muscles. The posterior cricoarytenoid muscles, the only muscles that can open the vocal cords, are innervated by this nerve.

The recurrent laryngeal nerves are the nerves of the sixth pharyngeal arch. The existence of the recurrent laryngeal nerve was first documented by the physician Galen. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Recurrent_Laryngeal_Nerve</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Recurrent_laryngeal_nerve</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Recurrent_Laryngeal_Nerve</IRI>
        <Literal xml:lang="en">RLN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal>å–‰è¿”ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal xml:lang="en">Damage to the recurrent laryngeal nerve.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal xml:lang="en">C103171</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C103171</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal xml:lang="en">Recurrent Laryngeal Nerve Injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Recurrent_Risk_Stratification_System</IRI>
        <Literal>å¤å‘é£Žé™©è¯„ä¼°ç³»ç»Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Recurrent_Risk_Stratification_System</IRI>
        <Literal xml:lang="en">the risk stratification system of having recurrent or persistent disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Recurrent_Risk_Stratification_System</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Region</IRI>
        <Literal>åœ°åŸŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Region</IRI>
        <Literal xml:lang="en">An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Region</IRI>
        <Literal xml:lang="en">C41129</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Region</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41129</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Region</IRI>
        <Literal xml:lang="en">Region</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Regional_Lymph_Node_Metastases</IRI>
        <Literal>å±€éƒ¨æ·‹å·´ç»“è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Regional_Lymph_Node_Metastases</IRI>
        <Literal xml:lang="en">he ATA lowand intermediate-risk categories are further characterized on the basis of respective clinical or pathologic features, such as the size of the primary tumor, number and size of locoregional lymph node metastases (as well as extranodal extension), specific histologic variant, vascular invasion, extent of extrathyroidal extension, or other potentially important factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Regional_Lymph_Node_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Reporting_System</IRI>
        <Literal>æŠ¥å‘Šç³»ç»Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Reporting_System</IRI>
        <Literal xml:lang="en">Reporting of information is a critical process in any organization. Information is used to let stakeholders know about the status of the project. They also use it to make good decision Project management reporting is complicated and it often involves multistage activities. The activities that are involved in management reporting include general documentation, financial control, business presentations and email communications. The project managers need to treat the information as harvestable data which can be summarized and interpreted using reporting systems.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Reporting_System</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://project-management-knowledge.com/definitions/r/reporting-systems/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Reproductive_history</IRI>
        <Literal>ç”Ÿè‚²å²</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Reproductive_history</IRI>
        <Literal xml:lang="en">An account of all reproductive events and problems a person has experienced. An important aggregate factor in epidemiological studies of women&apos;s health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Reproductive_history</IRI>
        <Literal xml:lang="en">C17655</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Reproductive_history</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17655</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Reproductive_history</IRI>
        <Literal xml:lang="en">Reproductive Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Reproductive_history</IRI>
        <Literal xml:lang="en">Reproductive History</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Reproductive_history</IRI>
        <Literal xml:lang="en">Reproductive Issues</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Resection</IRI>
        <Literal>æ‰‹æœ¯åˆ‡é™¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Resection</IRI>
        <Literal xml:lang="en">C158758</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Resection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C158758</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Resection</IRI>
        <Literal xml:lang="en">Resection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Resection</IRI>
        <Literal xml:lang="en">Surgical Resection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Respiratory_Compromise</IRI>
        <Literal>å‘¼å¸åŠŸèƒ½æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Respiratory_Compromise</IRI>
        <Literal xml:lang="en">Respiratory compromise describes a deterioration in respiratory function with a high likelihood of rapid progression to respiratory failure and death.[1] Respiratory failure occurs when inadequate gas exchange by the respiratory system occurs, with a low oxygen level or a high carbon dioxide level.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Respiratory_Compromise</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Respiratory_compromise</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal>è¯¯å¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal xml:lang="en">Accidental inhalation of a foreign material into the lungs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal xml:lang="en">C83507</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C83507</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal xml:lang="en">Aspiration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal xml:lang="en">Respiratory Tract Aspiration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Respiratory_Tract_Aspiration</IRI>
        <Literal xml:lang="en">Unintentional Material Aspiration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Response_to_Therapy_Categories</IRI>
        <Literal>å¯¹æ²»ç–—ååº”çš„ç±»åˆ«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Response_to_Therapy_Categories</IRI>
        <Literal xml:lang="en">Prediction of Response to Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Response_to_Therapy_Categories</IRI>
        <Literal xml:lang="en">C1514305</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Response_to_Therapy_Categories</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C18954</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Response_to_Therapy_Categories</IRI>
        <Literal xml:lang="en">Prediction of Response to Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">The cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal>å³å¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">The cone-like lobe of the thyroid gland that is located in the right side of the trachea.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">C33491</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C33491</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">Right Lobe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">Right Thyroid Gland Lobe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Right_Thyroid_Gland_Lobe</IRI>
        <Literal xml:lang="en">THYROID GLAND RIGHT LOBE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal xml:lang="en">In genetics, the likelihood that a hereditary trait or disorder present in one family member will occur again in other family members. This is distinguished from recurrence risk for cancer, which is the chance that a cancer that has been treated will recur.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal>å¤å‘é£Žé™©åˆ†å±‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal xml:lang="en">Recurrence Risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">URL:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C94368</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal xml:lang="en">C2986492</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal xml:lang="en">Recurrence Risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Stratification_of_Recurrence</IRI>
        <Literal xml:lang="en">recurrence risk</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">SRGAP1 (SLIT-ROBO Rho GTPase Activating Protein 1) is a Protein Coding gene. Diseases associated with SRGAP1 include Thyroid Cancer, Nonmedullary, 2 and Familial Hypocalciuric Hypercalcemia. Among its related pathways are Signaling by Rho GTPases and Axon guidance. Gene Ontology (GO) annotations related to this gene include GTPase activator activity and Rac GTPase binding. An important paralog of this gene is SRGAP3.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=SRGAP1&amp;keywords=SRGAP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">ARHGAP13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">KIAA1304</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">NMTC2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">Rho GTPase-Activating Protein 13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">SLIT-ROBO Rho GTPase Activating Protein 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">SLIT-ROBO Rho GTPase-Activating Protein 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#SRGAP1_Gene</IRI>
        <Literal xml:lang="en">SrGAP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">A mark left (usually on the skin) by the healing of injured tissue.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Scar</IRI>
        <Literal>ç˜¢ç—•å½¢æˆ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">A permanent mark left on the skin in the process of wound healing.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">C34483</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Scar</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C34483</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">SCAR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">Scar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scar</IRI>
        <Literal xml:lang="en">Scarring</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Seafood</IRI>
        <Literal>æµ·äº§å“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Seafood</IRI>
        <Literal xml:lang="en">Seafood is any form of sea life regarded as food by humans, prominently including fish and shellfish. Shellfish include various species of molluscs (e.g. clams), crustaceans (e.g. shrimps), and echinoderms (e.g. sea urchins). Historically, sea mammals such as whales and dolphins have been eaten as food, though that happens to a lesser extent in modern times. Edible sea plants such as some seaweeds and microalgae are widely eaten as sea vegetables around the world, especially in Asia. In North America, although not generally in the United Kingdom, the term &quot;seafood&quot; is extended to fresh water organisms eaten by humans, so all edible aquatic life may be referred to as &quot;seafood&quot;.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Seafood</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Seafood</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Seafood</IRI>
        <Literal xml:lang="en">sea food</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes</IRI>
        <Literal>æ‹©åŒºæ€§æ·‹å·´ç»“æ¸…æ‰«æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes</IRI>
        <Literal xml:lang="en">A surgical procedure in which the fibrofatty contents of the neck are removed in patients with clinically negative nodal disease in which there is a high risk of occult metastases.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes</IRI>
        <Literal xml:lang="en">C51786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Selective_Neck_Dissection_of_Cervical_Lymph_Nodes</IRI>
        <Literal xml:lang="en">Selective Neck Dissection of Cervical Lymph Nodes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Seroma</IRI>
        <Literal>è¡€æ¸…è‚¿</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Seroma</IRI>
        <Literal xml:lang="en">A collection of serum in the body.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Seroma</IRI>
        <Literal xml:lang="en">C50739</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Seroma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C50739</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Seroma</IRI>
        <Literal xml:lang="en">Seroma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Serum_Calcitonin</IRI>
        <Literal>è¡€æ¸…é™é’™ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Serum_Calcitonin</IRI>
        <Literal xml:lang="en">Calcitonin is a 32â€“amino acid polypeptide secreted by the parafollicular cells, or C cells, located superolaterally in each thyroid lobe. Calcitonin acts on the surface receptors of osteoclasts to inhibit calcium absorption and to lower peripheral serum calcium levels. Increased peripheral levels of serum calcium stimulate calcitonin secretion, which can be stimulated clinically by the infusion of calcium, pentagastrin, and alcohol. In normal human physiology, calcitonin does not appear to have a significant role. Patients with clinical calcitonin excess syndromes, such as medullary thyroid carcinoma (MTC), usually have little alteration in peripheral calcium metabolism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Serum_Calcitonin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001159</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal>è¡€æ¸…é’™</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal xml:lang="en">A quantitative measurement of the amount of calcium present in a sample of serum.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal xml:lang="en">C61020</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61020</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal xml:lang="en">Serum Calcium</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Serum_Calcium</IRI>
        <Literal xml:lang="en">Serum Calcium Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Serum_Magnesium_Measurement</IRI>
        <Literal>è¡€é•</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Serum_Magnesium_Measurement</IRI>
        <Literal xml:lang="en">A quantitative measurement of the amount of magnesium present in a sample of serum.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Serum_Magnesium_Measurement</IRI>
        <Literal xml:lang="en">C61035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Serum_Magnesium_Measurement</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Serum_Magnesium_Measurement</IRI>
        <Literal xml:lang="en">Serum Magnesium Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Serum_Phosphorus</IRI>
        <Literal>è¡€ç£·</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Serum_Phosphorus</IRI>
        <Literal xml:lang="en">The phosphorus blood test measures the amount of phosphate in the blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Serum_Phosphorus</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">www.ucsfhealth.org/tests/003478.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Single-like</IRI>
        <Literal>å•å‘</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Single-like</IRI>
        <Literal xml:lang="en">one of Ultrasonographic features of calcification in thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Single-like</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Skip_Metastases</IRI>
        <Literal>è·³è·ƒæ€§è½¬ç§»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Skip_Metastases</IRI>
        <Literal xml:lang="en">A discontinuous spread of malignancy in which uninvolved contiguous regions are interspersed with foci of involvement.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Skip_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://medical-dictionary.thefreedictionary.com/skip+metastases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Smoking</IRI>
        <Literal>å¸çƒŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Smoking</IRI>
        <Literal xml:lang="en">The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Smoking</IRI>
        <Literal xml:lang="en">C154329</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Smoking</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C154329</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Smoking</IRI>
        <Literal xml:lang="en">Smoking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Solid</IRI>
        <Literal>å®žæ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Solid</IRI>
        <Literal xml:lang="en">The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Solid</IRI>
        <Literal xml:lang="en">C45300</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Solid</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C45300</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal>å­¤ç«‹ç»“èŠ‚</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal xml:lang="en">only one nodule of thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal xml:lang="en">C41004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C41004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Solitary_nodule</IRI>
        <Literal xml:lang="en">Solitary Nodule</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sorafenib</IRI>
        <Literal>ç´¢æ‹‰éžå°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">C61948</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sorafenib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61948</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">BA4 43 9006</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">BAY 43-9006</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">Bay-439006</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">SORAFENIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">Sorafenib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sorafenib</IRI>
        <Literal xml:lang="en">sorafenib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal>å‰¯ç¥žç»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal xml:lang="en">The accessory nerve is a cranial nerve that supplies the sternocleidomastoid and trapezius muscles. It is considered the eleventh of twelve pairs of cranial nerves, or simply cranial nerve XI, as part of it was formerly believed to originate in the brain. The sternocleidomastoid muscle tilts and rotates the head, while the trapezius muscle, connecting to the scapula, acts to shrug the shoulder.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal xml:lang="en">C12911</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Accessory_nerve</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12911</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Spinal_Accessory_Nerve</IRI>
        <Literal xml:lang="en">Spinal Accessory Nerve</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal>æ¢­å½¢ç»†èƒžåž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal xml:lang="en">Spindle cell carcinoma is a type of cancer that begins in the skin or in tissues that line or cover internal organs and that contains long spindle-shaped cells. It is also called sarcomatoid carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal xml:lang="en">C53643</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Spindle_cell_carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C53643</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Spindle_Cell_Pattern</IRI>
        <Literal xml:lang="en">Spindle Cell Pattern</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Spindle_and_Squamoid_Cells</IRI>
        <Literal>æ¢­å½¢ç»†èƒžå’Œé³žçŠ¶ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Spindle_and_Squamoid_Cells</IRI>
        <Literal xml:lang="en">still of anaplastic thyroid carcinoma may show a more pure population of spindle and squamoid cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spindle_and_Squamoid_Cells</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2012.0302?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Spongiform</IRI>
        <Literal>æµ·ç»µçŠ¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Spongiform</IRI>
        <Literal xml:lang="en">a description of the noduleâ€™s sonographic features</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Spongiform</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sporadic_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal>æ•£å‘æ€§ç”²çŠ¶è…ºé«“æ ·ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sporadic_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">A non-hereditary medullary carcinoma of the thyroid gland not associated with multiple endocrine neoplasia.  The majority of thyroid gland medullary carcinomas are sporadic.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Sporadic_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">C46098</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sporadic_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C46098</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sporadic_Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Sporadic Thyroid Gland Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal>é³žçŠ¶ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal xml:lang="en">Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.(NCI-GLOSS Definition)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal xml:lang="en">C12849</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12849</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal xml:lang="en">Squamous Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal xml:lang="en">Squamous Cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Squamous_Cell</IRI>
        <Literal xml:lang="en">squamous cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140972</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140972</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Differentiated Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140995</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140995</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Thyroid Gland Follicular Cancer;Stage III Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III includes: T1-3, N1a, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. N1a: Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141045</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141045</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140983</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage III Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_III_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140983</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140969</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140969</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Differentiated Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140991</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140991</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Thyroid Gland Follicular Cancer;Stage II Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. N0: No evidence of locoregional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141044</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141044</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140980</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140980</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_II_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage II Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA includes: 55 years and older: T4b, Any N, M0. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140974</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140974</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Differentiated Thyroid Gland Cancer;Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA includes: T1-T3a, N0/NX, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141001</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141001</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Undifferentiated (Anaplastic) Stage IVA Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA includes: 55 years and older: T4b, Any N, M0. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140997</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140997</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Follicular Cancer;Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA includes: (T4a, Any N, M0); (T1-3, N1b, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. T4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. N1b: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes levels I, II, III, IV, or V or retropharyngeal lymph nodes. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141047</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141047</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140985</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">IVA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVA_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140975</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140975</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Differentiated Thyroid Gland Cancer;Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB includes: (T1-T3a, N1, M0); (T3b, Any N, M0); (T4, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. T4: Tumor of any size with gross extrathyroidal extension. N1: Metastasis to regional nodes. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141003</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141003</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Undifferentiated (Anaplastic) Stage IVB Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140998</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140998</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Folliculary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Follicular Cancer;Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease; tumor of any size with extension towards the spine or into nearby large blood vessels, invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141048</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141048</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140986</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">IVB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVB_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140986</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Anaplastic_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Undifferentiated (Anaplastic) Stage IVC Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IVC_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140973</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Differentiated Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140996</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140996</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Thyroid Gland Follicular Cancer;Stage IV Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV includes: IVA: (T4a, Any N, M0); (T1-3, N1b, M0); IVB: (T4b, Any N, M0); IVC: (Any T, Any N, M1). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. T4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. T4b: Very advanced disease; tumor of any size with extension towards the spine or into nearby large blood vessels, invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. N1b: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes levels I, II, III, IV, or V or retropharyngeal lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141046</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141046</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140984</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140984</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">IV</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_IV_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage IV Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140966</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140966</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Differentiated_Thyroid_Gland_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Differentiated Thyroid Gland Cancer;Stage I Differentiated Thyroid Gland Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140988</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140988</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Follicular Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Follicular_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Follicular Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C141043</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141043</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Medullary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Medullary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">C140977</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140977</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">I</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stage_I_Thyroid_Gland_Papillary_Carcinoma_AJCC_v8</IRI>
        <Literal xml:lang="en">Stage I Thyroid Gland Papillary Carcinoma AJCC v8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Staging_System</IRI>
        <Literal>åˆ†æœŸç³»ç»Ÿ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Staging_System</IRI>
        <Literal xml:lang="en">A systematic method for clinicopathologic evaluation of tumors.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Staging_System</IRI>
        <Literal xml:lang="en">C18004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Staging_System</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C18004</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Staging_System</IRI>
        <Literal xml:lang="en">Staging System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal>ç«‹ä½“å®šå‘æ”¾å°„æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">C118286</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C118286</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">SABR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">SBRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Stereotactic Ablative Body Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Stereotactic Body Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stereotactic_Body_Radiation_Therapy</IRI>
        <Literal xml:lang="en">stereotactic body radiation therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sternocleidomastoid_Autograft</IRI>
        <Literal>èƒ¸é”ä¹³çªè‚Œè‡ªä½“ç§»æ¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sternocleidomastoid_Autograft</IRI>
        <Literal xml:lang="en">human parathyroid autotransplantation into the sternocleidomastoid muscle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sternocleidomastoid_Autograft</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781437722277000010?scrollTo=%23hl0000483</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sternocleidomastoid_Muscle</IRI>
        <Literal>èƒ¸é”ä¹³çªè‚Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sternocleidomastoid_Muscle</IRI>
        <Literal xml:lang="en">The sternocleidomastoid muscle is one of the largest and most superficial cervical muscles. The primary actions of the muscle are rotation of the head to the opposite side and flexion of the neck. The sternocleidomastoid is innervated by the accessory nerve.

It is given the name sternocleidomastoid because it originates at the manubrium of the sternum (sterno-) and the clavicle (cleido-), and has an insertion at the mastoid process of the temporal bone of the skull. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sternocleidomastoid_Muscle</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Sternocleidomastoid_muscle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Stimulated_Serum_Calcitonin</IRI>
        <Literal>åˆºæ¿€æ€§è¡€æ¸…é™é’™ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Stimulated_Serum_Calcitonin</IRI>
        <Literal xml:lang="en">stimulated calcitonin levels are sensitive markers for primary or recurrent MTC.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Stimulated_Serum_Calcitonin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001159</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Structural_Incomplete_Response</IRI>
        <Literal>ç»“æž„æ€§ä¸å®Œå…¨ååº”</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Structural_Incomplete_Response</IRI>
        <Literal xml:lang="en">A structural incomplete response may lead to additional treatments or ongoing observation depending on multiple clinico-pathologic factors including the size, location, rate of growth, RAI avidity, 18FDG avidity, and specific pathology of the structural lesions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Structural_Incomplete_Response</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://eguideline.guidelinecentral.com/i/631815-differentiated-thyroid-cancer/21?</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal xml:lang="en">Self-limited thyroiditis presumed to be caused by a viral infection.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal>äºšæ€¥æ€§ç”²çŠ¶è…ºç‚Ž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal xml:lang="en">Self-limited inflammation of the thyroid gland.  The clinical course includes an initial phase of hyperthyroidism, followed by a phase of hypothyroidism, and eventually a return to normal thyroid function.  This category includes the subacute lymphocytic thyroiditis and subacute granulomatous thyroiditis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal xml:lang="en">C35071</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35071</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Subacute_Thyroiditis</IRI>
        <Literal xml:lang="en">Subacute Thyroiditis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Subclinical_Thyrotoxicosis</IRI>
        <Literal>äºšä¸´åºŠåž‹ç”²çŠ¶è…ºæ¯’ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Subclinical_Thyrotoxicosis</IRI>
        <Literal xml:lang="en">Subclinical thyrotoxicosis may be defined as a low serum thyrotrophin (TSH) concentration in an asymptomatic patient with normal serum free thyroxine (T4) and triiodothyronine (T3) concentrations.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Subclinical_Thyrotoxicosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://pmj.bmj.com/content/77/903/29</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Subtotal_Thyroidectomy</IRI>
        <Literal>ç”²çŠ¶è…ºè¿‘å…¨åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Subtotal_Thyroidectomy</IRI>
        <Literal xml:lang="en">Subtotal thyroidectomy is a surgical procedure, in which the surgeon leaves a small thyroid remnant in situ to preserve thyroid function, thereby preventing lifelong thyroid hormone supplementation therapy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Subtotal_Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.hindawi.com/journals/tswj/2012/548796/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sunitinib</IRI>
        <Literal>èˆ’å°¼æ›¿å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sunitinib</IRI>
        <Literal xml:lang="en">An indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sunitinib</IRI>
        <Literal xml:lang="en">sunitinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Sunitinib</IRI>
        <Literal xml:lang="en">C71622</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sunitinib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C71622</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sunitinib</IRI>
        <Literal xml:lang="en">1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-Sunitinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sunitinib</IRI>
        <Literal xml:lang="en">SUNITINIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Superior_Laryngeal_Nerve</IRI>
        <Literal>å–‰ä¸Šç¥žç»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Superior_Laryngeal_Nerve</IRI>
        <Literal xml:lang="en">The cricothyroid muscles are innervated by the superior laryngeal nerve. All other intrinsic laryngeal muscles are innervated by the recurrent laryngeal nerve.

The superior laryngeal nerve consists of two branches: the internal laryngeal nerve (sensory), which supplies sensory fibers to the laryngeal mucosa, and the external laryngeal nerve (motor), which innervates the cricothyroid muscle.

The recurrent laryngeal nerve gets its name from the fact that it loops below the aorta on its way to the intrinsic muscles of the larynx. The left recurrent laryngeal nerve passes under and around the aorta on its way to the larynx, whereas the right recurrent laryngeal nerve passes under and around the subclavian artery. Because the aorta is inferior to the subclavian artery, the left recurrent laryngeal nerve is a bit longer than the right recurrent laryngeal nerve. However, there is no discernible effect on the timing of neural impulses to the muscles these two nerves serve. By comparison with the recurrent laryngeal nerves, the superior laryngeal nerve takes a more direct route on the way to the cricothyroid muscles.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Superior_Laryngeal_Nerve</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Superior_laryngeal_nerve</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Superior_Laryngeal_Nerve</IRI>
        <Literal xml:lang="en">EBSLN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Superior_Thyroid_Artery</IRI>
        <Literal>ç”²çŠ¶è…ºä¸ŠåŠ¨è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Superior_Thyroid_Artery</IRI>
        <Literal xml:lang="en">The superior thyroid artery arises from the external carotid artery just below the level of the greater cornu of the hyoid bone and ends in the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Superior_Thyroid_Artery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Superior_thyroid_artery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Superior_Thyroid_Vein</IRI>
        <Literal>ç”²çŠ¶è…ºä¸Šé™è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Superior_Thyroid_Vein</IRI>
        <Literal xml:lang="en">The superior thyroid vein begins in the substance and on the surface of the thyroid gland, by tributaries corresponding with the branches of the superior thyroid artery, and ends in the upper part of the internal jugular vein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Superior_Thyroid_Vein</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Superior_thyroid_vein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Surgery</IRI>
        <Literal>æ‰‹æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Surgery</IRI>
        <Literal xml:lang="en">The branch of medical science that treats disease or injury by operative procedures.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Surgery</IRI>
        <Literal xml:lang="en">C17173</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Surgery</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17173</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Surgery</IRI>
        <Literal xml:lang="en">Surgery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Surgical_Complications</IRI>
        <Literal>æ‰‹æœ¯å¹¶å‘ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Surgical_Complications</IRI>
        <Literal xml:lang="en">the bulk of the literature supports increased complication rates, mainly recurrent laryngeal paralysis and permanent hypoparathyroidism with bilateral thyroid surgery when compared with unilateral surgery</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Surgical_Complications</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781437722277000307?scrollTo=%23hl0000660</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Survivorship_Care_Plan</IRI>
        <Literal>ç”Ÿå­˜æŠ¤ç†è®¡åˆ’</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Survivorship_Care_Plan</IRI>
        <Literal xml:lang="en">A document that contains a history of an individual&apos;s cancer treatment history as well as guidelines for monitoring and maintaining their health, including the need for future check-ups and cancer tests. The information may also include potential long-term late effects of the treatment received.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Survivorship_Care_Plan</IRI>
        <Literal xml:lang="en">C157525</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Survivorship_Care_Plan</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C157525</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Survivorship_Care_Plan</IRI>
        <Literal xml:lang="en">Survivorship Care Plan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal>å¯ç–‘æ¶æ€§çš„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal xml:lang="en">A microscopic finding indicating the presence of a cellular infiltrate or isolated cells that have features suspicious for malignancy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal xml:lang="en">C121869</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal xml:lang="en">Atypical and/or suspicious</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal xml:lang="en">Suspicious</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Suspicious_for_Malignancy</IRI>
        <Literal xml:lang="en">Suspicious for Malignancy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Symptoms</IRI>
        <Literal>ä¸´åºŠè¡¨çŽ°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Symptoms</IRI>
        <Literal xml:lang="en">A symptom (from Greek ÏƒÏÎ¼Ï€Ï„Ï‰Î¼Î±, &quot;accident, misfortune, that which befalls&quot;,from ÏƒÏ…Î¼Ï€Î¯Ï€Ï„Ï‰, &quot;I befall&quot;, from ÏƒÏ…Î½- &quot;together, with&quot; and Ï€Î¯Ï€Ï„Ï‰, &quot;I fall&quot;) is a departure from normal function or feeling which is apparent to a patient, reflecting the presence of an unusual state, or of a disease. A symptom can be subjective or objective. Tiredness is a subjective symptom whereas cough or fever are objective symptoms. In contrast to a symptom, a sign is a clue to a disease elicited by an examiner or a doctor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Symptoms</IRI>
        <Literal xml:lang="en">C157617</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Symptoms</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Symptom</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Symptoms</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C157617</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Symptoms</IRI>
        <Literal xml:lang="en">Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Synaptophysin</IRI>
        <Literal>çªè§¦å°æ³¡è›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Synaptophysin</IRI>
        <Literal xml:lang="en">Synaptophysin (313 aa, ~34 kDa) is encoded by the human SYP gene. This protein is involved in the targeting of synaptic vesicles</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Synaptophysin</IRI>
        <Literal xml:lang="en">C101146</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Synaptophysin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C101146</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Synaptophysin</IRI>
        <Literal xml:lang="en">Major Synaptic Vesicle Protein p38</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Synaptophysin</IRI>
        <Literal xml:lang="en">SYP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Synaptophysin</IRI>
        <Literal xml:lang="en">Synaptophysin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal>ç³»ç»Ÿæ€§æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal xml:lang="en">Chemotherapy where the agent travels throughout the body by blood circulation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal xml:lang="en">C64261</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C64261</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal xml:lang="en">Systemic Chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#System_chemotherapy</IRI>
        <Literal xml:lang="en">systemic chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal>T0æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">A primary tumor TNM finding indicating that there is no evidence of primary tumor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">C48719</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48719</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">T0 Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T0_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T0</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal>T1æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">C48720</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48720</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">C</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">T1 Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal>T1aæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">C48721</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48721</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">T1a Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T1a_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T1a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T1b_Stage_Finding</IRI>
        <Literal>T1bæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal>T2æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">C48724</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48724</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">C</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">T2 Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T2_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal>T3æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">C48728</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48728</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">T3 Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal>T3aæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota&apos;s fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">C48729</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">T3a Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T3a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3a_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48729</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal>T3bæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">C48730</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48730</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">T3b Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T3b_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T3b</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal>T4æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">C48732</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48732</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">T4 Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal>T4aæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">C48733</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C48733</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Cancer Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Primary Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Primary Tumor Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Stage Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a TNM Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Tumor Finding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">T4a Tumor Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T4a_Stage_Finding</IRI>
        <Literal xml:lang="en">Tumor Stage T4a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T4b_Stage_Finding</IRI>
        <Literal>T4bæœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#TERT_Gene</IRI>
        <Literal>ç«¯ç²’é…¶é€†è½¬å½•é…¶åŸºå› </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">TERT (Telomerase Reverse Transcriptase) is a Protein Coding gene. Diseases associated with TERT include Dyskeratosis Congenita, Autosomal Dominant 2 and Pulmonary Fibrosis And/Or Bone Marrow Failure, Telomere-Related, 1. Among its related pathways are Human T-cell leukemia virus 1 infection and HIF-1-alpha transcription factor network. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and tRNA binding.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">C18173</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#TERT_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=TERT&amp;keywords=TERT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">CMM9</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">DKCA2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">DKCB4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.7</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">EC 2.7.7.49</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">EST2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">HEST2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">HTRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">PFBMFT1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">TCS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">TP2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">TRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">Telomerase Catalytic Subunit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">Telomerase Reverse Transcriptase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TERT_Gene</IRI>
        <Literal xml:lang="en">Telomerase-Associated Protein 2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal>TNMåˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">C25384</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25384</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">AJCC staging system</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">C</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">TNM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">TNM Staging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">TNM Staging System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TNM_Staging_System</IRI>
        <Literal xml:lang="en">TNM staging system</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">TP53 (Tumor Protein P53) is a Protein Coding gene. Diseases associated with TP53 include Li-Fraumeni Syndrome and Osteogenic Sarcoma. Among its related pathways are Gastric cancer and RET signaling. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and protein heterodimerization activity. An important paralog of this gene is TP73.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">C17359</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#TP53_Gene</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.genecards.org/cgi-bin/carddisp.pl?gene=TP53&amp;keywords=TP53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Antigen NY-CO-13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">BCC7</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">BMFS5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Cellular Tumor Antigen P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">LFS1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Li-Fraumeni Syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Mutant Tumor Protein 53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">P53 Tumor Suppressor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Phosphoprotein P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">TRP53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Transformation-Related Protein 53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Tumor Protein 53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Tumor Protein P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Tumor Suppressor P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#TP53_Gene</IRI>
        <Literal xml:lang="en">Tumor Supressor P53</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#TSH_Inhibited_Serum_Thyroglobulin</IRI>
        <Literal>TSHæŠ‘åˆ¶ä¸‹ç”²çŠ¶è…ºçƒè›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#TSH_Inhibited_Serum_Thyroglobulin</IRI>
        <Literal xml:lang="en">The serum thyroglobulin level was measured under TSH inhibition to evaluate the biochemical recurrence of thyroid cancer patients after operation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#TSH_suppressive_therapy</IRI>
        <Literal>ä¿ƒç”²çŠ¶è…ºæ¿€ç´ æŠ‘åˆ¶æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#TSH_suppressive_therapy</IRI>
        <Literal xml:lang="en">Thyroid Stimulating Hormone (TSH) Suppression. Patients treated for differentiated thyroid cancer take a daily thyroid hormone replacement pill called levothyroxine (also known as T4). They take it both to avoid hypothyroidism (underactive thyroid condition) and to prevent growth or recurrence of their thyroid cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#TSH_suppressive_therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">www.thyca.org/pap-fol/more/tsh-suppression/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#T_Category</IRI>
        <Literal>Tåˆ†æœŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#T_Category</IRI>
        <Literal xml:lang="en">One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#T_Category</IRI>
        <Literal xml:lang="en">C25728</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#T_Category</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25728</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T_Category</IRI>
        <Literal xml:lang="en">T Category</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T_Category</IRI>
        <Literal xml:lang="en">T Classification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#T_Category</IRI>
        <Literal xml:lang="en">T Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tall-cell_Papillary_Thyroid_Carcinoma</IRI>
        <Literal>é«˜ç»†èƒžåž‹ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tall-cell_Papillary_Thyroid_Carcinoma</IRI>
        <Literal xml:lang="en">The tall cell variant is characterized by well-formed papillae that are covered by cells twice as tall as they are wide.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>é«˜ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of tall malignant follicular cells, arranged in papillary and trabecular patterns. Necrotic changes and high mitotic activity are present.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C35558</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35558</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Tall Cell Variant Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tall_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Tall Cell Variant Thyroid Gland Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal>ç´«æ‰çƒ·å¤šçƒ¯ç´«æ‰é†‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal xml:lang="en">A type of drug that blocks cell growth by stopping mitosis (cell division). Taxanes interfere with microtubules (cellular structures that help move chromosomes during mitosis). They are used to treat cancer. A taxane is a type of mitotic inhibitor and a type of antimicrotubule agent.(NCI-GLOSS Definition)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal xml:lang="en">C1490</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C1490</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal xml:lang="en">Taxane Compound</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal xml:lang="en">Taxanes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Taxane_Compound</IRI>
        <Literal xml:lang="en">taxane</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal>99mé«˜é”é…¸ç›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">One of the radioactive isotopes of technetium, a gamma/beta-emitter with a half life of 6 hours.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">C1642</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C1642</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">TECHNETIUM TC-99M</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">Tc 99m</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">Technetium 99m</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Technetium_TC-99m</IRI>
        <Literal xml:lang="en">Technetium TC-99m</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Temporary_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal>æš‚æ—¶æ€§å–‰è¿”ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Temporary_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal xml:lang="en">UNILATERAL RECURRENT LARYNGEAL nerve paralysis (URLNP) is a known complication of thyroid surgery. Even for experienced surgeons, a number of patients will have temporary laryngeal paralysis or paresis, which for some will become permanent (after 12 months)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Temporary_Recurrent_Laryngeal_Nerve_Injury</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pubmed/?term=15728196</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal>ä¼´éšç³–çš®è´¨æ¿€ç´ æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal xml:lang="en">Synthetically derived forms of the naturally occurring Glucocorticoids.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal xml:lang="en">C521</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C521</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal xml:lang="en">Glucocorticoid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Glucocorticoid</IRI>
        <Literal xml:lang="en">Therapeutic Glucocorticoid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal>æ²»ç–—æ€§æ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal xml:lang="en">Because PTC is the most common thyroid carcinoma and has a high frequency of lymph node metastasis, operative planning must include consideration of cervical lymphadenectomy. When considering lymphadenectomy, distinctions should be made between the central neck (level VI) and the lateral neck and between therapeutic dissection and prophylactic dissection. A prophylactic dissection is the clearance of a clinically uninvolved nodal basin, whereas therapeutic dissection is lymph node dissection in the setting of proven nodal metastasis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal xml:lang="en">C65003</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C65003</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001681</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Lymphadenectomy</IRI>
        <Literal xml:lang="en">Therapeutic Lymphadenectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">The drug, device, therapy, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). See also: test articles; devices; drug product; medicinal product; combination product.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal>æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">C49236</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C49236</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">TREAT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">TX</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Therapeutic Interventions</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Therapeutic Method</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Therapeutic Procedure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Therapeutic Technique</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">Treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">therapeutic intervention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Therapeutic_Procedure</IRI>
        <Literal xml:lang="en">therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Therapeutic_Thyroidectomy</IRI>
        <Literal>æ²»ç–—æ€§ç”²çŠ¶è…ºæ‰‹æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Therapeutic_Thyroidectomy</IRI>
        <Literal xml:lang="en">the goal of surgery should be to remove all the malignant neoplastic tissue present in the neck.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Therapeutic_Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323297387000149?scrollTo=%23hl0001958</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal>çƒ­æ¶ˆèž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal xml:lang="en">A procedure using heat to remove tissue or a part of the body, or destroy its function. For example, to remove the lining of the uterus, a catheter is inserted through the cervix into the uterus, a balloon at the end of the catheter is inflated, and fluid inside the balloon is heated to destroy the lining of the uterus.(NCI-GLOSS Definition)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal xml:lang="en">C15670</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15670</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal xml:lang="en">Thermal Ablation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thermal_Ablation_Therapy</IRI>
        <Literal xml:lang="en">thermal ablation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thick_Capsule</IRI>
        <Literal>åŽšå›Š</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thick_Capsule</IRI>
        <Literal xml:lang="en">Tumors prone to metastatic behavior often have a thick capsule and significant intratumoral fibrosis, and virtually all of them reveal vascular invasion or invasion of the tumor capsule.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thick_Capsule</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thickness_of_Neck</IRI>
        <Literal>é¢ˆç²—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thickness_of_Neck</IRI>
        <Literal xml:lang="en">typical phenotype features of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thickness_of_Neck</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thrombosis</IRI>
        <Literal>è¡€æ “å½¢æˆ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thrombosis</IRI>
        <Literal xml:lang="en">The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thrombosis</IRI>
        <Literal xml:lang="en">C26891</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thrombosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26891</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thrombosis</IRI>
        <Literal xml:lang="en">Thrombosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">A primary lymphoid organ generally located in the mediastinum near the thoracic inlet and/or along lateral aspects of the neck.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal>èƒ¸è…º</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">A bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes into lobules. The lobules contain an outer portion (cortical zone) which is rich in lymphocytes and an inner portion (medullary zone) which is rich in epithelial cells. It is an organ essential for the development of the immune system. Its function is the maturation of the progenitor lymphoid cells to thymocytes and subsequently to mature T-cells. It reaches its greatest weight at puberty and subsequently begins to involute.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">C12433</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12433</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">Reticuloendothelial System, Thymus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">THYMUS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">THYMUS GLAND</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">Thymus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">Thymus Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thymus_Gland</IRI>
        <Literal xml:lang="en">thymus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">A measurement of the thyroglobulin in a biological specimen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal>ç”²çŠ¶è…ºçƒè›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">The determination of the amount of the thyroglobulin in a sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">Thyroglobulin (2768 aa, ~305 kDa) is encoded by the human TG gene. This protein is involved in thyroid hormone synthesis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">C103446</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">C2304</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C103446</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2304</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">TG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">TGLOB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">Thyroglobulin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">Thyroglobulin Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroglobulin</IRI>
        <Literal xml:lang="en">thyroglobulin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal>ä¿ƒç”²çŠ¶è…ºæ¿€ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">A peptide hormone secreted by the anterior pituitary. It promotes the growth of the thyroid gland and stimulates the synthesis of thyroid hormones and the release of thyroxine by the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">C2280</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2280</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">TSH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyreotrophic Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyreotropin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyroid Stimulating Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyroid-Stimulating Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyrotropic Hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">Thyrotropin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid-Stimulating_Hormone</IRI>
        <Literal xml:lang="en">thyroid-stimulating hormone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Adjuvant_Therapy</IRI>
        <Literal>æ¸…ç¶æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Adjuvant_Therapy</IRI>
        <Literal xml:lang="en">used for treating distant metastasis, unresectable or residual papillary thyroid carcinoma (PTC), and most cases of follicular thyroid carcinoma (FTC) or HÃ¼rthle cell carcinoma (HCC).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Adjuvant_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B9780323240987000381?scrollTo=%23hl0000437</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Antithyroglobulin Antibody Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal>æŠ—ç”²çŠ¶è…ºçƒè›‹ç™½æŠ—ä½“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Antithyroglobulin Antibody Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">C81992</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C81992</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">THYATAB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Antithyroglobulin Antibodies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Antithyroglobulin_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Antithyroglobulin Antibody Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Blood_Supply</IRI>
        <Literal>ç”²çŠ¶è…ºè¡€ä¾›</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Blood_Supply</IRI>
        <Literal xml:lang="en">The thyroid is supplied with arterial blood from the superior thyroid artery, a branch of the external carotid artery, and the inferior thyroid artery, a branch of the thyrocervical trunk, and sometimes by an anatomical variant the thyroid ima artery, which has a variable origin.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Blood_Supply</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Cancer</IRI>
        <Literal>ç”²çŠ¶è…ºç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Cancer</IRI>
        <Literal xml:lang="en">Thyroid cancer is a rareÂ type of cancer that affects the thyroid gland, a small gland at the base of the neck that produces hormones.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Cancer</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.nhs.uk/conditions/thyroid-cancer/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A term that refers to the staging of differentiated thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C140965</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140965</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Differentiated_Gland_Carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Dominant_Nerve</IRI>
        <Literal>ç”²çŠ¶è…ºæ”¯é…ç¥žç»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Dominant_Nerve</IRI>
        <Literal xml:lang="en">Nerve innervation of thyroid gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Dominant_Nerve</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001060</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Function_Tests</IRI>
        <Literal>ç”²çŠ¶è…ºåŠŸèƒ½æ£€æµ‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Function_Tests</IRI>
        <Literal xml:lang="en">Thyroid function tests (TFTs) is a collective term for blood tests used to check the function of the thyroid.[1]

TFTs may be requested if a patient is thought to suffer from hyperthyroidism (overactive thyroid) or hypothyroidism (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as atrial fibrillation and anxiety disorder.

A TFT panel typically includes thyroid hormones such as thyroid-stimulating hormone (TSH, thyrotropin) and thyroxine (T4), and triiodothyronine (T3) depending on local laboratory policy. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Function_Tests</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Thyroid_function_tests</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal>æœªåˆ†åŒ–åž‹ç”²çŠ¶è…º</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">C3878</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3878</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">ATC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Anaplastic thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Dedifferentiated Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Metaplastic Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Pleomorphic Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Sarcomatoid Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Anaplastic Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Carcinosarcoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Giant Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Metaplastic Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Pleomorphic Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Sarcomatoid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Spindle Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Undifferentiated (Anaplastic) Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated (Anaplastic) Thyroid Gland Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated (Anaplastic) Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">Undifferentiated Thyroid Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_Carcinoma</IRI>
        <Literal xml:lang="en">anaplastic thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A term that refers to the staging of thyroid gland anaplastic carcinoma, following the rules of the TNM AJCC v8 classification system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C141000</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141000</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Anaplastic_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Thyroid Gland Undifferentiated (Anaplastic) Carcinoma by AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">A disorder characterized by excessive levels of thyroid hormone in the body. Common causes include an overactive thyroid gland or thyroid hormone overdose.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal>ç”²çŠ¶è…ºç–¾ç—…</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">A non-neoplastic or neoplastic disorder that affects the thyroid gland.  Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">C26893</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C26893</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Thyroid Gland Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Thyroid Gland Diseases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Thyroid Gland Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Thyroid Gland disorders</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Disorder</IRI>
        <Literal xml:lang="en">Thyroid disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">A malignant neoplasia arising from follicular cells of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal>ç”²çŠ¶è…ºæ»¤æ³¡çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterize the thyroid gland papillary carcinoma are absent.  Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">C8054</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C8054</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">CARCINOMA, FOLLICULAR CELL, MALIGNANT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">FTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Adenocarcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Cancer of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Cancer of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Cancer of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Cancer of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Follicular thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Follicular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Follicular Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Follicular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Well-Differentiated Follicular Adenocarcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Well-Differentiated Follicular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Well-differentiated Follicular Adenocarcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">Well-differentiated Follicular Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma</IRI>
        <Literal xml:lang="en">follicular thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal>ç”²çŠ¶è…ºæ»¤æ³¡ä¸Šçš®ç»†èƒž</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal xml:lang="en">An epithelial cell lining the thyroid follicles.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal xml:lang="en">C33783</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C33783</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal xml:lang="en">Thyroid Follicular Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal xml:lang="en">Thyroid Gland Follicular Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Cell</IRI>
        <Literal xml:lang="en">thyroid follicular cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A term that refers to the staging of follicular thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C140987</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140987</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Thyroid Gland Follicular Carcinoma by AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal>å—œé…¸ç»†èƒžç˜¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">A follicular carcinoma of the thyroid gland, characterized by the presence of large cells with eosinophilic granular cytoplasm and pleomorphic nuclei with prominent, eosinophilic nucleoli.  The nuclear features that characterize the papillary carcinomas of the thyroid gland are absent.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">C4946</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C4946</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Hurthle Cell Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Hurthle Cell Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Hurthle Cell Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Hurthle Cell Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Hurthle_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Hurthle Cell Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal>å³¡éƒ¨</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">C32887</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C32887</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">Central(levels 6-7)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">THYROID GLAND ISTHMUS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">Thyroid Gland isthmus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Isthmus</IRI>
        <Literal xml:lang="en">isthmus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Cancer that develops in C cells of the thyroid. The C cells make a hormone (calcitonin) that helps maintain a healthy level of calcium in the blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal>ç”²çŠ¶è…ºé«“æ ·ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">A neuroendocrine carcinoma arising from the C-cells of the thyroid gland.  It is closely associated with multiple endocrine neoplasia syndromes.  Approximately 10% to 20% of medullary thyroid carcinomas are familial.  Patients usually present with a thyroid nodule that is painless and firm.  In the majority of cases nodal involvement is present at diagnosis.  Surgery is the preferred treatment for both primary lesions and recurrences.  This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">C3879</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3879</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">C Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">C-Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">CARCINOMA, C-CELL, MALIGNANT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">MTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Parafollicular Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Medullary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Neuroendocrine Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Medullary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_Carcinoma</IRI>
        <Literal xml:lang="en">medullary thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A term that refers to the staging of thyroid gland medullary carcinoma, following the rules of the TNM AJCC v8 classification system. Differentiated and anaplastic thyroid gland carcinomas are staged according to the classification for thyroid-differentiated and anaplastic carcinoma. (from AJCC 8th Ed.)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C14104</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C141042</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Medullary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Thyroid Gland Medullary Carcinoma by AJCC v8 Stage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Cancer that forms in follicular cells in the thyroid and grows in small finger-like shapes. It grows slowly, is more common in women than in men, and often occurs before age 45. It is the most common type of thyroid cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal>ç”²çŠ¶è…ºä¹³å¤´çŠ¶ç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">C4035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C4035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">PTC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Cancer of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Cancer of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Cancer of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Cancer of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma of Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma of Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma of the Thyroid</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Carcinoma of the Thyroid Gland</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Thyroid Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Thyroid Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Thyroid Carcinoma, NOS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Papillary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Papillary Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Papillary Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_Carcinoma</IRI>
        <Literal xml:lang="en">papillary thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">A term that refers to the staging of papillary thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">C140976</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C140976</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Papillary_carcinoma_by_AJCC_v8_Stage</IRI>
        <Literal xml:lang="en">Thyroid Gland Papillary Carcinoma by AJCC v8 Stage;Tumor Stage (Pathologic)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal>ç”²çŠ¶è…ºé³žçŠ¶ç»†èƒžç™Œ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">A rapidly growing primary carcinoma of the thyroid gland composed of malignant squamous cells.  The clinical course is usually aggressive.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">C46008</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C46008</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Squamous Cell Thyroid Gland Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Squamous_Cell_Carcinoma</IRI>
        <Literal xml:lang="en">Thyroid Gland Squamous Cell Carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal>å³¡éƒ¨åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal xml:lang="en">Surgery involving excision of the isthmus of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal xml:lang="en">C51737</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51737</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal xml:lang="en">Excision of Thyroid Isthmus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Isthmectomy</IRI>
        <Literal xml:lang="en">Thyroid Isthmectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Lateral_Lobectomy</IRI>
        <Literal>ç”²çŠ¶è…ºä¾§å¶åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Lateral_Lobectomy</IRI>
        <Literal xml:lang="en">Thyroid lobectomy typically includes removal of the thyroid isthmus and pyramidal lobe (if present)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Lateral_Lobectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323299879000369?scrollTo=%23hl0001826</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Remnant_Ablation</IRI>
        <Literal>æ¸…ç”²æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Remnant_Ablation</IRI>
        <Literal xml:lang="en">adioiodine ablation refers to the destruction of macroscopic functioning remnants of normal thyroid tissue remaining after subtotal thyroidectomy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Remnant_Ablation</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/book/3-s2.0-B9780323483193000043?scrollTo=%23hl0001355</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">A measurement of the thyrotropin receptor antibody in a biological specimen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal>ä¿ƒç”²çŠ¶è…ºæ¿€ç´ å—ä½“æŠ—ä½“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">The determination of the amount of thyroid stimulating hormone receptor antibody present in a sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">C122158</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C122158</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">TSHRAB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Stimulating Hormone Receptor Antibody</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">Thyroid Stimulating Hormone Receptor Antibody Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">Thyrotropin Receptor Antibody</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Stimulating_Hormone_Receptor_Antibody</IRI>
        <Literal xml:lang="en">Thyrotropin Receptor Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Structure</IRI>
        <Literal>ç”²çŠ¶è…ºç»“æž„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Structure</IRI>
        <Literal xml:lang="en">This gland is composed of right and left lobes and an isthmus and weighs âˆ¼20 grams. As with all endocrine glands, it is highly vascularized to supply nutrients for hormone synthesis and blood flow for hormone transport. The functional units of the gland are the follicles ( Fig. 28.2 ). The follicular cells secrete thyroglobulin (Tg), the glycoprotein precursor to TH, into the follicular lumen, and the colloid is composed of modified Tg. The follicular cells are surrounded by a layer of epithelial cells. Scattered between the follicles are parafollicular cells, which produce calcitonin , or â€œCâ€ cells (see â€œMain Sites of Calcium Regulationâ€ in Chapter 31 ). G proteinâ€“coupled receptors for thyroid-stimulating hormone (TSH) are found on the follicular cell basal membrane.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Structure</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323358194000285?scrollTo=%23hl0000077</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal>ç”²çŠ¶è…ºè½¬å½•å› å­</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Thyroid transcription factor 1 (371 aa, ~39 kDa) is encoded by the human NKX2-1 gene. This protein is involved in transcriptional regulation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">C73445</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C73445</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Homeobox protein NK-2 homolog A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Homeobox protein Nkx-2.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">NKX2-1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">TTF-1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Thyroid Transcription Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Thyroid Transcription Factor 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Transcription_Factor_1</IRI>
        <Literal xml:lang="en">Thyroid nuclear factor 1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal>ç”²çŠ¶è…ºåˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal xml:lang="en">Surgery to remover part or all of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal xml:lang="en">C51648</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51648</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal xml:lang="en">Thyroidectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroidectomy</IRI>
        <Literal xml:lang="en">thyroidectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroxine</IRI>
        <Literal>ç”²çŠ¶è…ºç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">A hormone synthesized and secreted by the thyroid gland containing four iodine atoms and is converted to triiodothyronine (T3) in the body, influencing metabolism and organ function.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">C2302</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroxine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2302</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">L-3,5,5&apos;-tetraiodothyronine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">T4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">Thyroxine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">thyroxin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroxine</IRI>
        <Literal xml:lang="en">thyroxine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ti-Rads_level</IRI>
        <Literal>Ti-Radsåˆ†çº§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ti-Rads_level</IRI>
        <Literal xml:lang="en">The ultrasound features in the ACR TI-RADS are categorized as benign, minimally suspicious, moderately suspicious, or highly suspicious for malignancy. The point total determines the noduleâ€™s ACR TI-RADS level, which ranges from TR1 (benign) to TR5 (high suspicion of malignancy).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ti-Rads_level</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S1546144017301862?scrollTo=%231-s2.0-S1546144017301862-gr1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal>å®Œå…¨è‚ å¤–è¥å…»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">Total parenteral nutrition formulated for intravenous administration in patients who cannot eat or cannot get enough nutrients from the foods they eat. It is a liquid mixture of proteins, carbohydrates, fats, vitamins, minerals and other nutrients.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">C29484</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C29484</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">TPN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">Total Parenteral Nutrition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">hyperalimentation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">parenteral nutrition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Parenteral_Nutrition</IRI>
        <Literal xml:lang="en">total parenteral nutrition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Total_Thyroidectomy</IRI>
        <Literal>ç”²çŠ¶è…ºå…¨åˆ‡é™¤æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Total_Thyroidectomy</IRI>
        <Literal xml:lang="en">Surgery involving the complete excision of the thyroid gland.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Total_Thyroidectomy</IRI>
        <Literal xml:lang="en">C51762</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Total_Thyroidectomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C51762</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Total_Thyroidectomy</IRI>
        <Literal xml:lang="en">Total Thyroidectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Trabecular_Architecture</IRI>
        <Literal>å°æ¢ç»“æž„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Trabecular_Architecture</IRI>
        <Literal xml:lang="en">Tumors with insular, solid, or trabecular architecture, but lacking other diagnostic features of poorly differentiated carcinoma, do not demonstrate such an aggressive behavior and therefore should not be considered as poorly differentiated</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Trabecular_Architecture</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">The fibrocartilaginous tube extending from the larynx to the bronchi.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Trachea</IRI>
        <Literal>æ°”ç®¡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">C12428</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Trachea</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C12428</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">TRACHEA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">Trachea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">Windpipe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">trachea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trachea</IRI>
        <Literal xml:lang="en">windpipe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tracheotomy</IRI>
        <Literal>æ°”ç®¡é€ å£æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">Creation of a surgical opening into the trachea.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">C15341</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tracheotomy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15341</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">Tracheostomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">Tracheostomy Procedure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">Tracheotomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tracheotomy</IRI>
        <Literal xml:lang="en">tracheostomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Trans-triiodothyronine</IRI>
        <Literal>åå¼ä¸‰ç¢˜ç”²çŠ¶è…ºåŽŸæ°¨é…¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Trans-triiodothyronine</IRI>
        <Literal xml:lang="en">Anti-triiodothyronine, also known as 3,3&apos;,5&apos;-triiodothyronine, is a thyroid hormone existing in normal human serum. It is produced by T4 Deiodinating an iodine in the tyrosine ring of liver, kidney, pituitary gland and myocardium through the inner ring deiodinase.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Trans-triiodothyronine</IRI>
        <Literal xml:lang="en">rT3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Transient_Neonatal_Hypoparathyroidism</IRI>
        <Literal>æš‚æ—¶æ€§ç”²çŠ¶æ—è…ºåŠŸèƒ½å‡é€€ç—‡</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Transient_Neonatal_Hypoparathyroidism</IRI>
        <Literal xml:lang="en">A disorder of decreased production of parathyroid hormone by the parathyroid gland in a newborn. It is due to maternal hyperparathyroidism. It may be characterized by hypocalcemic seizures in the first weeks of life.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Transient_Neonatal_Hypoparathyroidism</IRI>
        <Literal xml:lang="en">C114907</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Transient_Neonatal_Hypoparathyroidism</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C114907</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Transient_Neonatal_Hypoparathyroidism</IRI>
        <Literal xml:lang="en">Transient Neonatal Hypoparathyroidism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Treatment_of_Brain_Metastases</IRI>
        <Literal>è„‘è½¬ç§»çš„æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Treatment_of_Brain_Metastases</IRI>
        <Literal xml:lang="en">the treatment of brain metastases of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Treatment_of_Brain_Metastases</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0360301612017245</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">A measurement of the total (free and bound) triiodothyronine in a biological specimen.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal>ä¸‰ç¢˜ç”²çŠ¶è…ºåŽŸæ°¨é…¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">The determination of the amount of free and bound triiodothyronine present in a sample.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">C74747</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C74747</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">T3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">Total T3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">Triiodothyronine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Triiodothyronine</IRI>
        <Literal xml:lang="en">Triiodothyronine Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Capsule_Invasion</IRI>
        <Literal>è‚¿ç˜¤è¢«è†œæµ¸æ¶¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Capsule_Invasion</IRI>
        <Literal xml:lang="en">Most of the encapsulated follicular variant papillary carcinomas show no invasive growth, whereas in about one-third of cases tumor capsule invasion, vascular invasion, or both are found.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Capsule_Invasion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal>è‚¿ç˜¤åæ­»</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal xml:lang="en">A morphologic finding that indicates the presence of cells undergoing necrosis within a tumor.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal xml:lang="en">C35957</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35957</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal xml:lang="en">Tumor Cell Necrosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Cell_Necrosis</IRI>
        <Literal xml:lang="en">Tumor Necrosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal>å‡ç˜¤æ‰‹æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">The surgical removal of as much of a malignant tumor as is reasonably possible. This procedure increases the effectiveness of the subsequent administration of chemotherapy and/or radiation therapy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">C15749</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C15749</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">Debulking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">Debulking Procedure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">Tumor Debulking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">debulking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Debulking</IRI>
        <Literal xml:lang="en">tumor debulking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Enlargement</IRI>
        <Literal>è‚¿ç˜¤å¢žå¤§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Enlargement</IRI>
        <Literal xml:lang="en">typical phenotype features of thyroid cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Enlargement</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal>è‚¿ç˜¤æ ‡è®°ç‰©</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal xml:lang="en">A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal xml:lang="en">C17220</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17220</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal xml:lang="en">Tumor Marker</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal xml:lang="en">Tumor Markers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Marker</IRI>
        <Literal xml:lang="en">tumor marker</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Tumor_Vascular_Invasion</IRI>
        <Literal>è¡€ç®¡æµ¸æ¶¦</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Tumor_Vascular_Invasion</IRI>
        <Literal xml:lang="en">A term referring to the presence of tumor emboli or tumor masses within any circulatory vessel.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Tumor_Vascular_Invasion</IRI>
        <Literal xml:lang="en">C35939</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Tumor_Vascular_Invasion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C35939</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tumor_Vascular_Invasion</IRI>
        <Literal xml:lang="en">Tumor Vascular Invasion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Typical_Revision_Lateral_Neck_Dissection</IRI>
        <Literal>å…¸åž‹çš„é¢ˆä¾§åŒºæ·‹å·´ç»“æ¸…æ‰«ä¿®æ­£æ‰‹æœ¯</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Typical_Revision_Lateral_Neck_Dissection</IRI>
        <Literal xml:lang="en">Revision surgery for nodal recurrences in the neck represents the primary therapeutic option for patients, but does not come without risk. The most recent ATA guidelines attempt to balance the risk of locoregional advancing disease and that of the efficacy and morbidity of therapeutic intervention. 30 Recommendations for revision central neck dissection are to operate on nodal disease larger than 8 mm in the smallest dimension</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Typical_Revision_Lateral_Neck_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S1043181017301173</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#U1_normal</IRI>
        <Literal xml:lang="en">Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#U1_normal</IRI>
        <Literal>U1æ­£å¸¸</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#U1_normal</IRI>
        <Literal xml:lang="en">Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#U1_normal</IRI>
        <Literal xml:lang="en">C14165</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#U1_normal</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C14165</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U1_normal</IRI>
        <Literal xml:lang="en">NORMAL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U1_normal</IRI>
        <Literal xml:lang="en">Normal</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#U2_benign</IRI>
        <Literal>U2è‰¯æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">C14172</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#U2_benign</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C14172</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">BENIGN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">Benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">Negative for malignancy/normal/benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U2_benign</IRI>
        <Literal xml:lang="en">benign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal>U3æ¶æ€§å¯ç–‘æ€§ä¸ç¡®å®š</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal xml:lang="en">The margin satisfies none of the other categories or cannot be determined with confidence.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal xml:lang="en">C157672</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C157672</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal xml:lang="en">Indeterminate Nodule</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U3_indeterminate_equivocal</IRI>
        <Literal xml:lang="en">Indeterminate Nodule Type</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#U4_suspicious</IRI>
        <Literal>U4å¯ç–‘</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#U4_suspicious</IRI>
        <Literal xml:lang="en">An impression that something is possible or probable.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#U4_suspicious</IRI>
        <Literal xml:lang="en">C85902</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#U4_suspicious</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C85902</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U4_suspicious</IRI>
        <Literal xml:lang="en">Suspicion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#U5_Malignant</IRI>
        <Literal>U5æ¶æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">C14143</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#U5_Malignant</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C14143</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">MALIGNANT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">Malignant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#U5_Malignant</IRI>
        <Literal xml:lang="en">malignant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ultrasonography</IRI>
        <Literal>è¶…å£°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">C17230</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ultrasonography</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C17230</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">2-Dimensional Grayscale Ultrasound Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">2-Dimensional Ultrasound Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">2D-US</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">ULTRASOUND</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">US</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">Ultrasonography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">Ultrasound</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">Ultrasound Imaging</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">Ultrasound Test</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">Ultrasound, Medical</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">ultrasonography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ultrasonography</IRI>
        <Literal xml:lang="en">ultrasound</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Ultrasound_Characteristics</IRI>
        <Literal>è¶…å£°ç‰¹ç‚¹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Ultrasound_Characteristics</IRI>
        <Literal xml:lang="en">ultrasound characteristics of thyroid nodules that are associated with risk of cancer. The high-risk characteristics include nodules that are large, are hypoechoic, contain microcalcifications, have irregular borders, or are taller than they are wide. Ultrasound characteristics associated with a low risk of thyroid cancer include nodules with more cystic components and those that have clear borders or are spongiform. Ultrasound characteristics help to stratify the risk of thyroid cancer and are used to determine when fine-needle aspiration (FNA) biopsy is indicated</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Ultrasound_Characteristics</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323376914001415?scrollTo=%23hl0000069</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Unclear_Information</IRI>
        <Literal>ä¸æ˜Žç±»åž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Unclear_Information</IRI>
        <Literal xml:lang="en">Problem associated with ambiguous, confusing information.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Unclear_Information</IRI>
        <Literal xml:lang="en">C133644</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Unclear_Information</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C133644</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Unclear_Information</IRI>
        <Literal xml:lang="en">Unclear type</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Urine_Calcium</IRI>
        <Literal>å°¿é’™</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Urine_Calcium</IRI>
        <Literal xml:lang="en">A quantitative measurement of the total amount of calcium present in a sample of urine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Urine_Calcium</IRI>
        <Literal xml:lang="en">C61046</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Urine_Calcium</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61046</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Urine_Calcium</IRI>
        <Literal xml:lang="en">Urine Calcium Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Urine_Magnesium</IRI>
        <Literal>å°¿é•</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Urine_Magnesium</IRI>
        <Literal xml:lang="en">A quantitative measurement of the total amount of magnesium present in a sample of urine.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Urine_Magnesium</IRI>
        <Literal xml:lang="en">C61049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Urine_Magnesium</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61049</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Urine_Magnesium</IRI>
        <Literal xml:lang="en">Urine Magnesium Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VEGF-Directed_Kinase_Inhibitor_Therapy</IRI>
        <Literal>VEGFä»‹å¯¼çš„æ¿€é…¶æŠ‘åˆ¶å‰‚æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#VEGF-Directed_Kinase_Inhibitor_Therapy</IRI>
        <Literal xml:lang="en">antibodies (antiâ€“vascular endothelial growth factor [VEGF]) should be considered as therapy of ATC.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#VEGF-Directed_Kinase_Inhibitor_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323476744000682?scrollTo=%23hl0001679</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VII_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIIåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#VII_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">The central neck includes lymph nodes in level VI and superior mediastinal nodes (previously referred to as level VII).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#VII_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781455746965001238?scrollTo=%23hl0001692</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VI_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#VI_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Central compartment (level VI) neck dissection should be considered in patients with papillary thyroid carcinoma and suspected HÃ¼rthle cell carcinoma.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#VI_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781455746965001238?scrollTo=%23hl0000804</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VIa_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIaåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VIb_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIbåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VIc_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIcåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VId_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIdåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#VIe_Level_Lymph_Node_Dissection</IRI>
        <Literal>VIeåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#V_Level_Lymph_Node_Dissection</IRI>
        <Literal>VåŒºæ·‹å·´ç»“æ¸…æ‰«</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#V_Level_Lymph_Node_Dissection</IRI>
        <Literal xml:lang="en">Level V is the posterior triangle group, which includes lymph nodes around the lower portion of the spinal accessory nerve and along the transverse cervical vessels. It is bounded by the triangle formed by the clavicle, the posterior border of the sternocleidomastoid muscle, and the anterior border of the trapezius muscle.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#V_Level_Lymph_Node_Dissection</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323415187000110?scrollTo=%23hl0001552</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Vandetanib</IRI>
        <Literal>å‡¡å¾·ä»–å°¼</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">C2737</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Vandetanib</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C2737</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">AZD6474</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">Caprelsa</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">VANDETANIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">Vandetanib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">ZD-6474</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">ZD6474</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">Zactima</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vandetanib</IRI>
        <Literal xml:lang="en">vandetanib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Venous</IRI>
        <Literal>é™è„‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Venous</IRI>
        <Literal xml:lang="en">Of, or pertaining to, or contained in, or performing the function of the veins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Venous</IRI>
        <Literal xml:lang="en">C25291</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Venous</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C25291</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Venous</IRI>
        <Literal xml:lang="en">Venous</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Very_low_suspicion</IRI>
        <Literal>éžå¸¸ä½Žåº¦å¯ç–‘æ¶æ€§</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Very_low_suspicion</IRI>
        <Literal xml:lang="en">Spongiform or partially cystic nodules without any of the sonographic features described in low, intermediate, or high suspicion patterns</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Very_low_suspicion</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0002961017313673?scrollTo=%23tbl1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal>å£°å¸¦éº»ç—¹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal xml:lang="en">Paralysis of the muscles of one or both vocal cords. Signs and symptoms include hoarseness, weak voice, dyspnea, and coughing. Affected individuals are at risk for aspiration pneumonia.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal xml:lang="en">C47814</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C47814</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal xml:lang="en">Vocal Cord Palsy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vocal_Cord_Paralysis</IRI>
        <Literal xml:lang="en">Vocal Cord Paralysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal>æ˜Žæ˜¾çš„å£°éŸ³æ”¹å˜</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal xml:lang="en">Change in the sound and/or speed of the voice. Causes include laryngeal polyp, laryngitis, laryngeal carcinoma, throat carcinoma, Parkinson&apos;s disease, multiple sclerosis, stroke, hypothyroidism, oral surgery, tracheostomy, tracheal injury, and laryngeal injury.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal xml:lang="en">C61043</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C61043</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal xml:lang="en">Change in Voice</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal xml:lang="en">Voice Alteration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Voice_Alteration</IRI>
        <Literal xml:lang="en">Voice alteration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Voice_Assessment</IRI>
        <Literal>è¯­éŸ³è¯„ä¼°</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Voice_Assessment</IRI>
        <Literal xml:lang="en">A voice assessment is used to identify the cause, symptoms and impact of the voice disorder. It can be used by the speech and language therapist with any child who is having difficulty with their voice. Speech and language therapists can use the information from the assessment to create individual therapy programmes that help the child to use their voice appropriately as well as providing them with advice and techniques on how to stop their voice disorder from reoccurring or worsening.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Voice_Assessment</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.sltforkids.co.uk/speech-clinic/services/assessments/voice-assessment/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Vomiting</IRI>
        <Literal>å‘•å</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">Forceful ejection of the contents of the stomach through the mouth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">C3442</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Vomiting</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3442</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">Emesis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">Vomiting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">emesis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Vomiting</IRI>
        <Literal xml:lang="en">vomit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Weight_Loss</IRI>
        <Literal>ä½“é‡ä¸‹é™</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Weight_Loss</IRI>
        <Literal xml:lang="en">A reduction in total body weight.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Weight_Loss</IRI>
        <Literal xml:lang="en">C3445</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Weight_Loss</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C3445</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Weight_Loss</IRI>
        <Literal xml:lang="en">Weight Decrease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Weight_Loss</IRI>
        <Literal xml:lang="en">Weight Loss</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Weight_Loss</IRI>
        <Literal xml:lang="en">Weight loss</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Whole-Body_Scintigraphy</IRI>
        <Literal>å…¨èº«æ”¾å°„æ´»æ€§ç¢˜ç´ æ‰«æ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Whole-Body_Scintigraphy</IRI>
        <Literal xml:lang="en">A diagnostic technique which produces a two- dimensional image of a desired anatomical structure or region with the use of radionuclides.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Whole-Body_Scintigraphy</IRI>
        <Literal xml:lang="en">C19565</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Whole-Body_Scintigraphy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C19565</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Whole-Body_Scintigraphy</IRI>
        <Literal xml:lang="en">Whole-Body Scintigraphy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#codon_634</IRI>
        <Literal>å¯†ç å­634</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#codon_634</IRI>
        <Literal xml:lang="en">Common mutation sites in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#codon_634</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#codon_883</IRI>
        <Literal>å¯†ç å­883</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#codon_883</IRI>
        <Literal xml:lang="en">Common mutation sites in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#codon_883</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#exon_10</IRI>
        <Literal>å¤–æ˜¾å­10</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#exon_10</IRI>
        <Literal xml:lang="en">Common mutation exon loci in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#exon_10</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#exon_15</IRI>
        <Literal>å¤–æ˜¾å­15</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#exon_15</IRI>
        <Literal xml:lang="en">Common mutation exon loci in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#exon_15</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#exon_16</IRI>
        <Literal>å¤–æ˜¾å­16</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#exon_16</IRI>
        <Literal xml:lang="en">Common mutation exon loci in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#exon_16</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#rh_TSH_Stimulated_Serum_Thyroglobulin</IRI>
        <Literal>ä¿ƒç”²çŠ¶è…ºç´ åˆºæ¿€ä¸‹çš„è¡€æ¸…ç”²çŠ¶è…ºçƒè›‹ç™½</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#rh_TSH_Stimulated_Serum_Thyroglobulin</IRI>
        <Literal xml:lang="en">Recombinant human (rh)TSH is a valid alternative to thyroid hormone withdrawal (THW) in the follow-up of patients who have received previous surgery for papillary or follicular thyroid cancer (differentiated thyroid cancer-DTC) [1 2] . RhTSH produces effective thyroid stimulation, is safe and avoids hypothyroidism-related side effects.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#rh_TSH_Stimulated_Serum_Thyroglobulin</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www-clinicalkey-com.rpa.skh.org.tw/#!/content/journal/1-s2.0-S0753332207000856</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#131I-labeled_Bivalent_Hapten</IRI>
        <Literal>ç¢˜131æ ‡è®°çš„äºŒä»·åŠæŠ—åŽŸ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#131I-labeled_Bivalent_Hapten</IRI>
        <Literal xml:lang="en">a 131 I-labeled bivalent hapten in patients with metastatic progressive MTC (defined with Ct doubling time  2 years), overall survival was significantly longer compared to high-risk untreated historical controls</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#131I-labeled_Bivalent_Hapten</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821456/</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#131I_Treatment</IRI>
        <Literal>ç¢˜131æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#131I_Treatment</IRI>
        <Literal xml:lang="en">Radioiodine therapy is a nuclear medicine treatment for an overactive thyroid, a condition called hyperthyroidism, and also may be used to treat thyroid cancer.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#131I_Treatment</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.radiologyinfo.org/en/info.cfm?pg=radioiodine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#131I_Treatment</IRI>
        <Literal xml:lang="en">131I therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#25-OH-Vitamin_D</IRI>
        <Literal>25-ç¾Ÿç»´ç”Ÿç´ D</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#25-OH-Vitamin_D</IRI>
        <Literal xml:lang="en">Calcifediol, also known as calcidiol, 25-hydroxycholecalciferol, or 25-hydroxyvitamin D (abbreviated 25(OH)D),[1] is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Physicians worldwide measure this metabolite to determine a patient&apos;s vitamin D status.[2][3] At a typical daily intake of vitamin D3, its full conversion to calcifediol takes approximately 7 days.(Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#25-OH-Vitamin_D</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Calcifediol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#CDISC_definition"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased. (NCI)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal>ä¸‰ç»´é€‚å½¢æ”¾å°„æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">C16035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C16035</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3-Dimensional Conformal Radiation Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3-dimensional conformal radiation therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3-dimensional radiation therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3D CONFORMAL RADIATION THERAPY</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3D CRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">3D-CRT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Conformal Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#3-Dimensional_Conformal_Radiation_Therapy</IRI>
        <Literal xml:lang="en">Radiation Conformal Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal>åŒç‰¹å¼‚æ€§å•å…‹éš†æŠ—ä½“</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal xml:lang="en">A bispecific monoclonal antibody (BsMAb) consisting of the Fab fragment of an anti-CEA monoclonal antibody (F6) coupled to the Fab fragment of an anti-DTPA-In monoclonal antibody (734) with potential radioimmunotherapeutic activity. In a two-step pretargeted radioimmunotherapeutic approach, this BsMAb, localizing to CEA-expressing tumor cells via the F6 Fab fragment, is introduced into patient first, followed by injection of indium 131-radiolabeled DTPA, which is recognized by the 734 Fab fragment of the BsMAb. Accordingly, a potentially lethal dose of indium 131 is delivered specifically to CEA-expressing tumor cells while minimizing radiotoxicity to normal tissues. CEA (carcinoembryonic antigen) is a tumor antigen overexpressed in many cancer types, including gastrointestinal, breast, non-small cell lung, and thyroid cancers. DTPA (diethylenetriaminepentaacetic acid) is a bivalent hapten.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal xml:lang="en">C68927</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C68927</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal xml:lang="en">Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anti-CEA/Anti-DTPA-In_(F6-734)_Bispecific_Antibody</IRI>
        <Literal xml:lang="en">F6-734 BsMAb</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal>å‰¯ç¥žç»æŸä¼¤</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">C58450</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C58450</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">Cranial Nerve XI Intra-Operative Injury, CTCAE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cranial_Nerve_XI_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">NERVES: CN XI (spinal accessory) intra-operative injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal>é¾‹é½¿</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal xml:lang="en">A disorder characterized by the decay of a tooth, in which it becomes softened, discolored and/or porous.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal xml:lang="en">C143402</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C143402</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal xml:lang="en">Dental Caries</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dental_Caries,_CTCAE</IRI>
        <Literal xml:lang="en">Dental Caries, CTCAE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Grossly_Negative_Margins_(R1_resection)</IRI>
        <Literal>å¤§ä½“åˆ‡ç¼˜é˜´æ€§ï¼ˆR1åˆ‡é™¤ï¼‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Grossly_Negative_Margins_(R1_resection)</IRI>
        <Literal xml:lang="en">R1 - cancer cells present microscopically at the resection margin (microscopic positive margin)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Grossly_Negative_Margins_(R1_resection)</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Resection_margin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Injection_(medicine)</IRI>
        <Literal>æ³¨å°„</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Injection_(medicine)</IRI>
        <Literal xml:lang="en">Injection (often referred to as a &quot;shot&quot; in US English, or a &quot;jab&quot; in UK English) is the act of putting a liquid, especially a drug, into a person&apos;s body using a needle (usually a hypodermic needle) and a syringe.[1] Injection is a technique for delivering drugs by parenteral administration, that is, administration via a route other than through the digestive tract. Parenteral injection includes subcutaneous, intramuscular, intravenous, intraperitoneal, intracardiac, intraarticular, and intracavernous injection.

Injection is generally administered as a bolus, but can possibly be used for continuous drug administration as well.[2] Even when administered as a bolus, the medication may be long-acting, and can then be called depot injection. Administration by an indwelling catheter is generally preferred instead of injection in case of more long-term or recurrent drug administration.

Injections are among the most common health care procedures, with at least 16 billion administered in developing and transitional countries each year.[3] 95% of injections are administered in curative care, 3% are for immunization, and the rest for other purposes, such as blood transfusions.[3] In some instances the term injection is used synonymously with inoculation even by different workers in the same hospital. This should not cause confusion; the focus is on what is being injected/inoculated, not the terminology of the procedure.

Since the process inherently involves a small puncture wound to the body (with varying degrees of pain depending on injection type and location, medication type, needle gauge, the skill of the individual administering the injection and the sensitivity of who is being injected), fear of needles is a common phobia. (Wikipedia)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Injection_(medicine)</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://en.wikipedia.org/wiki/Injection_(medicine)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Pankeratin(AE1/AE3)</IRI>
        <Literal>èƒ°æ¶²ç´ </Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Pankeratin(AE1/AE3)</IRI>
        <Literal xml:lang="en">Keratin cocktail that detects CK1 - 8, 10, 14 - 16 and 19, but does not detect CK17 or CK18 ;Often referred to in literature as &quot;keratin&quot; or &quot;pankeratin&quot;, although this may also refer to Cytokeratin MNF116 ;May cross react with GFAP, leading to aberrant staining of glial tumors (ependymoma, glioblastoma, schwannoma, Mod Pathol 2006;19:115) ;Note: staining pattern of cocktail may be different than staining pattern of AE1 and AE3 separately, due to different pretreatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Pankeratin(AE1/AE3)</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">http://www.pathologyoutlines.com/topic/stainsae1ae3.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal>ç£·è„‚é…°è‚Œé†‡-3-ç¾Ÿæ¿€é…¶</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V(D)J recombination and cell cycle checkpoints. (from LocusLink)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">C17270</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">1-Phosphatidylinositol 3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">EC 2.7.1.153</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">PI 3 Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">PI3 Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">PI3 kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">PI3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">PI3K</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Phosphatidylinositide 3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Phosphatidylinositol 3 Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Phosphatidylinositol 3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Phosphatidylinositol-3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Phosphatidylinositol-4,5-Bisphosphate 3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Type I Phosphatidylinositol Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">Type III Phosphoinositide 3-Kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Phosphatidylinositol-4,5-Bisphosphate_3-Kinase</IRI>
        <Literal xml:lang="en">phosphatidylinositol-3 kinase</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Salivary_Gland_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal>å”¾æ¶²è…ºç ´å</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Salivary_Gland_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">C59083</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Salivary_Gland_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C59083</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Salivary_Gland_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">Salivary Gland Intra-Operative Injury, CTCAE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Salivary_Gland_Intra-Operative_Injury,_CTCAE</IRI>
        <Literal xml:lang="en">Salivary gland intra-operative injury</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal>18æ°Ÿè„±æ°§è‘¡è„ç³–æ‰«æ</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">Positron emission tomography combined with computed tomography of the whole body with the use of the contrast agent sodium fluoride F 18 (18F-NaF) to enhance the image.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">C137906</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C137906</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">18F-NaF Whole-body PET/CT Scan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">NaF PET/CT WB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">PET/CT, Whole Body, Sodium Fluoride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">Sodium Fluoride Positron Emission Tomography/Computed Tomography of the Whole Body</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">Sodium Fluoride WB PET-CT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">WB PET/CT Scan with Sodium Fluoride</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">Whole Body 18F-NaF Positron Emission Tomography/Computed Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Sodium_Fluoride_Positron_Emission_Tomography/Computed_Tomography_of_the_Whole_Body</IRI>
        <Literal xml:lang="en">Whole Body Sodium Fluoride Positron Emission Tomography/Computed Tomography</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal>å¾®å°æµ¸æ¶¦åž‹ï¼ˆè¢«å›Šåž‹ï¼‰</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal xml:lang="en">A follicular carcinoma of the thyroid gland which shows capsular invasion only.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal xml:lang="en">C65200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C65200</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal xml:lang="en">FTC,Minimally Invasive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Minimally_Invasive</IRI>
        <Literal xml:lang="en">Thyroid Carcinoma,Minimally Invasive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal>å¹¿æ³›æµ¸æ¶¦åž‹</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal xml:lang="en">A follicular carcinoma of the thyroid gland with extension into surrounding thyroid or extrathyroid tissues.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#NCI_code"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal xml:lang="en">C156123</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C156123</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal xml:lang="en">FTC,Widely Invsive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Thyroid_Gland_Follicular_Carcinoma,_Widely_Invasive</IRI>
        <Literal xml:lang="en">Thyroid Gland Follicular Carcinomaï¼ŒWidely Invasive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#codon_918_(M918T)</IRI>
        <Literal>å¯†ç å­918</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#codon_918_(M918T)</IRI>
        <Literal xml:lang="en">Common mutation sites in medullary thyroid carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#codon_918_(M918T)</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#ligandâ€“directed_agent_denosumab</IRI>
        <Literal>é…ä½“å®šå‘åœ°è¯ºå•æŠ—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#ligandâ€“directed_agent_denosumab</IRI>
        <Literal xml:lang="en">the RANK ligandâ€“directed agent denosumab have been shown to delay time to occurrence of subsequent skeletal-related adverse events (fracture, pain, neurologic complications) and to improve symptoms, and these agents may provide benefits for patient with diffuse bonemetastases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#ligandâ€“directed_agent_denosumab</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#ChineseLabel"/>
        <IRI>#rhTSH_(Thyrogen)-Mediated_131I_Therapy</IRI>
        <Literal>é‡ç»„äººç”²çŠ¶è…ºä¿ƒæ¿€ç´ ï¼ˆç”²çŠ¶è…ºç´ ï¼‰ä»‹å¯¼çš„ç¢˜131æ²»ç–—</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#Definition"/>
        <IRI>#rhTSH_(Thyrogen)-Mediated_131I_Therapy</IRI>
        <Literal xml:lang="en">There are currently insufficient outcome data to recommend rhTSH-mediated therapy for all patients with distant metastatic disease being treated with 131I.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#URL"/>
        <IRI>#rhTSH_(Thyrogen)-Mediated_131I_Therapy</IRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#anyURI">https://www.liebertpub.com/doi/full/10.1089/thy.2015.0020?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</Literal>
    </AnnotationAssertion>
</Ontology>



<!-- Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi -->

